id	sid	tid	token	lemma	pos
bam-10847	1	1	p53	p53	NOUN
bam-10847	1	2	mutant	mutant	NOUN
bam-10847	1	3	-	-	PUNCT
bam-10847	1	4	type	type	NOUN
bam-10847	1	5	in	in	ADP
bam-10847	1	6	oral	oral	ADJ
bam-10847	1	7	squamous	squamous	ADJ
bam-10847	1	8	cell	cell	NOUN
bam-10847	1	9	carcinoma	carcinoma	NOUN
bam-10847	1	10	eur	eur	PROPN
bam-10847	1	11	j	j	PROPN
bam-10847	1	12	transl	transl	PROPN
bam-10847	1	13	myol	myol	ADV
bam-10847	1	14	33	33	NUM
bam-10847	1	15	(	(	PUNCT
bam-10847	1	16	1	1	NUM
bam-10847	1	17	)	)	PUNCT
bam-10847	1	18	10847	10847	NUM
bam-10847	1	19	,	,	PUNCT
bam-10847	1	20	2023	2023	NUM
bam-10847	1	21	doi	doi	NOUN
bam-10847	1	22	:	:	PUNCT
bam-10847	1	23	10.4081	10.4081	NUM
bam-10847	1	24	/	/	SYM
bam-10847	1	25	ejtm.2023.10847	ejtm.2023.10847	PROPN
bam-10847	1	26	1	1	NUM
bam-10847	1	27	immunoexpression	immunoexpression	NOUN
bam-10847	1	28	of	of	ADP
bam-10847	1	29	p53	p53	NOUN
bam-10847	1	30	mutant	mutant	NOUN
bam-10847	1	31	-	-	PUNCT
bam-10847	1	32	type	type	NOUN
bam-10847	1	33	in	in	ADP
bam-10847	1	34	iranian	iranian	ADJ
bam-10847	1	35	patients	patient	NOUN
bam-10847	1	36	with	with	ADP
bam-10847	1	37	primary	primary	ADJ
bam-10847	1	38	and	and	CCONJ
bam-10847	1	39	recurrence	recurrence	NOUN
bam-10847	1	40	oral	oral	ADJ
bam-10847	1	41	squamous	squamous	ADJ
bam-10847	1	42	cell	cell	NOUN
bam-10847	1	43	carcinoma	carcinoma	NOUN
bam-10847	1	44	hossein	hossein	PROPN
bam-10847	1	45	daneste	daneste	PROPN
bam-10847	1	46	(	(	PUNCT
bam-10847	1	47	1	1	NUM
bam-10847	1	48	)	)	PUNCT
bam-10847	1	49	,	,	PUNCT
bam-10847	1	50	azita	azita	NOUN
bam-10847	1	51	sadeghzadeh	sadeghzadeh	NOUN
bam-10847	1	52	(	(	PUNCT
bam-10847	1	53	2	2	NUM
bam-10847	1	54	)	)	PUNCT
bam-10847	1	55	,	,	PUNCT
bam-10847	1	56	maral	maral	ADJ
bam-10847	1	57	mokhtari	mokhtari	NOUN
bam-10847	1	58	(	(	PUNCT
bam-10847	1	59	3	3	NUM
bam-10847	1	60	)	)	PUNCT
bam-10847	1	61	,	,	PUNCT
bam-10847	1	62	hossein	hossein	PROPN
bam-10847	1	63	mohammadkhani	mohammadkhani	PROPN
bam-10847	1	64	(	(	PUNCT
bam-10847	1	65	1	1	NUM
bam-10847	1	66	)	)	PUNCT
bam-10847	1	67	,	,	PUNCT
bam-10847	1	68	fatemeh	fatemeh	VERB
bam-10847	1	69	lavaee	lavaee	ADV
bam-10847	1	70	(	(	PUNCT
bam-10847	1	71	2	2	NUM
bam-10847	1	72	)	)	PUNCT
bam-10847	1	73	,	,	PUNCT
bam-10847	1	74	javad	javad	PROPN
bam-10847	1	75	moayedi	moayedi	PROPN
bam-10847	1	76	(	(	PUNCT
bam-10847	1	77	4	4	NUM
bam-10847	1	78	)	)	PUNCT
bam-10847	1	79	(	(	PUNCT
bam-10847	1	80	1	1	X
bam-10847	1	81	)	)	PUNCT
bam-10847	1	82	department	department	NOUN
bam-10847	1	83	of	of	ADP
bam-10847	1	84	oral	oral	ADJ
bam-10847	1	85	and	and	CCONJ
bam-10847	1	86	maxillofacial	maxillofacial	ADJ
bam-10847	1	87	surgery	surgery	NOUN
bam-10847	1	88	,	,	PUNCT
bam-10847	1	89	school	school	NOUN
bam-10847	1	90	of	of	ADP
bam-10847	1	91	dentistry	dentistry	NOUN
bam-10847	1	92	,	,	PUNCT
bam-10847	1	93	shiraz	shiraz	PROPN
bam-10847	1	94	university	university	PROPN
bam-10847	1	95	of	of	ADP
bam-10847	1	96	medical	medical	ADJ
bam-10847	1	97	sciences	sciences	PROPN
bam-10847	1	98	,	,	PUNCT
bam-10847	1	99	shiraz	shiraz	PROPN
bam-10847	1	100	,	,	PUNCT
bam-10847	1	101	iran	iran	PROPN
bam-10847	1	102	;	;	PUNCT
bam-10847	1	103	(	(	PUNCT
bam-10847	1	104	2	2	X
bam-10847	1	105	)	)	PUNCT
bam-10847	1	106	oral	oral	ADJ
bam-10847	1	107	and	and	CCONJ
bam-10847	1	108	dental	dental	ADJ
bam-10847	1	109	disease	disease	NOUN
bam-10847	1	110	research	research	NOUN
bam-10847	1	111	center	center	NOUN
bam-10847	1	112	,	,	PUNCT
bam-10847	1	113	department	department	NOUN
bam-10847	1	114	of	of	ADP
bam-10847	1	115	oral	oral	ADJ
bam-10847	1	116	and	and	CCONJ
bam-10847	1	117	maxillofacial	maxillofacial	ADJ
bam-10847	1	118	medicine	medicine	NOUN
bam-10847	1	119	,	,	PUNCT
bam-10847	1	120	school	school	NOUN
bam-10847	1	121	of	of	ADP
bam-10847	1	122	dentistry	dentistry	NOUN
bam-10847	1	123	,	,	PUNCT
bam-10847	1	124	shiraz	shiraz	PROPN
bam-10847	1	125	university	university	PROPN
bam-10847	1	126	of	of	ADP
bam-10847	1	127	medical	medical	ADJ
bam-10847	1	128	sciences	sciences	PROPN
bam-10847	1	129	,	,	PUNCT
bam-10847	1	130	shiraz	shiraz	PROPN
bam-10847	1	131	,	,	PUNCT
bam-10847	1	132	iran	iran	PROPN
bam-10847	1	133	;	;	PUNCT
bam-10847	1	134	(	(	PUNCT
bam-10847	1	135	3	3	X
bam-10847	1	136	)	)	PUNCT
bam-10847	1	137	department	department	NOUN
bam-10847	1	138	of	of	ADP
bam-10847	1	139	pathology	pathology	PROPN
bam-10847	1	140	,	,	PUNCT
bam-10847	1	141	school	school	NOUN
bam-10847	1	142	of	of	ADP
bam-10847	1	143	medicine	medicine	NOUN
bam-10847	1	144	,	,	PUNCT
bam-10847	1	145	shiraz	shiraz	PROPN
bam-10847	1	146	university	university	PROPN
bam-10847	1	147	of	of	ADP
bam-10847	1	148	medical	medical	ADJ
bam-10847	1	149	sciences	sciences	PROPN
bam-10847	1	150	,	,	PUNCT
bam-10847	1	151	shiraz	shiraz	PROPN
bam-10847	1	152	,	,	PUNCT
bam-10847	1	153	iran	iran	PROPN
bam-10847	1	154	;	;	PUNCT
bam-10847	1	155	(	(	PUNCT
bam-10847	1	156	4	4	X
bam-10847	1	157	)	)	PUNCT
bam-10847	1	158	center	center	NOUN
bam-10847	1	159	of	of	ADP
bam-10847	1	160	comparative	comparative	ADJ
bam-10847	1	161	and	and	CCONJ
bam-10847	1	162	experimental	experimental	ADJ
bam-10847	1	163	medicine	medicine	NOUN
bam-10847	1	164	,	,	PUNCT
bam-10847	1	165	shiraz	shiraz	PROPN
bam-10847	1	166	university	university	PROPN
bam-10847	1	167	of	of	ADP
bam-10847	1	168	medical	medical	ADJ
bam-10847	1	169	sciences	sciences	PROPN
bam-10847	1	170	,	,	PUNCT
bam-10847	1	171	shiraz	shiraz	PROPN
bam-10847	1	172	,	,	PUNCT
bam-10847	1	173	iran	iran	PROPN
bam-10847	1	174	.	.	PUNCT
bam-10847	2	1	this	this	DET
bam-10847	2	2	article	article	NOUN
bam-10847	2	3	is	be	AUX
bam-10847	2	4	distributed	distribute	VERB
bam-10847	2	5	under	under	ADP
bam-10847	2	6	the	the	DET
bam-10847	2	7	terms	term	NOUN
bam-10847	2	8	of	of	ADP
bam-10847	2	9	the	the	DET
bam-10847	2	10	creative	creative	ADJ
bam-10847	2	11	commons	common	NOUN
bam-10847	2	12	attribution	attribution	NOUN
bam-10847	2	13	noncommercial	noncommercial	ADJ
bam-10847	2	14	license	license	NOUN
bam-10847	2	15	(	(	PUNCT
bam-10847	2	16	cc	cc	NOUN
bam-10847	2	17	by	by	ADP
bam-10847	2	18	-	-	PUNCT
bam-10847	2	19	nc	nc	PROPN
bam-10847	2	20	4.0	4.0	NUM
bam-10847	2	21	)	)	PUNCT
bam-10847	2	22	which	which	PRON
bam-10847	2	23	permits	permit	VERB
bam-10847	2	24	any	any	DET
bam-10847	2	25	noncommercial	noncommercial	ADJ
bam-10847	2	26	use	use	NOUN
bam-10847	2	27	,	,	PUNCT
bam-10847	2	28	distribution	distribution	NOUN
bam-10847	2	29	,	,	PUNCT
bam-10847	2	30	and	and	CCONJ
bam-10847	2	31	reproduction	reproduction	NOUN
bam-10847	2	32	in	in	ADP
bam-10847	2	33	any	any	DET
bam-10847	2	34	medium	medium	NOUN
bam-10847	2	35	,	,	PUNCT
bam-10847	2	36	provided	provide	VERB
bam-10847	2	37	the	the	DET
bam-10847	2	38	original	original	ADJ
bam-10847	2	39	author(s	author(s	NOUN
bam-10847	2	40	)	)	PUNCT
bam-10847	2	41	and	and	CCONJ
bam-10847	2	42	source	source	NOUN
bam-10847	2	43	are	be	AUX
bam-10847	2	44	credited	credit	VERB
bam-10847	2	45	.	.	PUNCT
bam-10847	3	1	abstract	abstract	ADJ
bam-10847	3	2	mutations	mutation	NOUN
bam-10847	3	3	in	in	ADP
bam-10847	3	4	tumor	tumor	NOUN
bam-10847	3	5	suppressor	suppressor	NOUN
bam-10847	3	6	p53	p53	NOUN
bam-10847	3	7	protein	protein	NOUN
bam-10847	3	8	can	can	AUX
bam-10847	3	9	occur	occur	VERB
bam-10847	3	10	at	at	ADP
bam-10847	3	11	different	different	ADJ
bam-10847	3	12	phases	phase	NOUN
bam-10847	3	13	of	of	ADP
bam-10847	3	14	malignant	malignant	ADJ
bam-10847	3	15	transformation	transformation	NOUN
bam-10847	3	16	and	and	CCONJ
bam-10847	3	17	affect	affect	VERB
bam-10847	3	18	the	the	DET
bam-10847	3	19	patient	patient	NOUN
bam-10847	3	20	's	's	PART
bam-10847	3	21	prognosis	prognosis	NOUN
bam-10847	3	22	.	.	PUNCT
bam-10847	4	1	this	this	DET
bam-10847	4	2	study	study	NOUN
bam-10847	4	3	aimed	aim	VERB
bam-10847	4	4	to	to	PART
bam-10847	4	5	evaluate	evaluate	VERB
bam-10847	4	6	the	the	DET
bam-10847	4	7	expression	expression	NOUN
bam-10847	4	8	of	of	ADP
bam-10847	4	9	mutant	mutant	ADJ
bam-10847	4	10	p53	p53	NOUN
bam-10847	4	11	protein	protein	NOUN
bam-10847	4	12	in	in	ADP
bam-10847	4	13	iranian	iranian	ADJ
bam-10847	4	14	patients	patient	NOUN
bam-10847	4	15	with	with	ADP
bam-10847	4	16	the	the	DET
bam-10847	4	17	primary	primary	ADJ
bam-10847	4	18	and	and	CCONJ
bam-10847	4	19	recurrence	recurrence	NOUN
bam-10847	4	20	oral	oral	ADJ
bam-10847	4	21	squamous	squamous	ADJ
bam-10847	4	22	cell	cell	NOUN
bam-10847	4	23	carcinoma	carcinoma	NOUN
bam-10847	4	24	(	(	PUNCT
bam-10847	4	25	oscc	oscc	ADJ
bam-10847	4	26	)	)	PUNCT
bam-10847	4	27	.	.	PUNCT
bam-10847	5	1	this	this	DET
bam-10847	5	2	retrospective	retrospective	ADJ
bam-10847	5	3	cross	cross	ADJ
bam-10847	5	4	-	-	ADJ
bam-10847	5	5	sectional	sectional	ADJ
bam-10847	5	6	study	study	NOUN
bam-10847	5	7	conducted	conduct	VERB
bam-10847	5	8	on	on	ADP
bam-10847	5	9	a	a	DET
bam-10847	5	10	group	group	NOUN
bam-10847	5	11	of	of	ADP
bam-10847	5	12	patients	patient	NOUN
bam-10847	5	13	with	with	ADP
bam-10847	5	14	the	the	DET
bam-10847	5	15	primary	primary	ADJ
bam-10847	5	16	oscc	oscc	PROPN
bam-10847	5	17	(	(	PUNCT
bam-10847	5	18	n=122	n=122	NUM
bam-10847	5	19	)	)	PUNCT
bam-10847	5	20	and	and	CCONJ
bam-10847	5	21	the	the	DET
bam-10847	5	22	control	control	NOUN
bam-10847	5	23	subjects	subject	NOUN
bam-10847	5	24	with	with	ADP
bam-10847	5	25	oral	oral	ADJ
bam-10847	5	26	noncancerous	noncancerous	ADJ
bam-10847	5	27	reactive	reactive	ADJ
bam-10847	5	28	lesions	lesion	NOUN
bam-10847	5	29	(	(	PUNCT
bam-10847	5	30	n=80	n=80	NOUN
bam-10847	5	31	)	)	PUNCT
bam-10847	5	32	.	.	PUNCT
bam-10847	6	1	immunohistochemistry	immunohistochemistry	PROPN
bam-10847	6	2	was	be	AUX
bam-10847	6	3	performed	perform	VERB
bam-10847	6	4	with	with	ADP
bam-10847	6	5	the	the	DET
bam-10847	6	6	do-7	do-7	NOUN
bam-10847	6	7	monoclonal	monoclonal	NOUN
bam-10847	6	8	antibody	antibody	NOUN
bam-10847	6	9	against	against	ADP
bam-10847	6	10	p53	p53	NOUN
bam-10847	6	11	protein	protein	NOUN
bam-10847	6	12	,	,	PUNCT
bam-10847	6	13	and	and	CCONJ
bam-10847	6	14	samples	sample	NOUN
bam-10847	6	15	with	with	ADP
bam-10847	6	16	≥10	≥10	ADP
bam-10847	6	17	%	%	NOUN
bam-10847	6	18	immunostaining	immunostaine	VERB
bam-10847	6	19	were	be	AUX
bam-10847	6	20	considered	consider	VERB
bam-10847	6	21	positive	positive	ADJ
bam-10847	6	22	.	.	PUNCT
bam-10847	7	1	statistical	statistical	ADJ
bam-10847	7	2	analyses	analysis	NOUN
bam-10847	7	3	were	be	AUX
bam-10847	7	4	carried	carry	VERB
bam-10847	7	5	out	out	ADP
bam-10847	7	6	using	use	VERB
bam-10847	7	7	spss	spss	PROPN
bam-10847	7	8	.	.	PUNCT
bam-10847	8	1	positive	positive	ADJ
bam-10847	8	2	staining	stain	VERB
bam-10847	8	3	for	for	ADP
bam-10847	8	4	p53	p53	NOUN
bam-10847	8	5	was	be	AUX
bam-10847	8	6	observed	observe	VERB
bam-10847	8	7	in	in	ADP
bam-10847	8	8	none	none	NOUN
bam-10847	8	9	of	of	ADP
bam-10847	8	10	the	the	DET
bam-10847	8	11	control	control	NOUN
bam-10847	8	12	subjects	subject	NOUN
bam-10847	8	13	and	and	CCONJ
bam-10847	8	14	57.4	57.4	NUM
bam-10847	8	15	%	%	NOUN
bam-10847	8	16	(	(	PUNCT
bam-10847	8	17	70	70	NUM
bam-10847	8	18	of	of	ADP
bam-10847	8	19	122	122	NUM
bam-10847	8	20	)	)	PUNCT
bam-10847	8	21	of	of	ADP
bam-10847	8	22	the	the	DET
bam-10847	8	23	primary	primary	ADJ
bam-10847	8	24	oscc	oscc	PROPN
bam-10847	8	25	patients	patient	NOUN
bam-10847	8	26	(	(	PUNCT
bam-10847	8	27	p<0.0001	p<0.0001	NOUN
bam-10847	8	28	,	,	PUNCT
bam-10847	8	29	or=107.69	or=107.69	NOUN
bam-10847	8	30	,	,	PUNCT
bam-10847	8	31	95%ci=6.49	95%ci=6.49	NUM
bam-10847	8	32	-	-	SYM
bam-10847	8	33	179.0	179.0	NUM
bam-10847	8	34	)	)	PUNCT
bam-10847	8	35	.	.	PUNCT
bam-10847	9	1	the	the	DET
bam-10847	9	2	p53	p53	NOUN
bam-10847	9	3	immunopositivity	immunopositivity	NOUN
bam-10847	9	4	had	have	VERB
bam-10847	9	5	no	no	DET
bam-10847	9	6	significant	significant	ADJ
bam-10847	9	7	differences	difference	NOUN
bam-10847	9	8	between	between	ADP
bam-10847	9	9	males	male	NOUN
bam-10847	9	10	and	and	CCONJ
bam-10847	9	11	females	female	NOUN
bam-10847	9	12	(	(	PUNCT
bam-10847	9	13	54.2	54.2	NUM
bam-10847	9	14	%	%	NOUN
bam-10847	9	15	vs.	vs.	ADP
bam-10847	9	16	62	62	NUM
bam-10847	9	17	%	%	NOUN
bam-10847	9	18	,	,	PUNCT
bam-10847	9	19	p=0.390	p=0.390	ADJ
bam-10847	9	20	)	)	PUNCT
bam-10847	9	21	,	,	PUNCT
bam-10847	9	22	but	but	CCONJ
bam-10847	9	23	significantly	significantly	ADV
bam-10847	9	24	different	different	ADJ
bam-10847	9	25	between	between	ADP
bam-10847	9	26	those	those	PRON
bam-10847	9	27	aged	age	VERB
bam-10847	9	28	below	below	ADP
bam-10847	9	29	and	and	CCONJ
bam-10847	9	30	over	over	ADP
bam-10847	9	31	50	50	NUM
bam-10847	9	32	years	year	NOUN
bam-10847	9	33	(	(	PUNCT
bam-10847	9	34	p<0.0001	p<0.0001	NOUN
bam-10847	9	35	,	,	PUNCT
bam-10847	9	36	or=4.52	or=4.52	NOUN
bam-10847	9	37	,	,	PUNCT
bam-10847	9	38	95%ci=1.07	95%ci=1.07	NUM
bam-10847	9	39	-	-	SYM
bam-10847	9	40	12.05	12.05	NUM
bam-10847	9	41	)	)	PUNCT
bam-10847	9	42	.	.	PUNCT
bam-10847	10	1	during	during	ADP
bam-10847	10	2	followup	followup	NOUN
bam-10847	10	3	,	,	PUNCT
bam-10847	10	4	oscc	oscc	ADJ
bam-10847	10	5	recurrence	recurrence	NOUN
bam-10847	10	6	occurred	occur	VERB
bam-10847	10	7	in	in	ADP
bam-10847	10	8	104	104	NUM
bam-10847	10	9	patients	patient	NOUN
bam-10847	10	10	,	,	PUNCT
bam-10847	10	11	but	but	CCONJ
bam-10847	10	12	the	the	DET
bam-10847	10	13	phenotype	phenotype	NOUN
bam-10847	10	14	of	of	ADP
bam-10847	10	15	the	the	DET
bam-10847	10	16	mutant	mutant	ADJ
bam-10847	10	17	p53	p53	NOUN
bam-10847	10	18	protein	protein	NOUN
bam-10847	10	19	in	in	ADP
bam-10847	10	20	patients	patient	NOUN
bam-10847	10	21	who	who	PRON
bam-10847	10	22	relapsed	relapse	VERB
bam-10847	10	23	was	be	AUX
bam-10847	10	24	the	the	DET
bam-10847	10	25	same	same	ADJ
bam-10847	10	26	as	as	ADP
bam-10847	10	27	in	in	ADP
bam-10847	10	28	matched	match	VERB
bam-10847	10	29	primary	primary	ADJ
bam-10847	10	30	tumors	tumor	NOUN
bam-10847	10	31	(	(	PUNCT
bam-10847	10	32	p=0.763	p=0.763	NOUN
bam-10847	10	33	)	)	PUNCT
bam-10847	10	34	.	.	PUNCT
bam-10847	11	1	risk	risk	NOUN
bam-10847	11	2	of	of	ADP
bam-10847	11	3	recurrence	recurrence	NOUN
bam-10847	11	4	had	have	VERB
bam-10847	11	5	no	no	DET
bam-10847	11	6	significant	significant	ADJ
bam-10847	11	7	differences	difference	NOUN
bam-10847	11	8	between	between	ADP
bam-10847	11	9	p53	p53	NOUN
bam-10847	11	10	-	-	PUNCT
bam-10847	11	11	positive	positive	ADJ
bam-10847	11	12	and	and	CCONJ
bam-10847	11	13	p53	p53	NOUN
bam-10847	11	14	-	-	PUNCT
bam-10847	11	15	negative	negative	ADJ
bam-10847	11	16	cases	case	NOUN
bam-10847	11	17	(	(	PUNCT
bam-10847	11	18	p=0.953	p=0.953	NOUN
bam-10847	11	19	)	)	PUNCT
bam-10847	11	20	,	,	PUNCT
bam-10847	11	21	males	male	NOUN
bam-10847	11	22	and	and	CCONJ
bam-10847	11	23	females	female	NOUN
bam-10847	11	24	(	(	PUNCT
bam-10847	11	25	p=0.263	p=0.263	NOUN
bam-10847	11	26	)	)	PUNCT
bam-10847	11	27	,	,	PUNCT
bam-10847	11	28	and	and	CCONJ
bam-10847	11	29	age	age	NOUN
bam-10847	11	30	below	below	ADV
bam-10847	11	31	and	and	CCONJ
bam-10847	11	32	over	over	ADP
bam-10847	11	33	50	50	NUM
bam-10847	11	34	years	year	NOUN
bam-10847	11	35	(	(	PUNCT
bam-10847	11	36	p=0.223	p=0.223	NOUN
bam-10847	11	37	)	)	PUNCT
bam-10847	11	38	.	.	PUNCT
bam-10847	12	1	despite	despite	SCONJ
bam-10847	12	2	its	its	PRON
bam-10847	12	3	confirmed	confirm	VERB
bam-10847	12	4	diagnostic	diagnostic	ADJ
bam-10847	12	5	value	value	NOUN
bam-10847	12	6	,	,	PUNCT
bam-10847	12	7	the	the	DET
bam-10847	12	8	immunoexpression	immunoexpression	NOUN
bam-10847	12	9	of	of	ADP
bam-10847	12	10	the	the	DET
bam-10847	12	11	p53	p53	NOUN
bam-10847	12	12	mutant	mutant	NOUN
bam-10847	12	13	protein	protein	NOUN
bam-10847	12	14	in	in	ADP
bam-10847	12	15	oscc	oscc	ADV
bam-10847	12	16	in	in	ADP
bam-10847	12	17	cancer	cancer	NOUN
bam-10847	12	18	recurrence	recurrence	NOUN
bam-10847	12	19	was	be	AUX
bam-10847	12	20	the	the	DET
bam-10847	12	21	same	same	ADJ
bam-10847	12	22	as	as	ADP
bam-10847	12	23	in	in	ADP
bam-10847	12	24	the	the	DET
bam-10847	12	25	primary	primary	ADJ
bam-10847	12	26	tumor	tumor	NOUN
bam-10847	12	27	.	.	PUNCT
bam-10847	13	1	however	however	ADV
bam-10847	13	2	,	,	PUNCT
bam-10847	13	3	further	further	ADJ
bam-10847	13	4	studies	study	NOUN
bam-10847	13	5	with	with	ADP
bam-10847	13	6	a	a	DET
bam-10847	13	7	larger	large	ADJ
bam-10847	13	8	sample	sample	NOUN
bam-10847	13	9	size	size	NOUN
bam-10847	13	10	and	and	CCONJ
bam-10847	13	11	longer	long	ADV
bam-10847	13	12	follow	follow	VERB
bam-10847	13	13	-	-	PUNCT
bam-10847	13	14	up	up	NOUN
bam-10847	13	15	are	be	AUX
bam-10847	13	16	needed	need	VERB
bam-10847	13	17	to	to	PART
bam-10847	13	18	confirm	confirm	VERB
bam-10847	13	19	or	or	CCONJ
bam-10847	13	20	change	change	VERB
bam-10847	13	21	our	our	PRON
bam-10847	13	22	conclusions	conclusion	NOUN
bam-10847	13	23	.	.	PUNCT
bam-10847	14	1	key	key	ADJ
bam-10847	14	2	words	word	NOUN
bam-10847	14	3	:	:	PUNCT
bam-10847	14	4	immunohistochemistry	immunohistochemistry	NOUN
bam-10847	14	5	(	(	PUNCT
bam-10847	14	6	ihc	ihc	PROPN
bam-10847	14	7	)	)	PUNCT
bam-10847	14	8	;	;	PUNCT
bam-10847	14	9	oral	oral	ADJ
bam-10847	14	10	squamous	squamous	ADJ
bam-10847	14	11	cell	cell	NOUN
bam-10847	14	12	carcinoma	carcinoma	NOUN
bam-10847	14	13	(	(	PUNCT
bam-10847	14	14	oscc	oscc	ADJ
bam-10847	14	15	)	)	PUNCT
bam-10847	14	16	;	;	PUNCT
bam-10847	14	17	p53	p53	NOUN
bam-10847	14	18	;	;	PUNCT
bam-10847	14	19	primary	primary	ADJ
bam-10847	14	20	tumor	tumor	NOUN
bam-10847	14	21	;	;	PUNCT
bam-10847	14	22	recurrence	recurrence	NOUN
bam-10847	14	23	.	.	PUNCT
bam-10847	15	1	eur	eur	PROPN
bam-10847	15	2	j	j	PROPN
bam-10847	15	3	transl	transl	PROPN
bam-10847	15	4	myol	myol	ADV
bam-10847	15	5	33	33	NUM
bam-10847	15	6	(	(	PUNCT
bam-10847	15	7	1	1	NUM
bam-10847	15	8	)	)	PUNCT
bam-10847	15	9	10847	10847	NUM
bam-10847	15	10	,	,	PUNCT
bam-10847	15	11	2023	2023	NUM
bam-10847	15	12	doi	doi	NOUN
bam-10847	15	13	:	:	PUNCT
bam-10847	15	14	10.4081	10.4081	NUM
bam-10847	15	15	/	/	SYM
bam-10847	15	16	ejtm.2023.10847	ejtm.2023.10847	NOUN
bam-10847	15	17	head	head	NOUN
bam-10847	15	18	and	and	CCONJ
bam-10847	15	19	neck	neck	VERB
bam-10847	15	20	squamous	squamous	ADJ
bam-10847	15	21	cell	cell	NOUN
bam-10847	15	22	carcinoma	carcinoma	NOUN
bam-10847	15	23	(	(	PUNCT
bam-10847	15	24	hnscc	hnscc	NOUN
bam-10847	15	25	)	)	PUNCT
bam-10847	15	26	is	be	AUX
bam-10847	15	27	one	one	NUM
bam-10847	15	28	of	of	ADP
bam-10847	15	29	the	the	DET
bam-10847	15	30	most	most	ADV
bam-10847	15	31	aggressive	aggressive	ADJ
bam-10847	15	32	and	and	CCONJ
bam-10847	15	33	heterogeneous	heterogeneous	ADJ
bam-10847	15	34	human	human	ADJ
bam-10847	15	35	malignancies	malignancy	NOUN
bam-10847	15	36	,	,	PUNCT
bam-10847	15	37	with	with	ADP
bam-10847	15	38	approximately	approximately	ADV
bam-10847	15	39	890,000	890,000	NUM
bam-10847	15	40	new	new	ADJ
bam-10847	15	41	cases	case	NOUN
bam-10847	15	42	and	and	CCONJ
bam-10847	15	43	450,000	450,000	NUM
bam-10847	15	44	deaths	death	NOUN
bam-10847	15	45	annually	annually	ADV
bam-10847	15	46	.	.	PUNCT
bam-10847	16	1	they	they	PRON
bam-10847	16	2	are	be	AUX
bam-10847	16	3	primarily	primarily	ADV
bam-10847	16	4	not	not	PART
bam-10847	16	5	hereditary	hereditary	ADJ
bam-10847	16	6	,	,	PUNCT
bam-10847	16	7	but	but	CCONJ
bam-10847	16	8	typically	typically	ADV
bam-10847	16	9	developed	develop	VERB
bam-10847	16	10	in	in	ADP
bam-10847	16	11	the	the	DET
bam-10847	16	12	sixth	sixth	ADJ
bam-10847	16	13	to	to	PART
bam-10847	16	14	seventh	seventh	ADJ
bam-10847	16	15	decade	decade	NOUN
bam-10847	16	16	of	of	ADP
bam-10847	16	17	life	life	NOUN
bam-10847	16	18	.	.	PUNCT
bam-10847	17	1	oral	oral	ADJ
bam-10847	17	2	squamous	squamous	ADJ
bam-10847	17	3	cell	cell	NOUN
bam-10847	17	4	carcinoma	carcinoma	NOUN
bam-10847	17	5	(	(	PUNCT
bam-10847	17	6	oscc	oscc	ADJ
bam-10847	17	7	)	)	PUNCT
bam-10847	17	8	originate	originate	VERB
bam-10847	17	9	from	from	ADP
bam-10847	17	10	the	the	DET
bam-10847	17	11	epithelial	epithelial	ADJ
bam-10847	17	12	lining	lining	NOUN
bam-10847	17	13	of	of	ADP
bam-10847	17	14	the	the	DET
bam-10847	17	15	oral	oral	ADJ
bam-10847	17	16	cavity	cavity	NOUN
bam-10847	17	17	,	,	PUNCT
bam-10847	17	18	pharynx	pharynx	NOUN
bam-10847	17	19	,	,	PUNCT
bam-10847	17	20	larynx	larynx	NOUN
bam-10847	17	21	,	,	PUNCT
bam-10847	17	22	and	and	CCONJ
bam-10847	17	23	nasal	nasal	ADJ
bam-10847	17	24	cavity	cavity	NOUN
bam-10847	17	25	and	and	CCONJ
bam-10847	17	26	is	be	AUX
bam-10847	17	27	the	the	DET
bam-10847	17	28	most	most	ADV
bam-10847	17	29	common	common	ADJ
bam-10847	17	30	tumor	tumor	NOUN
bam-10847	17	31	of	of	ADP
bam-10847	17	32	the	the	DET
bam-10847	17	33	head	head	NOUN
bam-10847	17	34	and	and	CCONJ
bam-10847	17	35	neck	neck	NOUN
bam-10847	17	36	,	,	PUNCT
bam-10847	17	37	encompassing	encompass	VERB
bam-10847	17	38	about	about	ADP
bam-10847	17	39	90	90	NUM
bam-10847	17	40	%	%	NOUN
bam-10847	17	41	of	of	ADP
bam-10847	17	42	malignant	malignant	ADJ
bam-10847	17	43	lesions	lesion	NOUN
bam-10847	17	44	in	in	ADP
bam-10847	17	45	the	the	DET
bam-10847	17	46	oral	oral	ADJ
bam-10847	17	47	cavity.1,2	cavity.1,2	ADJ
bam-10847	17	48	due	due	ADP
bam-10847	17	49	to	to	ADP
bam-10847	17	50	the	the	DET
bam-10847	17	51	painless	painless	ADJ
bam-10847	17	52	presentation	presentation	NOUN
bam-10847	17	53	,	,	PUNCT
bam-10847	17	54	the	the	DET
bam-10847	17	55	initial	initial	ADJ
bam-10847	17	56	wrong	wrong	ADJ
bam-10847	17	57	diagnosis	diagnosis	NOUN
bam-10847	17	58	,	,	PUNCT
bam-10847	17	59	or	or	CCONJ
bam-10847	17	60	the	the	DET
bam-10847	17	61	ignorance	ignorance	NOUN
bam-10847	17	62	from	from	ADP
bam-10847	17	63	the	the	DET
bam-10847	17	64	patient	patient	NOUN
bam-10847	17	65	,	,	PUNCT
bam-10847	17	66	oscc	oscc	ADJ
bam-10847	17	67	cases	case	NOUN
bam-10847	17	68	is	be	AUX
bam-10847	17	69	often	often	ADV
bam-10847	17	70	diagnosed	diagnose	VERB
bam-10847	17	71	at	at	ADP
bam-10847	17	72	an	an	DET
bam-10847	17	73	advanced	advanced	ADJ
bam-10847	17	74	stages	stage	NOUN
bam-10847	17	75	accompanied	accompany	VERB
bam-10847	17	76	by	by	ADP
bam-10847	17	77	metastasis	metastasis	NOUN
bam-10847	17	78	.	.	PUNCT
bam-10847	18	1	although	although	SCONJ
bam-10847	18	2	such	such	ADJ
bam-10847	18	3	patients	patient	NOUN
bam-10847	18	4	are	be	AUX
bam-10847	18	5	managed	manage	VERB
bam-10847	18	6	with	with	ADP
bam-10847	18	7	aggressive	aggressive	ADJ
bam-10847	18	8	multimodal	multimodal	NOUN
bam-10847	18	9	treatment	treatment	NOUN
bam-10847	18	10	,	,	PUNCT
bam-10847	18	11	cases	case	NOUN
bam-10847	18	12	lead	lead	VERB
bam-10847	18	13	to	to	ADP
bam-10847	18	14	a	a	DET
bam-10847	18	15	poor	poor	ADJ
bam-10847	18	16	prognosis	prognosis	NOUN
bam-10847	18	17	and	and	CCONJ
bam-10847	18	18	cause	cause	VERB
bam-10847	18	19	significant	significant	ADJ
bam-10847	18	20	morbidity	morbidity	NOUN
bam-10847	18	21	and	and	CCONJ
bam-10847	18	22	mortality	mortality	NOUN
bam-10847	18	23	.	.	PUNCT
bam-10847	19	1	indeed	indeed	ADV
bam-10847	19	2	,	,	PUNCT
bam-10847	19	3	postoperative	postoperative	ADJ
bam-10847	19	4	tumor	tumor	NOUN
bam-10847	19	5	recurrence	recurrence	NOUN
bam-10847	19	6	is	be	AUX
bam-10847	19	7	an	an	DET
bam-10847	19	8	important	important	ADJ
bam-10847	19	9	prognostic	prognostic	ADJ
bam-10847	19	10	factor	factor	NOUN
bam-10847	19	11	in	in	ADP
bam-10847	19	12	patients	patient	NOUN
bam-10847	19	13	with	with	ADP
bam-10847	19	14	oscc	oscc	NOUN
bam-10847	19	15	that	that	PRON
bam-10847	19	16	affected	affect	VERB
bam-10847	19	17	the	the	DET
bam-10847	19	18	5	5	NUM
bam-10847	19	19	-	-	PUNCT
bam-10847	19	20	year	year	NOUN
bam-10847	19	21	survival	survival	NOUN
bam-10847	19	22	rate	rate	NOUN
bam-10847	19	23	.	.	PUNCT
bam-10847	20	1	poor	poor	ADJ
bam-10847	20	2	oral	oral	ADJ
bam-10847	20	3	hygiene	hygiene	NOUN
bam-10847	20	4	,	,	PUNCT
bam-10847	20	5	alcohol	alcohol	NOUN
bam-10847	20	6	abuse	abuse	NOUN
bam-10847	20	7	,	,	PUNCT
bam-10847	20	8	tobacco	tobacco	NOUN
bam-10847	20	9	,	,	PUNCT
bam-10847	20	10	and	and	CCONJ
bam-10847	20	11	immunodeficiency	immunodeficiency	NOUN
bam-10847	20	12	have	have	AUX
bam-10847	20	13	been	be	AUX
bam-10847	20	14	proposed	propose	VERB
bam-10847	20	15	to	to	PART
bam-10847	20	16	be	be	AUX
bam-10847	20	17	responsible	responsible	ADJ
bam-10847	20	18	for	for	ADP
bam-10847	20	19	the	the	DET
bam-10847	20	20	development	development	NOUN
bam-10847	20	21	of	of	ADP
bam-10847	20	22	osccs.3	osccs.3	NOUN
bam-10847	20	23	-	-	SYM
bam-10847	20	24	7	7	NUM
bam-10847	20	25	those	those	DET
bam-10847	20	26	carcinogens	carcinogen	NOUN
bam-10847	20	27	may	may	AUX
bam-10847	20	28	predispose	predispose	VERB
bam-10847	20	29	individuals	individual	NOUN
bam-10847	20	30	to	to	PART
bam-10847	20	31	develop	develop	VERB
bam-10847	20	32	tumor	tumor	NOUN
bam-10847	20	33	,	,	PUNCT
bam-10847	20	34	but	but	CCONJ
bam-10847	20	35	a	a	DET
bam-10847	20	36	large	large	ADJ
bam-10847	20	37	proportion	proportion	NOUN
bam-10847	20	38	of	of	ADP
bam-10847	20	39	cases	case	NOUN
bam-10847	20	40	still	still	ADV
bam-10847	20	41	develops	develop	VERB
bam-10847	20	42	oscc	oscc	ADV
bam-10847	20	43	in	in	ADP
bam-10847	20	44	absence	absence	NOUN
bam-10847	20	45	of	of	ADP
bam-10847	20	46	carcinogen	carcinogen	NOUN
bam-10847	20	47	exposure	exposure	NOUN
bam-10847	20	48	.	.	PUNCT
bam-10847	21	1	previous	previous	ADJ
bam-10847	21	2	studies	study	NOUN
bam-10847	21	3	have	have	AUX
bam-10847	21	4	described	describe	VERB
bam-10847	21	5	multiple	multiple	ADJ
bam-10847	21	6	chromosomal	chromosomal	ADJ
bam-10847	21	7	abnormalities	abnormality	NOUN
bam-10847	21	8	and	and	CCONJ
bam-10847	21	9	genetic	genetic	ADJ
bam-10847	21	10	instability	instability	NOUN
bam-10847	21	11	in	in	ADP
bam-10847	21	12	non	non	ADJ
bam-10847	21	13	-co	-co	PROPN
bam-10847	21	14	mmerc	mmerc	PROPN
bam-10847	21	15	ial	ial	PROPN
bam-10847	21	16	us	us	PROPN
bam-10847	21	17	e	e	NOUN
bam-10847	21	18	o	o	NOUN
bam-10847	21	19	nly	nly	ADV
bam-10847	21	20	p53	p53	VERB
bam-10847	21	21	mutant	mutant	NOUN
bam-10847	21	22	-	-	PUNCT
bam-10847	21	23	type	type	NOUN
bam-10847	21	24	in	in	ADP
bam-10847	21	25	oral	oral	ADJ
bam-10847	21	26	squamous	squamous	ADJ
bam-10847	21	27	cell	cell	NOUN
bam-10847	21	28	carcinoma	carcinoma	NOUN
bam-10847	21	29	eur	eur	PROPN
bam-10847	21	30	j	j	PROPN
bam-10847	21	31	transl	transl	PROPN
bam-10847	21	32	myol	myol	ADV
bam-10847	21	33	33	33	NUM
bam-10847	21	34	(	(	PUNCT
bam-10847	21	35	1	1	NUM
bam-10847	21	36	)	)	PUNCT
bam-10847	21	37	10847	10847	NUM
bam-10847	21	38	,	,	PUNCT
bam-10847	21	39	2023	2023	NUM
bam-10847	21	40	doi	doi	NOUN
bam-10847	21	41	:	:	PUNCT
bam-10847	21	42	10.4081	10.4081	NUM
bam-10847	21	43	/	/	SYM
bam-10847	21	44	ejtm.2023.10847	ejtm.2023.10847	PROPN
bam-10847	21	45	2	2	NUM
bam-10847	21	46	patients	patient	NOUN
bam-10847	21	47	with	with	ADP
bam-10847	21	48	hnsccs	hnsccs	NOUN
bam-10847	21	49	,	,	PUNCT
bam-10847	21	50	which	which	PRON
bam-10847	21	51	may	may	AUX
bam-10847	21	52	be	be	AUX
bam-10847	21	53	required	require	VERB
bam-10847	21	54	for	for	ADP
bam-10847	21	55	tumorigenesis	tumorigenesis	NOUN
bam-10847	21	56	and	and	CCONJ
bam-10847	21	57	full	full	ADJ
bam-10847	21	58	transformation	transformation	NOUN
bam-10847	21	59	to	to	ADP
bam-10847	21	60	invasive	invasive	ADJ
bam-10847	21	61	form	form	NOUN
bam-10847	21	62	.	.	PUNCT
bam-10847	22	1	inactivation	inactivation	NOUN
bam-10847	22	2	or	or	CCONJ
bam-10847	22	3	deletion	deletion	NOUN
bam-10847	22	4	of	of	ADP
bam-10847	22	5	the	the	DET
bam-10847	22	6	tumor	tumor	NOUN
bam-10847	22	7	suppressor	suppressor	NOUN
bam-10847	22	8	genes	gene	NOUN
bam-10847	22	9	such	such	ADJ
bam-10847	22	10	as	as	ADP
bam-10847	22	11	tp53	tp53	PROPN
bam-10847	22	12	as	as	ADV
bam-10847	22	13	well	well	ADV
bam-10847	22	14	as	as	ADP
bam-10847	22	15	overexpression	overexpression	NOUN
bam-10847	22	16	of	of	ADP
bam-10847	22	17	the	the	DET
bam-10847	22	18	epidermal	epidermal	ADJ
bam-10847	22	19	growth	growth	NOUN
bam-10847	22	20	factor	factor	NOUN
bam-10847	22	21	receptor	receptor	NOUN
bam-10847	22	22	(	(	PUNCT
bam-10847	22	23	egfr	egfr	X
bam-10847	22	24	)	)	PUNCT
bam-10847	22	25	are	be	AUX
bam-10847	22	26	the	the	DET
bam-10847	22	27	predominant	predominant	ADJ
bam-10847	22	28	pathogenetic	pathogenetic	ADJ
bam-10847	22	29	events	event	NOUN
bam-10847	22	30	in	in	ADP
bam-10847	22	31	hnsccs	hnsccs	NOUN
bam-10847	22	32	.	.	PUNCT
bam-10847	23	1	they	they	PRON
bam-10847	23	2	not	not	PART
bam-10847	23	3	only	only	ADV
bam-10847	23	4	predispose	predispose	VERB
bam-10847	23	5	cells	cell	NOUN
bam-10847	23	6	to	to	PART
bam-10847	23	7	initiate	initiate	VERB
bam-10847	23	8	the	the	DET
bam-10847	23	9	tumorigenesis	tumorigenesis	NOUN
bam-10847	23	10	cascade	cascade	NOUN
bam-10847	23	11	but	but	CCONJ
bam-10847	23	12	are	be	AUX
bam-10847	23	13	also	also	ADV
bam-10847	23	14	associated	associate	VERB
bam-10847	23	15	with	with	ADP
bam-10847	23	16	poor	poor	ADJ
bam-10847	23	17	clinical	clinical	ADJ
bam-10847	23	18	response	response	NOUN
bam-10847	23	19	and	and	CCONJ
bam-10847	23	20	outcome.8	outcome.8	PROPN
bam-10847	23	21	-	-	PUNCT
bam-10847	23	22	11	11	NUM
bam-10847	23	23	the	the	DET
bam-10847	23	24	p53	p53	NOUN
bam-10847	23	25	protein	protein	NOUN
bam-10847	23	26	,	,	PUNCT
bam-10847	23	27	encoded	encode	VERB
bam-10847	23	28	by	by	ADP
bam-10847	23	29	the	the	DET
bam-10847	23	30	tp53	tp53	PROPN
bam-10847	23	31	gene	gene	NOUN
bam-10847	23	32	regulates	regulate	VERB
bam-10847	23	33	the	the	DET
bam-10847	23	34	expression	expression	NOUN
bam-10847	23	35	of	of	ADP
bam-10847	23	36	a	a	DET
bam-10847	23	37	vast	vast	ADJ
bam-10847	23	38	array	array	NOUN
bam-10847	23	39	of	of	ADP
bam-10847	23	40	genes	gene	NOUN
bam-10847	23	41	involved	involve	VERB
bam-10847	23	42	in	in	ADP
bam-10847	23	43	cell	cell	NOUN
bam-10847	23	44	cycle	cycle	NOUN
bam-10847	23	45	arrest	arrest	NOUN
bam-10847	23	46	,	,	PUNCT
bam-10847	23	47	cellular	cellular	ADJ
bam-10847	23	48	senescence	senescence	NOUN
bam-10847	23	49	,	,	PUNCT
bam-10847	23	50	deoxyribonucleic	deoxyribonucleic	ADJ
bam-10847	23	51	acid	acid	NOUN
bam-10847	23	52	(	(	PUNCT
bam-10847	23	53	dna	dna	NOUN
bam-10847	23	54	)	)	PUNCT
bam-10847	23	55	repair	repair	NOUN
bam-10847	23	56	,	,	PUNCT
bam-10847	23	57	metabolism	metabolism	NOUN
bam-10847	23	58	,	,	PUNCT
bam-10847	23	59	differentiation	differentiation	NOUN
bam-10847	23	60	,	,	PUNCT
bam-10847	23	61	and	and	CCONJ
bam-10847	23	62	apoptosis	apoptosis	NOUN
bam-10847	23	63	.	.	PUNCT
bam-10847	24	1	due	due	ADP
bam-10847	24	2	to	to	ADP
bam-10847	24	3	maintenance	maintenance	NOUN
bam-10847	24	4	of	of	ADP
bam-10847	24	5	genome	genome	NOUN
bam-10847	24	6	stability	stability	NOUN
bam-10847	24	7	,	,	PUNCT
bam-10847	24	8	p53	p53	NOUN
bam-10847	24	9	is	be	AUX
bam-10847	24	10	known	know	VERB
bam-10847	24	11	as	as	ADP
bam-10847	24	12	the	the	DET
bam-10847	24	13	guardian	guardian	NOUN
bam-10847	24	14	of	of	ADP
bam-10847	24	15	the	the	DET
bam-10847	24	16	genome	genome	NOUN
bam-10847	24	17	.	.	PUNCT
bam-10847	25	1	the	the	DET
bam-10847	25	2	majority	majority	NOUN
bam-10847	25	3	of	of	ADP
bam-10847	25	4	human	human	ADJ
bam-10847	25	5	cancer	cancer	NOUN
bam-10847	25	6	cells	cell	NOUN
bam-10847	25	7	exhibit	exhibit	VERB
bam-10847	25	8	the	the	DET
bam-10847	25	9	inactivation	inactivation	NOUN
bam-10847	25	10	of	of	ADP
bam-10847	25	11	the	the	DET
bam-10847	25	12	p53	p53	NOUN
bam-10847	25	13	pathway	pathway	NOUN
bam-10847	25	14	through	through	ADP
bam-10847	25	15	mutations	mutation	NOUN
bam-10847	25	16	,	,	PUNCT
bam-10847	25	17	dysregulation	dysregulation	NOUN
bam-10847	25	18	of	of	ADP
bam-10847	25	19	endogenous	endogenous	ADJ
bam-10847	25	20	regulators	regulator	NOUN
bam-10847	25	21	,	,	PUNCT
bam-10847	25	22	and	and	CCONJ
bam-10847	25	23	by	by	ADP
bam-10847	25	24	the	the	DET
bam-10847	25	25	human	human	PROPN
bam-10847	25	26	papilloma	papilloma	PROPN
bam-10847	25	27	virus	virus	NOUN
bam-10847	25	28	e6	e6	VERB
bam-10847	25	29	protein	protein	NOUN
bam-10847	25	30	.	.	PUNCT
bam-10847	26	1	emerging	emerge	VERB
bam-10847	26	2	evidence	evidence	NOUN
bam-10847	26	3	suggests	suggest	VERB
bam-10847	26	4	that	that	SCONJ
bam-10847	26	5	p53	p53	NOUN
bam-10847	26	6	is	be	AUX
bam-10847	26	7	activated	activate	VERB
bam-10847	26	8	in	in	ADP
bam-10847	26	9	response	response	NOUN
bam-10847	26	10	to	to	ADP
bam-10847	26	11	many	many	ADJ
bam-10847	26	12	stress	stress	NOUN
bam-10847	26	13	stimuli	stimulus	NOUN
bam-10847	26	14	such	such	ADJ
bam-10847	26	15	as	as	ADP
bam-10847	26	16	dna	dna	PROPN
bam-10847	26	17	damage	damage	NOUN
bam-10847	26	18	,	,	PUNCT
bam-10847	26	19	hypoxia	hypoxia	NOUN
bam-10847	26	20	,	,	PUNCT
bam-10847	26	21	high	high	ADJ
bam-10847	26	22	reactive	reactive	ADJ
bam-10847	26	23	oxygen	oxygen	NOUN
bam-10847	26	24	species	specie	NOUN
bam-10847	26	25	(	(	PUNCT
bam-10847	26	26	ros	ros	PROPN
bam-10847	26	27	)	)	PUNCT
bam-10847	26	28	levels	level	NOUN
bam-10847	26	29	,	,	PUNCT
bam-10847	26	30	heat	heat	NOUN
bam-10847	26	31	shock	shock	NOUN
bam-10847	26	32	,	,	PUNCT
bam-10847	26	33	overexpression	overexpression	NOUN
bam-10847	26	34	of	of	ADP
bam-10847	26	35	oncogenes	oncogene	NOUN
bam-10847	26	36	,	,	PUNCT
bam-10847	26	37	and	and	CCONJ
bam-10847	26	38	nutrient	nutrient	ADJ
bam-10847	26	39	deficiency	deficiency	NOUN
bam-10847	26	40	.	.	PUNCT
bam-10847	27	1	however	however	ADV
bam-10847	27	2	,	,	PUNCT
bam-10847	27	3	these	these	DET
bam-10847	27	4	responses	response	NOUN
bam-10847	27	5	appear	appear	VERB
bam-10847	27	6	to	to	PART
bam-10847	27	7	depend	depend	VERB
bam-10847	27	8	on	on	ADP
bam-10847	27	9	type	type	NOUN
bam-10847	27	10	and	and	CCONJ
bam-10847	27	11	severity	severity	NOUN
bam-10847	27	12	of	of	ADP
bam-10847	27	13	the	the	DET
bam-10847	27	14	stressors.12	stressors.12	NOUN
bam-10847	27	15	-	-	SYM
bam-10847	27	16	15	15	NUM
bam-10847	27	17	three	three	NUM
bam-10847	27	18	different	different	ADJ
bam-10847	27	19	tp53	tp53	PROPN
bam-10847	27	20	status	status	NOUN
bam-10847	27	21	/	/	SYM
bam-10847	27	22	p53	p53	NOUN
bam-10847	27	23	function	function	NOUN
bam-10847	27	24	including	include	VERB
bam-10847	27	25	wild	wild	ADJ
bam-10847	27	26	-	-	PUNCT
bam-10847	27	27	type	type	NOUN
bam-10847	27	28	(	(	PUNCT
bam-10847	27	29	p53wt	p53wt	PROPN
bam-10847	27	30	)	)	PUNCT
bam-10847	27	31	,	,	PUNCT
bam-10847	27	32	mutant	mutant	NOUN
bam-10847	27	33	-	-	PUNCT
bam-10847	27	34	type	type	NOUN
bam-10847	27	35	(	(	PUNCT
bam-10847	27	36	p53mt	p53mt	NOUN
bam-10847	27	37	)	)	PUNCT
bam-10847	27	38	,	,	PUNCT
bam-10847	27	39	and	and	CCONJ
bam-10847	27	40	deletion	deletion	NOUN
bam-10847	27	41	(	(	PUNCT
bam-10847	27	42	null	null	NOUN
bam-10847	27	43	-	-	PUNCT
bam-10847	27	44	type	type	NOUN
bam-10847	27	45	or	or	CCONJ
bam-10847	27	46	p53null	p53null	NOUN
bam-10847	27	47	)	)	PUNCT
bam-10847	27	48	can	can	AUX
bam-10847	27	49	be	be	AUX
bam-10847	27	50	found	find	VERB
bam-10847	27	51	in	in	ADP
bam-10847	27	52	cancer	cancer	NOUN
bam-10847	27	53	cells	cell	NOUN
bam-10847	27	54	.	.	PUNCT
bam-10847	28	1	clinically	clinically	ADV
bam-10847	28	2	,	,	PUNCT
bam-10847	28	3	wild	wild	ADJ
bam-10847	28	4	-	-	PUNCT
bam-10847	28	5	type	type	NOUN
bam-10847	28	6	(	(	PUNCT
bam-10847	28	7	wt	wt	NOUN
bam-10847	28	8	)	)	PUNCT
bam-10847	28	9	tp53	tp53	PROPN
bam-10847	28	10	-	-	PUNCT
bam-10847	28	11	carrying	carry	VERB
bam-10847	28	12	subjects	subject	NOUN
bam-10847	28	13	have	have	AUX
bam-10847	28	14	shown	show	VERB
bam-10847	28	15	a	a	DET
bam-10847	28	16	trend	trend	NOUN
bam-10847	28	17	toward	toward	ADP
bam-10847	28	18	a	a	DET
bam-10847	28	19	better	well	ADJ
bam-10847	28	20	response	response	NOUN
bam-10847	28	21	to	to	ADP
bam-10847	28	22	radiotherapy	radiotherapy	NOUN
bam-10847	28	23	and	and	CCONJ
bam-10847	28	24	chemotherapy	chemotherapy	NOUN
bam-10847	28	25	;	;	PUNCT
bam-10847	28	26	however	however	ADV
bam-10847	28	27	,	,	PUNCT
bam-10847	28	28	loss	loss	NOUN
bam-10847	28	29	of	of	ADP
bam-10847	28	30	wild	wild	ADJ
bam-10847	28	31	-	-	PUNCT
bam-10847	28	32	type	type	NOUN
bam-10847	28	33	p53	p53	NOUN
bam-10847	28	34	function	function	NOUN
bam-10847	28	35	has	have	VERB
bam-10847	28	36	a	a	DET
bam-10847	28	37	dominantnegative	dominantnegative	ADJ
bam-10847	28	38	effect	effect	NOUN
bam-10847	28	39	on	on	ADP
bam-10847	28	40	the	the	DET
bam-10847	28	41	remaining	remain	VERB
bam-10847	28	42	wild	wild	ADJ
bam-10847	28	43	-	-	PUNCT
bam-10847	28	44	type	type	NOUN
bam-10847	28	45	p53	p53	NOUN
bam-10847	28	46	and	and	CCONJ
bam-10847	28	47	are	be	AUX
bam-10847	28	48	significantly	significantly	ADV
bam-10847	28	49	associated	associate	VERB
bam-10847	28	50	with	with	ADP
bam-10847	28	51	resistance	resistance	NOUN
bam-10847	28	52	to	to	ADP
bam-10847	28	53	treatments	treatment	NOUN
bam-10847	28	54	and	and	CCONJ
bam-10847	28	55	short	short	ADJ
bam-10847	28	56	survival	survival	NOUN
bam-10847	28	57	time	time	NOUN
bam-10847	28	58	.	.	PUNCT
bam-10847	29	1	besides	besides	SCONJ
bam-10847	29	2	,	,	PUNCT
bam-10847	29	3	p53mt	p53mt	NUM
bam-10847	29	4	proteins	protein	NOUN
bam-10847	29	5	exert	exert	VERB
bam-10847	29	6	additional	additional	ADJ
bam-10847	29	7	oncogenic	oncogenic	ADJ
bam-10847	29	8	functions	function	NOUN
bam-10847	29	9	that	that	PRON
bam-10847	29	10	promote	promote	VERB
bam-10847	29	11	tumorigenesis	tumorigenesis	NOUN
bam-10847	29	12	,	,	PUNCT
bam-10847	29	13	progression	progression	NOUN
bam-10847	29	14	,	,	PUNCT
bam-10847	29	15	and	and	CCONJ
bam-10847	29	16	metastasis.11,16,17	metastasis.11,16,17	ADV
bam-10847	29	17	although	although	SCONJ
bam-10847	29	18	non	non	ADJ
bam-10847	29	19	-	-	ADJ
bam-10847	29	20	mutated	mutate	VERB
bam-10847	29	21	tumor	tumor	NOUN
bam-10847	29	22	suppressor	suppressor	NOUN
bam-10847	29	23	p53	p53	NOUN
bam-10847	29	24	protein	protein	NOUN
bam-10847	29	25	plays	play	VERB
bam-10847	29	26	an	an	DET
bam-10847	29	27	important	important	ADJ
bam-10847	29	28	role	role	NOUN
bam-10847	29	29	in	in	ADP
bam-10847	29	30	the	the	DET
bam-10847	29	31	prevention	prevention	NOUN
bam-10847	29	32	of	of	ADP
bam-10847	29	33	malignancies	malignancy	NOUN
bam-10847	29	34	,	,	PUNCT
bam-10847	29	35	mutations	mutation	NOUN
bam-10847	29	36	in	in	ADP
bam-10847	29	37	the	the	DET
bam-10847	29	38	tp53	tp53	PROPN
bam-10847	29	39	gene	gene	NOUN
bam-10847	29	40	are	be	AUX
bam-10847	29	41	the	the	DET
bam-10847	29	42	most	most	ADV
bam-10847	29	43	common	common	ADJ
bam-10847	29	44	molecular	molecular	ADJ
bam-10847	29	45	defects	defect	NOUN
bam-10847	29	46	in	in	ADP
bam-10847	29	47	oscc	oscc	ADJ
bam-10847	29	48	.	.	PUNCT
bam-10847	30	1	in	in	ADP
bam-10847	30	2	iranian	iranian	ADJ
bam-10847	30	3	population	population	NOUN
bam-10847	30	4	,	,	PUNCT
bam-10847	30	5	oscc	oscc	ADV
bam-10847	30	6	is	be	AUX
bam-10847	30	7	a	a	DET
bam-10847	30	8	common	common	ADJ
bam-10847	30	9	cancer	cancer	NOUN
bam-10847	30	10	;	;	PUNCT
bam-10847	30	11	however	however	ADV
bam-10847	30	12	,	,	PUNCT
bam-10847	30	13	a	a	DET
bam-10847	30	14	few	few	ADJ
bam-10847	30	15	studies	study	NOUN
bam-10847	30	16	with	with	ADP
bam-10847	30	17	limited	limited	ADJ
bam-10847	30	18	scopes	scope	NOUN
bam-10847	30	19	have	have	AUX
bam-10847	30	20	investigated	investigate	VERB
bam-10847	30	21	the	the	DET
bam-10847	30	22	correlation	correlation	NOUN
bam-10847	30	23	of	of	ADP
bam-10847	30	24	p53	p53	NOUN
bam-10847	30	25	protein	protein	NOUN
bam-10847	30	26	expression	expression	NOUN
bam-10847	30	27	with	with	ADP
bam-10847	30	28	development	development	NOUN
bam-10847	30	29	and	and	CCONJ
bam-10847	30	30	progression	progression	NOUN
bam-10847	30	31	of	of	ADP
bam-10847	30	32	osccs	osccs	NOUN
bam-10847	30	33	in	in	ADP
bam-10847	30	34	iranian	iranian	PROPN
bam-10847	30	35	patients.18	patients.18	PROPN
bam-10847	30	36	-	-	PUNCT
bam-10847	30	37	22	22	NUM
bam-10847	30	38	besides	besides	SCONJ
bam-10847	30	39	,	,	PUNCT
bam-10847	30	40	and	and	CCONJ
bam-10847	30	41	to	to	ADP
bam-10847	30	42	the	the	DET
bam-10847	30	43	best	good	ADJ
bam-10847	30	44	of	of	ADP
bam-10847	30	45	our	our	PRON
bam-10847	30	46	knowledge	knowledge	NOUN
bam-10847	30	47	,	,	PUNCT
bam-10847	30	48	there	there	PRON
bam-10847	30	49	is	be	VERB
bam-10847	30	50	n't	not	PART
bam-10847	30	51	any	any	DET
bam-10847	30	52	published	publish	VERB
bam-10847	30	53	study	study	NOUN
bam-10847	30	54	regarding	regard	VERB
bam-10847	30	55	the	the	DET
bam-10847	30	56	possible	possible	ADJ
bam-10847	30	57	changes	change	NOUN
bam-10847	30	58	in	in	ADP
bam-10847	30	59	the	the	DET
bam-10847	30	60	expression	expression	NOUN
bam-10847	30	61	of	of	ADP
bam-10847	30	62	mutant	mutant	ADJ
bam-10847	30	63	p53	p53	NOUN
bam-10847	30	64	protein	protein	NOUN
bam-10847	30	65	between	between	ADP
bam-10847	30	66	oscc	oscc	ADJ
bam-10847	30	67	patients	patient	NOUN
bam-10847	30	68	with	with	ADP
bam-10847	30	69	the	the	DET
bam-10847	30	70	primary	primary	ADJ
bam-10847	30	71	and	and	CCONJ
bam-10847	30	72	recurrence	recurrence	NOUN
bam-10847	30	73	tumors	tumor	NOUN
bam-10847	30	74	.	.	PUNCT
bam-10847	31	1	therefore	therefore	ADV
bam-10847	31	2	,	,	PUNCT
bam-10847	31	3	this	this	DET
bam-10847	31	4	study	study	NOUN
bam-10847	31	5	for	for	ADP
bam-10847	31	6	the	the	DET
bam-10847	31	7	first	first	ADJ
bam-10847	31	8	time	time	NOUN
bam-10847	31	9	,	,	PUNCT
bam-10847	31	10	aimed	aim	VERB
bam-10847	31	11	to	to	PART
bam-10847	31	12	compare	compare	VERB
bam-10847	31	13	the	the	DET
bam-10847	31	14	pattern	pattern	NOUN
bam-10847	31	15	of	of	ADP
bam-10847	31	16	p53mt	p53mt	VERB
bam-10847	31	17	protein	protein	NOUN
bam-10847	31	18	expression	expression	NOUN
bam-10847	31	19	in	in	ADP
bam-10847	31	20	iranian	iranian	ADJ
bam-10847	31	21	patients	patient	NOUN
bam-10847	31	22	with	with	ADP
bam-10847	31	23	primary	primary	ADJ
bam-10847	31	24	and	and	CCONJ
bam-10847	31	25	recurrence	recurrence	NOUN
bam-10847	31	26	oscc	oscc	ADJ
bam-10847	31	27	.	.	PUNCT
bam-10847	32	1	materials	material	NOUN
bam-10847	32	2	and	and	CCONJ
bam-10847	32	3	methods	method	NOUN
bam-10847	32	4	ethics	ethic	NOUN
bam-10847	32	5	the	the	DET
bam-10847	32	6	protocol	protocol	NOUN
bam-10847	32	7	of	of	ADP
bam-10847	32	8	this	this	DET
bam-10847	32	9	study	study	NOUN
bam-10847	32	10	was	be	AUX
bam-10847	32	11	approved	approve	VERB
bam-10847	32	12	by	by	ADP
bam-10847	32	13	local	local	ADJ
bam-10847	32	14	ethics	ethic	NOUN
bam-10847	32	15	committee	committee	PROPN
bam-10847	32	16	of	of	ADP
bam-10847	32	17	shiraz	shiraz	PROPN
bam-10847	32	18	university	university	PROPN
bam-10847	32	19	of	of	ADP
bam-10847	32	20	medical	medical	ADJ
bam-10847	32	21	sciences	sciences	PROPN
bam-10847	32	22	,	,	PUNCT
bam-10847	32	23	shiraz	shiraz	PROPN
bam-10847	32	24	,	,	PUNCT
bam-10847	32	25	iran	iran	PROPN
bam-10847	32	26	(	(	PUNCT
bam-10847	32	27	approval	approval	NOUN
bam-10847	32	28	i	i	PROPN
bam-10847	32	29	d	d	NOUN
bam-10847	32	30	:	:	PUNCT
bam-10847	32	31	ir.sums.dental.rec	ir.sums.dental.rec	NOUN
bam-10847	32	32	.	.	PUNCT
bam-10847	33	1	1401.017	1401.017	X
bam-10847	33	2	)	)	PUNCT
bam-10847	33	3	.	.	PUNCT
bam-10847	34	1	human	human	ADJ
bam-10847	34	2	participation	participation	NOUN
bam-10847	34	3	was	be	AUX
bam-10847	34	4	in	in	ADP
bam-10847	34	5	accordance	accordance	NOUN
bam-10847	34	6	with	with	ADP
bam-10847	34	7	the	the	DET
bam-10847	34	8	ethical	ethical	ADJ
bam-10847	34	9	standards	standard	NOUN
bam-10847	34	10	of	of	ADP
bam-10847	34	11	the	the	DET
bam-10847	34	12	institutional	institutional	ADJ
bam-10847	34	13	and/or	and/or	CCONJ
bam-10847	34	14	national	national	PROPN
bam-10847	34	15	research	research	PROPN
bam-10847	34	16	committee	committee	PROPN
bam-10847	34	17	as	as	ADV
bam-10847	34	18	well	well	ADV
bam-10847	34	19	as	as	ADP
bam-10847	34	20	the	the	DET
bam-10847	34	21	1964	1964	NUM
bam-10847	34	22	helsinki	helsinki	PROPN
bam-10847	34	23	declaration	declaration	PROPN
bam-10847	34	24	and	and	CCONJ
bam-10847	34	25	its	its	PRON
bam-10847	34	26	later	later	ADJ
bam-10847	34	27	amendments	amendment	NOUN
bam-10847	34	28	.	.	PUNCT
bam-10847	35	1	written	write	VERB
bam-10847	35	2	informed	informed	ADJ
bam-10847	35	3	consent	consent	NOUN
bam-10847	35	4	was	be	AUX
bam-10847	35	5	obtained	obtain	VERB
bam-10847	35	6	from	from	ADP
bam-10847	35	7	each	each	DET
bam-10847	35	8	participants	participant	NOUN
bam-10847	35	9	or	or	CCONJ
bam-10847	35	10	his	his	PRON
bam-10847	35	11	/	/	SYM
bam-10847	35	12	her	her	PRON
bam-10847	35	13	parent	parent	NOUN
bam-10847	35	14	or	or	CCONJ
bam-10847	35	15	guardians	guardian	NOUN
bam-10847	35	16	after	after	ADP
bam-10847	35	17	explaining	explain	VERB
bam-10847	35	18	the	the	DET
bam-10847	35	19	study	study	NOUN
bam-10847	35	20	protocol	protocol	NOUN
bam-10847	35	21	and	and	CCONJ
bam-10847	35	22	objectives	objective	NOUN
bam-10847	35	23	.	.	PUNCT
bam-10847	36	1	in	in	ADP
bam-10847	36	2	this	this	DET
bam-10847	36	3	retrospective	retrospective	ADJ
bam-10847	36	4	cross	cross	ADJ
bam-10847	36	5	-	-	ADJ
bam-10847	36	6	sectional	sectional	ADJ
bam-10847	36	7	study	study	NOUN
bam-10847	36	8	,	,	PUNCT
bam-10847	36	9	a	a	DET
bam-10847	36	10	total	total	NOUN
bam-10847	36	11	of	of	ADP
bam-10847	36	12	122	122	NUM
bam-10847	36	13	iranian	iranian	ADJ
bam-10847	36	14	patients	patient	NOUN
bam-10847	36	15	with	with	ADP
bam-10847	36	16	a	a	DET
bam-10847	36	17	pathologically	pathologically	ADV
bam-10847	36	18	confirmed	confirm	VERB
bam-10847	36	19	diagnosis	diagnosis	NOUN
bam-10847	36	20	of	of	ADP
bam-10847	36	21	the	the	DET
bam-10847	36	22	primary	primary	NOUN
bam-10847	36	23	oscc	oscc	ADV
bam-10847	36	24	were	be	AUX
bam-10847	36	25	enrolled	enrol	VERB
bam-10847	36	26	,	,	PUNCT
bam-10847	36	27	without	without	ADP
bam-10847	36	28	any	any	DET
bam-10847	36	29	limitation	limitation	NOUN
bam-10847	36	30	in	in	ADP
bam-10847	36	31	age	age	NOUN
bam-10847	36	32	and	and	CCONJ
bam-10847	36	33	gender	gender	NOUN
bam-10847	36	34	.	.	PUNCT
bam-10847	37	1	all	all	DET
bam-10847	37	2	patients	patient	NOUN
bam-10847	37	3	were	be	AUX
bam-10847	37	4	referred	refer	VERB
bam-10847	37	5	to	to	ADP
bam-10847	37	6	namazi	namazi	VERB
bam-10847	37	7	hospital	hospital	NOUN
bam-10847	37	8	,	,	PUNCT
bam-10847	37	9	khalili	khalili	PROPN
bam-10847	37	10	hospital	hospital	PROPN
bam-10847	37	11	,	,	PUNCT
bam-10847	37	12	or	or	CCONJ
bam-10847	37	13	madar	madar	PROPN
bam-10847	37	14	va	va	PROPN
bam-10847	37	15	kodak	kodak	PROPN
bam-10847	37	16	hospital	hospital	PROPN
bam-10847	37	17	,	,	PUNCT
bam-10847	37	18	all	all	PRON
bam-10847	37	19	affiliated	affiliate	VERB
bam-10847	37	20	with	with	ADP
bam-10847	37	21	the	the	DET
bam-10847	37	22	shiraz	shiraz	PROPN
bam-10847	37	23	university	university	PROPN
bam-10847	37	24	of	of	ADP
bam-10847	37	25	medical	medical	ADJ
bam-10847	37	26	sciences	sciences	PROPN
bam-10847	37	27	,	,	PUNCT
bam-10847	37	28	shiraz	shiraz	PROPN
bam-10847	37	29	,	,	PUNCT
bam-10847	37	30	iran	iran	PROPN
bam-10847	37	31	between	between	ADP
bam-10847	37	32	march	march	PROPN
bam-10847	37	33	2012	2012	NUM
bam-10847	37	34	and	and	CCONJ
bam-10847	37	35	2022	2022	NUM
bam-10847	37	36	(	(	PUNCT
bam-10847	37	37	over	over	ADP
bam-10847	37	38	a	a	DET
bam-10847	37	39	period	period	NOUN
bam-10847	37	40	of	of	ADP
bam-10847	37	41	10	10	NUM
bam-10847	37	42	years	year	NOUN
bam-10847	37	43	)	)	PUNCT
bam-10847	37	44	.	.	PUNCT
bam-10847	38	1	medical	medical	ADJ
bam-10847	38	2	records	record	NOUN
bam-10847	38	3	were	be	AUX
bam-10847	38	4	obtained	obtain	VERB
bam-10847	38	5	from	from	ADP
bam-10847	38	6	the	the	DET
bam-10847	38	7	patients	patient	NOUN
bam-10847	38	8	'	'	PART
bam-10847	38	9	database	database	NOUN
bam-10847	38	10	.	.	PUNCT
bam-10847	39	1	patients	patient	NOUN
bam-10847	39	2	with	with	ADP
bam-10847	39	3	a	a	DET
bam-10847	39	4	history	history	NOUN
bam-10847	39	5	of	of	ADP
bam-10847	39	6	systemic	systemic	ADJ
bam-10847	39	7	or	or	CCONJ
bam-10847	39	8	inflammatory	inflammatory	ADJ
bam-10847	39	9	diseases	disease	NOUN
bam-10847	39	10	or	or	CCONJ
bam-10847	39	11	a	a	DET
bam-10847	39	12	history	history	NOUN
bam-10847	39	13	of	of	ADP
bam-10847	39	14	radio	radio	NOUN
bam-10847	39	15	/	/	SYM
bam-10847	39	16	chemotherapy	chemotherapy	NOUN
bam-10847	39	17	prior	prior	ADV
bam-10847	39	18	to	to	ADP
bam-10847	39	19	the	the	DET
bam-10847	39	20	first	first	ADJ
bam-10847	39	21	surgical	surgical	ADJ
bam-10847	39	22	treatment	treatment	NOUN
bam-10847	39	23	as	as	ADV
bam-10847	39	24	well	well	ADV
bam-10847	39	25	as	as	ADP
bam-10847	39	26	those	those	PRON
bam-10847	39	27	with	with	ADP
bam-10847	39	28	evidence	evidence	NOUN
bam-10847	39	29	of	of	ADP
bam-10847	39	30	tumors	tumor	NOUN
bam-10847	39	31	,	,	PUNCT
bam-10847	39	32	except	except	SCONJ
bam-10847	39	33	oscc	oscc	ADV
bam-10847	39	34	were	be	AUX
bam-10847	39	35	excluded	exclude	VERB
bam-10847	39	36	.	.	PUNCT
bam-10847	40	1	all	all	DET
bam-10847	40	2	patients	patient	NOUN
bam-10847	40	3	were	be	AUX
bam-10847	40	4	routinely	routinely	ADV
bam-10847	40	5	followed	follow	VERB
bam-10847	40	6	-	-	PUNCT
bam-10847	40	7	up	up	ADP
bam-10847	40	8	according	accord	VERB
bam-10847	40	9	to	to	ADP
bam-10847	40	10	the	the	DET
bam-10847	40	11	institutional	institutional	ADJ
bam-10847	40	12	guidelines	guideline	NOUN
bam-10847	40	13	.	.	PUNCT
bam-10847	41	1	the	the	DET
bam-10847	41	2	mean	mean	ADJ
bam-10847	41	3	follow	follow	VERB
bam-10847	41	4	-	-	PUNCT
bam-10847	41	5	up	up	ADP
bam-10847	41	6	duration	duration	NOUN
bam-10847	41	7	of	of	ADP
bam-10847	41	8	the	the	DET
bam-10847	41	9	enrolled	enrol	VERB
bam-10847	41	10	patients	patient	NOUN
bam-10847	41	11	was	be	AUX
bam-10847	41	12	36	36	NUM
bam-10847	41	13	months	month	NOUN
bam-10847	41	14	.	.	PUNCT
bam-10847	42	1	the	the	DET
bam-10847	42	2	control	control	NOUN
bam-10847	42	3	group	group	NOUN
bam-10847	42	4	of	of	ADP
bam-10847	42	5	this	this	DET
bam-10847	42	6	study	study	NOUN
bam-10847	42	7	(	(	PUNCT
bam-10847	42	8	n=80	n=80	PROPN
bam-10847	42	9	)	)	PUNCT
bam-10847	42	10	was	be	AUX
bam-10847	42	11	selected	select	VERB
bam-10847	42	12	from	from	ADP
bam-10847	42	13	those	those	PRON
bam-10847	42	14	without	without	ADP
bam-10847	42	15	a	a	DET
bam-10847	42	16	history	history	NOUN
bam-10847	42	17	of	of	ADP
bam-10847	42	18	cancer	cancer	NOUN
bam-10847	42	19	,	,	PUNCT
bam-10847	42	20	who	who	PRON
bam-10847	42	21	were	be	AUX
bam-10847	42	22	referred	refer	VERB
bam-10847	42	23	to	to	ADP
bam-10847	42	24	shiraz	shiraz	PROPN
bam-10847	42	25	dentistry	dentistry	PROPN
bam-10847	42	26	school	school	NOUN
bam-10847	42	27	for	for	ADP
bam-10847	42	28	evaluating	evaluate	VERB
bam-10847	42	29	different	different	ADJ
bam-10847	42	30	types	type	NOUN
bam-10847	42	31	of	of	ADP
bam-10847	42	32	noncancerous	noncancerous	ADJ
bam-10847	42	33	reactive	reactive	ADJ
bam-10847	42	34	lesions	lesion	NOUN
bam-10847	42	35	of	of	ADP
bam-10847	42	36	the	the	DET
bam-10847	42	37	oral	oral	ADJ
bam-10847	42	38	cavity	cavity	NOUN
bam-10847	42	39	.	.	PUNCT
bam-10847	43	1	they	they	PRON
bam-10847	43	2	fulfilled	fulfil	VERB
bam-10847	43	3	all	all	DET
bam-10847	43	4	exclusion	exclusion	NOUN
bam-10847	43	5	criteria	criterion	NOUN
bam-10847	43	6	mentioned	mention	VERB
bam-10847	43	7	above	above	ADV
bam-10847	43	8	,	,	PUNCT
bam-10847	43	9	and	and	CCONJ
bam-10847	43	10	were	be	AUX
bam-10847	43	11	matched	match	VERB
bam-10847	43	12	by	by	ADP
bam-10847	43	13	age	age	NOUN
bam-10847	43	14	and	and	CCONJ
bam-10847	43	15	gender	gender	NOUN
bam-10847	43	16	to	to	ADP
bam-10847	43	17	each	each	DET
bam-10847	43	18	case	case	NOUN
bam-10847	43	19	.	.	PUNCT
bam-10847	44	1	sample	sample	NOUN
bam-10847	44	2	collection	collection	NOUN
bam-10847	44	3	the	the	DET
bam-10847	44	4	paraffin	paraffin	NOUN
bam-10847	44	5	-	-	PUNCT
bam-10847	44	6	embedded	embed	VERB
bam-10847	44	7	tissue	tissue	NOUN
bam-10847	44	8	blocks	block	NOUN
bam-10847	44	9	were	be	AUX
bam-10847	44	10	retrieved	retrieve	VERB
bam-10847	44	11	from	from	ADP
bam-10847	44	12	the	the	DET
bam-10847	44	13	archives	archive	NOUN
bam-10847	44	14	of	of	ADP
bam-10847	44	15	the	the	DET
bam-10847	44	16	pathology	pathology	PROPN
bam-10847	44	17	department	department	NOUN
bam-10847	44	18	of	of	ADP
bam-10847	44	19	school	school	NOUN
bam-10847	44	20	of	of	ADP
bam-10847	44	21	dentistry	dentistry	NOUN
bam-10847	44	22	,	,	PUNCT
bam-10847	44	23	shiraz	shiraz	PROPN
bam-10847	44	24	university	university	PROPN
bam-10847	44	25	of	of	ADP
bam-10847	44	26	medical	medical	ADJ
bam-10847	44	27	sciences	sciences	PROPN
bam-10847	44	28	,	,	PUNCT
bam-10847	44	29	shiraz	shiraz	PROPN
bam-10847	44	30	,	,	PUNCT
bam-10847	44	31	iran	iran	PROPN
bam-10847	44	32	.	.	PUNCT
bam-10847	45	1	the	the	DET
bam-10847	45	2	serial	serial	ADJ
bam-10847	45	3	sections	section	NOUN
bam-10847	45	4	of	of	ADP
bam-10847	45	5	5	5	NUM
bam-10847	45	6	μm	μm	NOUN
bam-10847	45	7	thicknesses	thickness	NOUN
bam-10847	45	8	were	be	AUX
bam-10847	45	9	cut	cut	VERB
bam-10847	45	10	using	use	VERB
bam-10847	45	11	a	a	DET
bam-10847	45	12	microtome	microtome	NOUN
bam-10847	45	13	(	(	PUNCT
bam-10847	45	14	did	do	AUX
bam-10847	45	15	sabz	sabz	PROPN
bam-10847	45	16	co.	co.	PROPN
bam-10847	45	17	,	,	PUNCT
bam-10847	45	18	iran	iran	PROPN
bam-10847	45	19	)	)	PUNCT
bam-10847	45	20	,	,	PUNCT
bam-10847	45	21	and	and	CCONJ
bam-10847	45	22	stained	stain	VERB
bam-10847	45	23	with	with	ADP
bam-10847	45	24	hematoxylin	hematoxylin	NOUN
bam-10847	45	25	and	and	CCONJ
bam-10847	45	26	eosin	eosin	NOUN
bam-10847	45	27	(	(	PUNCT
bam-10847	45	28	h	h	NOUN
bam-10847	45	29	&	&	CCONJ
bam-10847	45	30	e	e	NOUN
bam-10847	45	31	)	)	PUNCT
bam-10847	45	32	.	.	PUNCT
bam-10847	46	1	slides	slide	NOUN
bam-10847	46	2	were	be	AUX
bam-10847	46	3	re	re	VERB
bam-10847	46	4	-	-	VERB
bam-10847	46	5	evaluated	evaluate	VERB
bam-10847	46	6	by	by	ADP
bam-10847	46	7	two	two	NUM
bam-10847	46	8	independent	independent	ADJ
bam-10847	46	9	oral	oral	ADJ
bam-10847	46	10	and	and	CCONJ
bam-10847	46	11	maxillofacial	maxillofacial	ADJ
bam-10847	46	12	pathologists	pathologist	NOUN
bam-10847	46	13	using	use	VERB
bam-10847	46	14	a	a	DET
bam-10847	46	15	double	double	ADJ
bam-10847	46	16	-	-	PUNCT
bam-10847	46	17	headed	head	VERB
bam-10847	46	18	microscope	microscope	NOUN
bam-10847	46	19	(	(	PUNCT
bam-10847	46	20	olympus	olympus	PROPN
bam-10847	46	21	bx51	bx51	PROPN
bam-10847	46	22	)	)	PUNCT
bam-10847	46	23	to	to	PART
bam-10847	46	24	confirm	confirm	VERB
bam-10847	46	25	the	the	DET
bam-10847	46	26	initial	initial	ADJ
bam-10847	46	27	diagnosis	diagnosis	NOUN
bam-10847	46	28	of	of	ADP
bam-10847	46	29	oscc	oscc	ADJ
bam-10847	46	30	.	.	PUNCT
bam-10847	47	1	the	the	DET
bam-10847	47	2	clinical	clinical	ADJ
bam-10847	47	3	staging	staging	NOUN
bam-10847	47	4	of	of	ADP
bam-10847	47	5	patients	patient	NOUN
bam-10847	47	6	was	be	AUX
bam-10847	47	7	determined	determine	VERB
bam-10847	47	8	according	accord	VERB
bam-10847	47	9	to	to	ADP
bam-10847	47	10	the	the	DET
bam-10847	47	11	tumor	tumor	NOUN
bam-10847	47	12	,	,	PUNCT
bam-10847	47	13	node	node	NOUN
bam-10847	47	14	,	,	PUNCT
bam-10847	47	15	and	and	CCONJ
bam-10847	47	16	metastasis	metastasis	NOUN
bam-10847	47	17	(	(	PUNCT
bam-10847	47	18	tnm	tnm	NOUN
bam-10847	47	19	)	)	PUNCT
bam-10847	47	20	staging	staging	NOUN
bam-10847	47	21	system	system	NOUN
bam-10847	47	22	of	of	ADP
bam-10847	47	23	the	the	DET
bam-10847	47	24	american	american	PROPN
bam-10847	47	25	joint	joint	PROPN
bam-10847	47	26	committee	committee	PROPN
bam-10847	47	27	on	on	ADP
bam-10847	47	28	cancer	cancer	NOUN
bam-10847	47	29	(	(	PUNCT
bam-10847	47	30	ajcc	ajcc	PROPN
bam-10847	47	31	)	)	PUNCT
bam-10847	47	32	.	.	PUNCT
bam-10847	48	1	the	the	DET
bam-10847	48	2	histopathological	histopathological	ADJ
bam-10847	48	3	grade	grade	NOUN
bam-10847	48	4	of	of	ADP
bam-10847	48	5	oscc	oscc	PROPN
bam-10847	48	6	was	be	AUX
bam-10847	48	7	determined	determine	VERB
bam-10847	48	8	based	base	VERB
bam-10847	48	9	on	on	ADP
bam-10847	48	10	world	world	NOUN
bam-10847	48	11	health	health	NOUN
bam-10847	48	12	organization	organization	NOUN
bam-10847	48	13	(	(	PUNCT
bam-10847	48	14	who	who	PRON
bam-10847	48	15	)	)	PUNCT
bam-10847	48	16	criteria,23	criteria,23	NOUN
bam-10847	48	17	and	and	CCONJ
bam-10847	48	18	broder	broder	PROPN
bam-10847	48	19	's	's	PART
bam-10847	48	20	classification	classification	NOUN
bam-10847	48	21	for	for	ADP
bam-10847	48	22	histopathologic	histopathologic	ADJ
bam-10847	48	23	grading.24	grading.24	NOUN
bam-10847	48	24	finally	finally	ADV
bam-10847	48	25	,	,	PUNCT
bam-10847	48	26	the	the	DET
bam-10847	48	27	paraffin	paraffin	NOUN
bam-10847	48	28	-	-	PUNCT
bam-10847	48	29	embedded	embed	VERB
bam-10847	48	30	tissue	tissue	NOUN
bam-10847	48	31	blocks	block	NOUN
bam-10847	48	32	with	with	ADP
bam-10847	48	33	adequate	adequate	ADJ
bam-10847	48	34	tissue	tissue	NOUN
bam-10847	48	35	and	and	CCONJ
bam-10847	48	36	definite	definite	ADJ
bam-10847	48	37	diagnosis	diagnosis	NOUN
bam-10847	48	38	were	be	AUX
bam-10847	48	39	selected	select	VERB
bam-10847	48	40	.	.	PUNCT
bam-10847	49	1	immunohistochemical	immunohistochemical	ADJ
bam-10847	49	2	staining	stain	VERB
bam-10847	49	3	the	the	DET
bam-10847	49	4	sections	section	NOUN
bam-10847	49	5	with	with	ADP
bam-10847	49	6	4	4	NUM
bam-10847	49	7	μm	μm	NUM
bam-10847	49	8	thickness	thickness	NOUN
bam-10847	49	9	were	be	AUX
bam-10847	49	10	made	make	VERB
bam-10847	49	11	and	and	CCONJ
bam-10847	49	12	mounted	mount	VERB
bam-10847	49	13	on	on	ADP
bam-10847	49	14	poly	poly	ADJ
bam-10847	49	15	-	-	PUNCT
bam-10847	49	16	l	l	NOUN
bam-10847	49	17	-	-	PUNCT
bam-10847	49	18	lysine	lysine	NOUN
bam-10847	49	19	-	-	PUNCT
bam-10847	49	20	coated	coat	VERB
bam-10847	49	21	glass	glass	NOUN
bam-10847	49	22	slides	slide	NOUN
bam-10847	49	23	for	for	ADP
bam-10847	49	24	immunohistochemistry	immunohistochemistry	NOUN
bam-10847	49	25	(	(	PUNCT
bam-10847	49	26	ihc	ihc	PROPN
bam-10847	49	27	)	)	PUNCT
bam-10847	49	28	analysis	analysis	NOUN
bam-10847	49	29	,	,	PUNCT
bam-10847	49	30	according	accord	VERB
bam-10847	49	31	to	to	ADP
bam-10847	49	32	the	the	DET
bam-10847	49	33	instructions	instruction	NOUN
bam-10847	49	34	provided	provide	VERB
bam-10847	49	35	by	by	ADP
bam-10847	49	36	the	the	DET
bam-10847	49	37	manufacturers	manufacturer	NOUN
bam-10847	49	38	.	.	PUNCT
bam-10847	50	1	after	after	ADP
bam-10847	50	2	deparaffinization	deparaffinization	NOUN
bam-10847	50	3	in	in	ADP
bam-10847	50	4	xylene	xylene	NOUN
bam-10847	50	5	and	and	CCONJ
bam-10847	50	6	dehydration	dehydration	NOUN
bam-10847	50	7	in	in	ADP
bam-10847	50	8	alcohol	alcohol	NOUN
bam-10847	50	9	,	,	PUNCT
bam-10847	50	10	the	the	DET
bam-10847	50	11	activity	activity	NOUN
bam-10847	50	12	of	of	ADP
bam-10847	50	13	endogenous	endogenous	ADJ
bam-10847	50	14	peroxidase	peroxidase	NOUN
bam-10847	50	15	was	be	AUX
bam-10847	50	16	blocked	block	VERB
bam-10847	50	17	using	use	VERB
bam-10847	50	18	0.3	0.3	NUM
bam-10847	50	19	%	%	NOUN
bam-10847	50	20	hydrogen	hydrogen	NOUN
bam-10847	50	21	peroxide	peroxide	NOUN
bam-10847	50	22	solution	solution	NOUN
bam-10847	50	23	in	in	ADP
bam-10847	50	24	methanol	methanol	NOUN
bam-10847	50	25	for	for	ADP
bam-10847	50	26	half	half	DET
bam-10847	50	27	an	an	DET
bam-10847	50	28	hour	hour	NOUN
bam-10847	50	29	.	.	PUNCT
bam-10847	51	1	antigen	antigen	PROPN
bam-10847	51	2	retrieval	retrieval	NOUN
bam-10847	51	3	was	be	AUX
bam-10847	51	4	performed	perform	VERB
bam-10847	51	5	using	use	VERB
bam-10847	51	6	0.1	0.1	NUM
bam-10847	51	7	m	m	NOUN
bam-10847	51	8	sodium	sodium	NOUN
bam-10847	51	9	citrate	citrate	NOUN
bam-10847	51	10	buffer	buffer	NOUN
bam-10847	51	11	(	(	PUNCT
bam-10847	51	12	ph=6.0	ph=6.0	NOUN
bam-10847	51	13	)	)	PUNCT
bam-10847	51	14	and	and	CCONJ
bam-10847	51	15	then	then	ADV
bam-10847	51	16	,	,	PUNCT
bam-10847	51	17	slides	slide	NOUN
bam-10847	51	18	were	be	AUX
bam-10847	51	19	non	non	ADJ
bam-10847	51	20	-co	-co	PROPN
bam-10847	51	21	mmerc	mmerc	PROPN
bam-10847	51	22	ial	ial	PROPN
bam-10847	51	23	us	us	PROPN
bam-10847	51	24	e	e	NOUN
bam-10847	51	25	o	o	NOUN
bam-10847	51	26	nly	nly	ADV
bam-10847	51	27	p53	p53	VERB
bam-10847	51	28	mutant	mutant	NOUN
bam-10847	51	29	-	-	PUNCT
bam-10847	51	30	type	type	NOUN
bam-10847	51	31	in	in	ADP
bam-10847	51	32	oral	oral	ADJ
bam-10847	51	33	squamous	squamous	ADJ
bam-10847	51	34	cell	cell	NOUN
bam-10847	51	35	carcinoma	carcinoma	NOUN
bam-10847	51	36	eur	eur	PROPN
bam-10847	51	37	j	j	PROPN
bam-10847	51	38	transl	transl	PROPN
bam-10847	51	39	myol	myol	ADV
bam-10847	51	40	33	33	NUM
bam-10847	51	41	(	(	PUNCT
bam-10847	51	42	1	1	NUM
bam-10847	51	43	)	)	PUNCT
bam-10847	51	44	10847	10847	NUM
bam-10847	51	45	,	,	PUNCT
bam-10847	51	46	2023	2023	NUM
bam-10847	51	47	doi	doi	NOUN
bam-10847	51	48	:	:	PUNCT
bam-10847	51	49	10.4081	10.4081	NUM
bam-10847	51	50	/	/	SYM
bam-10847	51	51	ejtm.2023.10847	ejtm.2023.10847	PROPN
bam-10847	51	52	3	3	NUM
bam-10847	51	53	microwaved	microwave	VERB
bam-10847	51	54	twice	twice	ADV
bam-10847	51	55	for	for	ADP
bam-10847	51	56	15	15	NUM
bam-10847	51	57	minutes	minute	NOUN
bam-10847	51	58	.	.	PUNCT
bam-10847	52	1	the	the	DET
bam-10847	52	2	sections	section	NOUN
bam-10847	52	3	were	be	AUX
bam-10847	52	4	incubated	incubate	VERB
bam-10847	52	5	for	for	ADP
bam-10847	52	6	30	30	NUM
bam-10847	52	7	minutes	minute	NOUN
bam-10847	52	8	at	at	ADP
bam-10847	52	9	room	room	NOUN
bam-10847	52	10	temperature	temperature	NOUN
bam-10847	52	11	with	with	ADP
bam-10847	52	12	the	the	DET
bam-10847	52	13	primary	primary	ADJ
bam-10847	52	14	monoclonal	monoclonal	NOUN
bam-10847	52	15	antibody	antibody	NOUN
bam-10847	52	16	against	against	ADP
bam-10847	52	17	p53	p53	NOUN
bam-10847	52	18	(	(	PUNCT
bam-10847	52	19	do-7	do-7	PROPN
bam-10847	52	20	,	,	PUNCT
bam-10847	52	21	dako	dako	PROPN
bam-10847	52	22	sa	sa	PROPN
bam-10847	52	23	,	,	PUNCT
bam-10847	52	24	glostrup	glostrup	NOUN
bam-10847	52	25	,	,	PUNCT
bam-10847	52	26	denmark	denmark	NOUN
bam-10847	52	27	)	)	PUNCT
bam-10847	52	28	using	use	VERB
bam-10847	52	29	dilution	dilution	NOUN
bam-10847	52	30	of	of	ADP
bam-10847	52	31	1:50	1:50	NUM
bam-10847	52	32	.	.	PUNCT
bam-10847	53	1	subsequently	subsequently	ADV
bam-10847	53	2	,	,	PUNCT
bam-10847	53	3	the	the	DET
bam-10847	53	4	sections	section	NOUN
bam-10847	53	5	were	be	AUX
bam-10847	53	6	incubated	incubate	VERB
bam-10847	53	7	with	with	ADP
bam-10847	53	8	avidinbiotin	avidinbiotin	ADJ
bam-10847	53	9	-	-	PUNCT
bam-10847	53	10	peroxidase	peroxidase	NOUN
bam-10847	53	11	complex	complex	NOUN
bam-10847	53	12	followed	follow	VERB
bam-10847	53	13	by	by	ADP
bam-10847	53	14	immersion	immersion	NOUN
bam-10847	53	15	in	in	ADP
bam-10847	53	16	diaminobenzidine	diaminobenzidine	ADJ
bam-10847	53	17	-	-	PUNCT
bam-10847	53	18	h2o2	h2o2	NOUN
bam-10847	53	19	substrate	substrate	NOUN
bam-10847	53	20	(	(	PUNCT
bam-10847	53	21	5	5	NUM
bam-10847	53	22	minutes	minute	NOUN
bam-10847	53	23	,	,	PUNCT
bam-10847	53	24	room	room	NOUN
bam-10847	53	25	temperature	temperature	NOUN
bam-10847	53	26	)	)	PUNCT
bam-10847	53	27	for	for	ADP
bam-10847	53	28	chromogen	chromogen	NOUN
bam-10847	53	29	development	development	NOUN
bam-10847	53	30	.	.	PUNCT
bam-10847	54	1	finally	finally	ADV
bam-10847	54	2	,	,	PUNCT
bam-10847	54	3	the	the	DET
bam-10847	54	4	sections	section	NOUN
bam-10847	54	5	were	be	AUX
bam-10847	54	6	counterstained	counterstaine	VERB
bam-10847	54	7	with	with	ADP
bam-10847	54	8	mayer	mayer	PROPN
bam-10847	54	9	's	's	PART
bam-10847	54	10	haematoxylin	haematoxylin	NOUN
bam-10847	54	11	.	.	PUNCT
bam-10847	55	1	the	the	DET
bam-10847	55	2	slides	slide	NOUN
bam-10847	55	3	were	be	AUX
bam-10847	55	4	rinsed	rinse	VERB
bam-10847	55	5	under	under	ADP
bam-10847	55	6	running	run	VERB
bam-10847	55	7	water	water	NOUN
bam-10847	55	8	,	,	PUNCT
bam-10847	55	9	dried	dry	VERB
bam-10847	55	10	,	,	PUNCT
bam-10847	55	11	and	and	CCONJ
bam-10847	55	12	covered	cover	VERB
bam-10847	55	13	with	with	ADP
bam-10847	55	14	a	a	DET
bam-10847	55	15	cover	cover	NOUN
bam-10847	55	16	slip	slip	NOUN
bam-10847	55	17	.	.	PUNCT
bam-10847	56	1	samples	sample	NOUN
bam-10847	56	2	of	of	ADP
bam-10847	56	3	the	the	DET
bam-10847	56	4	control	control	NOUN
bam-10847	56	5	group	group	NOUN
bam-10847	56	6	were	be	AUX
bam-10847	56	7	also	also	ADV
bam-10847	56	8	stained	stain	VERB
bam-10847	56	9	with	with	ADP
bam-10847	56	10	the	the	DET
bam-10847	56	11	same	same	ADJ
bam-10847	56	12	amount	amount	NOUN
bam-10847	56	13	of	of	ADP
bam-10847	56	14	antibody	antibody	NOUN
bam-10847	56	15	used	use	VERB
bam-10847	56	16	for	for	ADP
bam-10847	56	17	staining	stain	VERB
bam-10847	56	18	of	of	ADP
bam-10847	56	19	tumoral	tumoral	ADJ
bam-10847	56	20	tissue	tissue	NOUN
bam-10847	56	21	.	.	PUNCT
bam-10847	57	1	the	the	DET
bam-10847	57	2	negative	negative	ADJ
bam-10847	57	3	control	control	PROPN
bam-10847	57	4	sample	sample	NOUN
bam-10847	57	5	underwent	undergo	VERB
bam-10847	57	6	all	all	DET
bam-10847	57	7	the	the	DET
bam-10847	57	8	staining	stain	VERB
bam-10847	57	9	procedure	procedure	NOUN
bam-10847	57	10	,	,	PUNCT
bam-10847	57	11	but	but	CCONJ
bam-10847	57	12	incubated	incubate	VERB
bam-10847	57	13	with	with	ADP
bam-10847	57	14	phosphate	phosphate	NOUN
bam-10847	57	15	-	-	PUNCT
bam-10847	57	16	buffered	buffer	VERB
bam-10847	57	17	saline	saline	NOUN
bam-10847	57	18	instead	instead	ADV
bam-10847	57	19	of	of	ADP
bam-10847	57	20	the	the	DET
bam-10847	57	21	primary	primary	ADJ
bam-10847	57	22	antibody	antibody	NOUN
bam-10847	57	23	.	.	PUNCT
bam-10847	58	1	the	the	DET
bam-10847	58	2	stained	stain	VERB
bam-10847	58	3	slides	slide	NOUN
bam-10847	58	4	were	be	AUX
bam-10847	58	5	evaluated	evaluate	VERB
bam-10847	58	6	by	by	ADP
bam-10847	58	7	two	two	NUM
bam-10847	58	8	oral	oral	ADJ
bam-10847	58	9	and	and	CCONJ
bam-10847	58	10	maxillofacial	maxillofacial	ADJ
bam-10847	58	11	pathologists	pathologist	NOUN
bam-10847	58	12	blinded	blind	VERB
bam-10847	58	13	to	to	ADP
bam-10847	58	14	the	the	DET
bam-10847	58	15	clinical	clinical	ADJ
bam-10847	58	16	data	datum	NOUN
bam-10847	58	17	,	,	PUNCT
bam-10847	58	18	and	and	CCONJ
bam-10847	58	19	possible	possible	ADJ
bam-10847	58	20	disagreements	disagreement	NOUN
bam-10847	58	21	were	be	AUX
bam-10847	58	22	resolved	resolve	VERB
bam-10847	58	23	by	by	ADP
bam-10847	58	24	consensus	consensus	NOUN
bam-10847	58	25	.	.	PUNCT
bam-10847	59	1	the	the	DET
bam-10847	59	2	labeling	labeling	NOUN
bam-10847	59	3	index	index	NOUN
bam-10847	59	4	(	(	PUNCT
bam-10847	59	5	li	li	PROPN
bam-10847	59	6	)	)	PUNCT
bam-10847	59	7	for	for	ADP
bam-10847	59	8	p53	p53	NOUN
bam-10847	59	9	was	be	AUX
bam-10847	59	10	calculated	calculate	VERB
bam-10847	59	11	by	by	ADP
bam-10847	59	12	assessing	assess	VERB
bam-10847	59	13	the	the	DET
bam-10847	59	14	nuclear	nuclear	ADJ
bam-10847	59	15	immunopositivity	immunopositivity	NOUN
bam-10847	59	16	in	in	ADP
bam-10847	59	17	1000	1000	NUM
bam-10847	59	18	neoplastic	neoplastic	ADJ
bam-10847	59	19	cells	cell	NOUN
bam-10847	59	20	in	in	ADP
bam-10847	59	21	10	10	NUM
bam-10847	59	22	hpfs	hpf	NOUN
bam-10847	59	23	.	.	PUNCT
bam-10847	60	1	samples	sample	NOUN
bam-10847	60	2	with	with	ADP
bam-10847	60	3	≥10	≥10	ADP
bam-10847	60	4	%	%	NOUN
bam-10847	60	5	immunostaining	immunostaine	VERB
bam-10847	60	6	were	be	AUX
bam-10847	60	7	considered	consider	VERB
bam-10847	60	8	p53	p53	NOUN
bam-10847	60	9	-	-	PUNCT
bam-10847	60	10	positive.25	positive.25	NOUN
bam-10847	60	11	statistical	statistical	ADJ
bam-10847	60	12	analysis	analysis	NOUN
bam-10847	60	13	all	all	DET
bam-10847	60	14	statistical	statistical	ADJ
bam-10847	60	15	analyses	analysis	NOUN
bam-10847	60	16	were	be	AUX
bam-10847	60	17	carried	carry	VERB
bam-10847	60	18	out	out	ADP
bam-10847	60	19	using	use	VERB
bam-10847	60	20	spss	spss	PROPN
bam-10847	60	21	version	version	NOUN
bam-10847	60	22	22.0	22.0	NUM
bam-10847	60	23	(	(	PUNCT
bam-10847	60	24	ibm	ibm	PROPN
bam-10847	60	25	,	,	PUNCT
bam-10847	60	26	armonk	armonk	PROPN
bam-10847	60	27	,	,	PUNCT
bam-10847	60	28	ny	ny	PROPN
bam-10847	60	29	,	,	PUNCT
bam-10847	60	30	usa	usa	PROPN
bam-10847	60	31	)	)	PUNCT
bam-10847	60	32	.	.	PUNCT
bam-10847	61	1	variables	variable	NOUN
bam-10847	61	2	were	be	AUX
bam-10847	61	3	tested	test	VERB
bam-10847	61	4	for	for	ADP
bam-10847	61	5	normal	normal	ADJ
bam-10847	61	6	dispersion	dispersion	NOUN
bam-10847	61	7	by	by	ADP
bam-10847	61	8	kolmogorov	kolmogorov	ADJ
bam-10847	61	9	-	-	PUNCT
bam-10847	61	10	smirnov	smirnov	ADJ
bam-10847	61	11	test	test	NOUN
bam-10847	61	12	and	and	CCONJ
bam-10847	61	13	continuous	continuous	ADJ
bam-10847	61	14	data	datum	NOUN
bam-10847	61	15	were	be	AUX
bam-10847	61	16	expressed	express	VERB
bam-10847	61	17	as	as	ADP
bam-10847	61	18	a	a	DET
bam-10847	61	19	mean	mean	ADJ
bam-10847	61	20	±	±	NUM
bam-10847	61	21	sd	sd	NOUN
bam-10847	61	22	.	.	PUNCT
bam-10847	62	1	comparisons	comparison	NOUN
bam-10847	62	2	between	between	ADP
bam-10847	62	3	the	the	DET
bam-10847	62	4	study	study	NOUN
bam-10847	62	5	groups	group	NOUN
bam-10847	62	6	were	be	AUX
bam-10847	62	7	made	make	VERB
bam-10847	62	8	by	by	ADP
bam-10847	62	9	one	one	NUM
bam-10847	62	10	-	-	PUNCT
bam-10847	62	11	way	way	NOUN
bam-10847	62	12	analysis	analysis	NOUN
bam-10847	62	13	of	of	ADP
bam-10847	62	14	variance	variance	NOUN
bam-10847	62	15	(	(	PUNCT
bam-10847	62	16	anova	anova	PROPN
bam-10847	62	17	)	)	PUNCT
bam-10847	62	18	,	,	PUNCT
bam-10847	62	19	with	with	ADP
bam-10847	62	20	a	a	DET
bam-10847	62	21	posthoc	posthoc	NOUN
bam-10847	62	22	tukey	tukey	NOUN
bam-10847	62	23	test	test	NOUN
bam-10847	62	24	.	.	PUNCT
bam-10847	63	1	chi	chi	ADJ
bam-10847	63	2	-	-	PUNCT
bam-10847	63	3	square	square	ADJ
bam-10847	63	4	test	test	NOUN
bam-10847	63	5	and	and	CCONJ
bam-10847	63	6	odds	odd	NOUN
bam-10847	63	7	ratio	ratio	NOUN
bam-10847	63	8	(	(	PUNCT
bam-10847	63	9	or	or	CCONJ
bam-10847	63	10	)	)	PUNCT
bam-10847	63	11	were	be	AUX
bam-10847	63	12	used	use	VERB
bam-10847	63	13	to	to	PART
bam-10847	63	14	compare	compare	VERB
bam-10847	63	15	the	the	DET
bam-10847	63	16	mutant	mutant	ADJ
bam-10847	63	17	p53	p53	NOUN
bam-10847	63	18	levels	level	NOUN
bam-10847	63	19	in	in	ADP
bam-10847	63	20	the	the	DET
bam-10847	63	21	case	case	NOUN
bam-10847	63	22	and	and	CCONJ
bam-10847	63	23	control	control	NOUN
bam-10847	63	24	groups	group	NOUN
bam-10847	63	25	.	.	PUNCT
bam-10847	64	1	the	the	DET
bam-10847	64	2	cox	cox	PROPN
bam-10847	64	3	’s	’s	PART
bam-10847	64	4	proportional	proportional	ADJ
bam-10847	64	5	hazard	hazard	NOUN
bam-10847	64	6	regression	regression	NOUN
bam-10847	64	7	and	and	CCONJ
bam-10847	64	8	hazard	hazard	NOUN
bam-10847	64	9	ratio	ratio	NOUN
bam-10847	64	10	(	(	PUNCT
bam-10847	64	11	hr	hr	NOUN
bam-10847	64	12	)	)	PUNCT
bam-10847	64	13	were	be	AUX
bam-10847	64	14	used	use	VERB
bam-10847	64	15	to	to	PART
bam-10847	64	16	determine	determine	VERB
bam-10847	64	17	the	the	DET
bam-10847	64	18	effect	effect	NOUN
bam-10847	64	19	of	of	ADP
bam-10847	64	20	p53mt	p53mt	NUM
bam-10847	64	21	and	and	CCONJ
bam-10847	64	22	other	other	ADJ
bam-10847	64	23	categorical	categorical	ADJ
bam-10847	64	24	variables	variable	NOUN
bam-10847	64	25	on	on	ADP
bam-10847	64	26	the	the	DET
bam-10847	64	27	probability	probability	NOUN
bam-10847	64	28	of	of	ADP
bam-10847	64	29	oscc	oscc	ADJ
bam-10847	64	30	recurrence	recurrence	NOUN
bam-10847	64	31	.	.	PUNCT
bam-10847	65	1	all	all	PRON
bam-10847	65	2	reported	report	VERB
bam-10847	65	3	probabilities	probability	NOUN
bam-10847	65	4	(	(	PUNCT
bam-10847	65	5	p	p	NOUN
bam-10847	65	6	value	value	NOUN
bam-10847	65	7	)	)	PUNCT
bam-10847	65	8	were	be	AUX
bam-10847	65	9	two	two	NUM
bam-10847	65	10	-	-	PUNCT
bam-10847	65	11	sided	sided	ADJ
bam-10847	65	12	,	,	PUNCT
bam-10847	65	13	and	and	CCONJ
bam-10847	65	14	considered	consider	VERB
bam-10847	65	15	statistically	statistically	ADV
bam-10847	65	16	significant	significant	ADJ
bam-10847	65	17	if	if	SCONJ
bam-10847	65	18	less	less	ADJ
bam-10847	65	19	than	than	ADP
bam-10847	65	20	0.05	0.05	NUM
bam-10847	65	21	.	.	PUNCT
bam-10847	66	1	results	result	VERB
bam-10847	66	2	the	the	DET
bam-10847	66	3	oscc	oscc	PROPN
bam-10847	66	4	group	group	NOUN
bam-10847	66	5	(	(	PUNCT
bam-10847	66	6	n=122	n=122	PROPN
bam-10847	66	7	)	)	PUNCT
bam-10847	66	8	consisted	consist	VERB
bam-10847	66	9	of	of	ADP
bam-10847	66	10	72	72	NUM
bam-10847	66	11	(	(	PUNCT
bam-10847	66	12	59	59	NUM
bam-10847	66	13	%	%	NOUN
bam-10847	66	14	)	)	PUNCT
bam-10847	66	15	males	male	NOUN
bam-10847	66	16	and	and	CCONJ
bam-10847	66	17	50	50	NUM
bam-10847	66	18	(	(	PUNCT
bam-10847	66	19	41	41	NUM
bam-10847	66	20	%	%	NOUN
bam-10847	66	21	)	)	PUNCT
bam-10847	66	22	females	female	NOUN
bam-10847	66	23	with	with	ADP
bam-10847	66	24	a	a	DET
bam-10847	66	25	mean	mean	ADJ
bam-10847	66	26	age	age	NOUN
bam-10847	66	27	of	of	ADP
bam-10847	66	28	64.6	64.6	NUM
bam-10847	66	29	 	 	SPACE
bam-10847	66	30	±12.6	±12.6	NUM
bam-10847	66	31	years	year	NOUN
bam-10847	66	32	(	(	PUNCT
bam-10847	66	33	range	range	NOUN
bam-10847	66	34	of	of	ADP
bam-10847	66	35	31	31	NUM
bam-10847	66	36	to	to	PART
bam-10847	66	37	78	78	NUM
bam-10847	66	38	years	year	NOUN
bam-10847	66	39	)	)	PUNCT
bam-10847	66	40	.	.	PUNCT
bam-10847	67	1	the	the	DET
bam-10847	67	2	participants	participant	NOUN
bam-10847	67	3	in	in	ADP
bam-10847	67	4	the	the	DET
bam-10847	67	5	control	control	NOUN
bam-10847	67	6	group	group	NOUN
bam-10847	67	7	(	(	PUNCT
bam-10847	67	8	n=80	n=80	PROPN
bam-10847	67	9	)	)	PUNCT
bam-10847	67	10	were	be	AUX
bam-10847	67	11	matched	match	VERB
bam-10847	67	12	for	for	ADP
bam-10847	67	13	age	age	NOUN
bam-10847	67	14	and	and	CCONJ
bam-10847	67	15	sex	sex	NOUN
bam-10847	67	16	distribution	distribution	NOUN
bam-10847	67	17	with	with	ADP
bam-10847	67	18	the	the	DET
bam-10847	67	19	patients	patient	NOUN
bam-10847	67	20	group	group	NOUN
bam-10847	67	21	;	;	PUNCT
bam-10847	67	22	therefore	therefore	ADV
bam-10847	67	23	,	,	PUNCT
bam-10847	67	24	there	there	PRON
bam-10847	67	25	were	be	VERB
bam-10847	67	26	no	no	DET
bam-10847	67	27	statistically	statistically	ADV
bam-10847	67	28	significant	significant	ADJ
bam-10847	67	29	differences	difference	NOUN
bam-10847	67	30	between	between	ADP
bam-10847	67	31	the	the	DET
bam-10847	67	32	study	study	NOUN
bam-10847	67	33	groups	group	NOUN
bam-10847	67	34	(	(	PUNCT
bam-10847	67	35	p>0.05	p>0.05	PROPN
bam-10847	67	36	)	)	PUNCT
bam-10847	67	37	.	.	PUNCT
bam-10847	68	1	the	the	DET
bam-10847	68	2	mutant	mutant	ADJ
bam-10847	68	3	p53	p53	NOUN
bam-10847	68	4	protein	protein	NOUN
bam-10847	68	5	was	be	AUX
bam-10847	68	6	detected	detect	VERB
bam-10847	68	7	by	by	ADP
bam-10847	68	8	ihc	ihc	PROPN
bam-10847	68	9	in	in	ADP
bam-10847	68	10	57.4	57.4	NUM
bam-10847	68	11	%	%	NOUN
bam-10847	68	12	(	(	PUNCT
bam-10847	68	13	70	70	NUM
bam-10847	68	14	out	out	ADP
bam-10847	68	15	of	of	ADP
bam-10847	68	16	122	122	NUM
bam-10847	68	17	)	)	PUNCT
bam-10847	68	18	of	of	ADP
bam-10847	68	19	patients	patient	NOUN
bam-10847	68	20	with	with	ADP
bam-10847	68	21	the	the	DET
bam-10847	68	22	primary	primary	NOUN
bam-10847	68	23	oscc	oscc	ADV
bam-10847	68	24	;	;	PUNCT
bam-10847	68	25	however	however	ADV
bam-10847	68	26	,	,	PUNCT
bam-10847	68	27	none	none	NOUN
bam-10847	68	28	of	of	ADP
bam-10847	68	29	the	the	DET
bam-10847	68	30	samples	sample	NOUN
bam-10847	68	31	was	be	AUX
bam-10847	68	32	positive	positive	ADJ
bam-10847	68	33	in	in	ADP
bam-10847	68	34	the	the	DET
bam-10847	68	35	control	control	NOUN
bam-10847	68	36	group	group	NOUN
bam-10847	68	37	(	(	PUNCT
bam-10847	68	38	p<0.0001	p<0.0001	NOUN
bam-10847	68	39	,	,	PUNCT
bam-10847	68	40	or=107.69	or=107.69	NOUN
bam-10847	68	41	,	,	PUNCT
bam-10847	68	42	95%ci=6.49	95%ci=6.49	NUM
bam-10847	68	43	-	-	SYM
bam-10847	68	44	179.0	179.0	NUM
bam-10847	68	45	)	)	PUNCT
bam-10847	68	46	.	.	PUNCT
bam-10847	69	1	in	in	ADP
bam-10847	69	2	patients	patient	NOUN
bam-10847	69	3	with	with	ADP
bam-10847	69	4	the	the	DET
bam-10847	69	5	primary	primary	ADJ
bam-10847	69	6	oscc	oscc	ADV
bam-10847	69	7	,	,	PUNCT
bam-10847	69	8	the	the	DET
bam-10847	69	9	rate	rate	NOUN
bam-10847	69	10	of	of	ADP
bam-10847	69	11	positive	positive	ADJ
bam-10847	69	12	p53mt	p53mt	NUM
bam-10847	69	13	protein	protein	NOUN
bam-10847	69	14	had	have	VERB
bam-10847	69	15	no	no	DET
bam-10847	69	16	statistically	statistically	ADV
bam-10847	69	17	significant	significant	ADJ
bam-10847	69	18	differences	difference	NOUN
bam-10847	69	19	between	between	ADP
bam-10847	69	20	males	male	NOUN
bam-10847	69	21	and	and	CCONJ
bam-10847	69	22	females	female	NOUN
bam-10847	69	23	(	(	PUNCT
bam-10847	69	24	54.2	54.2	NUM
bam-10847	69	25	%	%	NOUN
bam-10847	69	26	vs.	vs.	ADP
bam-10847	69	27	62	62	NUM
bam-10847	69	28	%	%	NOUN
bam-10847	69	29	,	,	PUNCT
bam-10847	69	30	p=0.390	p=0.390	ADJ
bam-10847	69	31	,	,	PUNCT
bam-10847	69	32	or=0.72	or=0.72	NOUN
bam-10847	69	33	,	,	PUNCT
bam-10847	69	34	95%ci=0.35	95%ci=0.35	NUM
bam-10847	69	35	-	-	SYM
bam-10847	69	36	1.51	1.51	NUM
bam-10847	69	37	)	)	PUNCT
bam-10847	69	38	;	;	PUNCT
bam-10847	69	39	however	however	ADV
bam-10847	69	40	,	,	PUNCT
bam-10847	69	41	there	there	PRON
bam-10847	69	42	was	be	VERB
bam-10847	69	43	a	a	DET
bam-10847	69	44	significant	significant	ADJ
bam-10847	69	45	difference	difference	NOUN
bam-10847	69	46	in	in	ADP
bam-10847	69	47	the	the	DET
bam-10847	69	48	p53	p53	NOUN
bam-10847	69	49	immunopositivity	immunopositivity	NOUN
bam-10847	69	50	between	between	ADP
bam-10847	69	51	those	those	PRON
bam-10847	69	52	below	below	ADP
bam-10847	69	53	and	and	CCONJ
bam-10847	69	54	over	over	ADP
bam-10847	69	55	50	50	NUM
bam-10847	69	56	years	year	NOUN
bam-10847	69	57	,	,	PUNCT
bam-10847	69	58	as	as	SCONJ
bam-10847	69	59	it	it	PRON
bam-10847	69	60	was	be	AUX
bam-10847	69	61	detected	detect	VERB
bam-10847	69	62	in	in	ADP
bam-10847	69	63	81.3	81.3	NUM
bam-10847	69	64	%	%	NOUN
bam-10847	69	65	(	(	PUNCT
bam-10847	69	66	26	26	NUM
bam-10847	69	67	out	out	ADP
bam-10847	69	68	of	of	ADP
bam-10847	69	69	32	32	NUM
bam-10847	69	70	)	)	PUNCT
bam-10847	69	71	of	of	ADP
bam-10847	69	72	patients	patient	NOUN
bam-10847	69	73	aged	age	VERB
bam-10847	69	74	below	below	ADP
bam-10847	69	75	50	50	NUM
bam-10847	69	76	years	year	NOUN
bam-10847	69	77	in	in	ADP
bam-10847	69	78	comparison	comparison	NOUN
bam-10847	69	79	to	to	ADP
bam-10847	69	80	48.9	48.9	NUM
bam-10847	69	81	%	%	NOUN
bam-10847	69	82	(	(	PUNCT
bam-10847	69	83	44	44	NUM
bam-10847	69	84	out	out	ADP
bam-10847	69	85	of	of	ADP
bam-10847	69	86	90	90	NUM
bam-10847	69	87	)	)	PUNCT
bam-10847	69	88	of	of	ADP
bam-10847	69	89	patients	patient	NOUN
bam-10847	69	90	aged	age	VERB
bam-10847	69	91	over	over	ADP
bam-10847	69	92	50	50	NUM
bam-10847	69	93	years	year	NOUN
bam-10847	69	94	(	(	PUNCT
bam-10847	69	95	p<0.0001	p<0.0001	NOUN
bam-10847	69	96	,	,	PUNCT
bam-10847	69	97	or=4.52	or=4.52	NOUN
bam-10847	69	98	,	,	PUNCT
bam-10847	69	99	95%ci=1.0712.05	95%ci=1.0712.05	NUM
bam-10847	69	100	)	)	PUNCT
bam-10847	69	101	.	.	PUNCT
bam-10847	70	1	the	the	DET
bam-10847	70	2	immunoexpression	immunoexpression	NOUN
bam-10847	70	3	of	of	ADP
bam-10847	70	4	p53mt	p53mt	NUM
bam-10847	70	5	protein	protein	NOUN
bam-10847	70	6	is	be	AUX
bam-10847	70	7	presented	present	VERB
bam-10847	70	8	in	in	ADP
bam-10847	70	9	figure	figure	NOUN
bam-10847	70	10	1	1	NUM
bam-10847	70	11	.	.	PUNCT
bam-10847	71	1	discussion	discussion	NOUN
bam-10847	71	2	oscc	oscc	ADV
bam-10847	71	3	is	be	AUX
bam-10847	71	4	one	one	NUM
bam-10847	71	5	of	of	ADP
bam-10847	71	6	the	the	DET
bam-10847	71	7	most	most	ADV
bam-10847	71	8	common	common	ADJ
bam-10847	71	9	causes	cause	NOUN
bam-10847	71	10	of	of	ADP
bam-10847	71	11	cancerrelated	cancerrelate	VERB
bam-10847	71	12	deaths	death	NOUN
bam-10847	71	13	worldwide	worldwide	ADV
bam-10847	71	14	and	and	CCONJ
bam-10847	71	15	its	its	PRON
bam-10847	71	16	global	global	ADJ
bam-10847	71	17	burden	burden	NOUN
bam-10847	71	18	is	be	AUX
bam-10847	71	19	expected	expect	VERB
bam-10847	71	20	to	to	PART
bam-10847	71	21	grow	grow	VERB
bam-10847	71	22	rapidly	rapidly	ADV
bam-10847	71	23	due	due	ADJ
bam-10847	71	24	to	to	ADP
bam-10847	71	25	the	the	DET
bam-10847	71	26	population	population	NOUN
bam-10847	71	27	growth	growth	NOUN
bam-10847	71	28	and	and	CCONJ
bam-10847	71	29	aging	aging	NOUN
bam-10847	71	30	.	.	PUNCT
bam-10847	72	1	early	early	ADJ
bam-10847	72	2	diagnosis	diagnosis	NOUN
bam-10847	72	3	of	of	ADP
bam-10847	72	4	osccs	osccs	NOUN
bam-10847	72	5	is	be	AUX
bam-10847	72	6	a	a	DET
bam-10847	72	7	priority	priority	NOUN
bam-10847	72	8	health	health	NOUN
bam-10847	72	9	objective	objective	NOUN
bam-10847	72	10	,	,	PUNCT
bam-10847	72	11	lead	lead	VERB
bam-10847	72	12	to	to	ADP
bam-10847	72	13	less	less	ADJ
bam-10847	72	14	damages	damage	NOUN
bam-10847	72	15	and	and	CCONJ
bam-10847	72	16	a	a	DET
bam-10847	72	17	better	well	ADJ
bam-10847	72	18	prognosis	prognosis	NOUN
bam-10847	72	19	;	;	PUNCT
bam-10847	72	20	hence	hence	ADV
bam-10847	72	21	,	,	PUNCT
bam-10847	72	22	it	it	PRON
bam-10847	72	23	is	be	AUX
bam-10847	72	24	crucial	crucial	ADJ
bam-10847	72	25	to	to	PART
bam-10847	72	26	identify	identify	VERB
bam-10847	72	27	potential	potential	ADJ
bam-10847	72	28	biomarkers	biomarker	NOUN
bam-10847	72	29	to	to	PART
bam-10847	72	30	improve	improve	VERB
bam-10847	72	31	diagnosis	diagnosis	NOUN
bam-10847	72	32	,	,	PUNCT
bam-10847	72	33	prognosis	prognosis	NOUN
bam-10847	72	34	,	,	PUNCT
bam-10847	72	35	and	and	CCONJ
bam-10847	72	36	the	the	DET
bam-10847	72	37	treatment	treatment	NOUN
bam-10847	72	38	outcome	outcome	NOUN
bam-10847	72	39	of	of	ADP
bam-10847	72	40	such	such	ADJ
bam-10847	72	41	patients.4	patients.4	PROPN
bam-10847	72	42	-	-	PUNCT
bam-10847	72	43	6	6	NUM
bam-10847	72	44	loss	loss	NOUN
bam-10847	72	45	of	of	ADP
bam-10847	72	46	the	the	DET
bam-10847	72	47	p53	p53	NOUN
bam-10847	72	48	tumor	tumor	NOUN
bam-10847	72	49	suppressor	suppressor	NOUN
bam-10847	72	50	activity	activity	NOUN
bam-10847	72	51	is	be	AUX
bam-10847	72	52	an	an	DET
bam-10847	72	53	important	important	ADJ
bam-10847	72	54	step	step	NOUN
bam-10847	72	55	in	in	ADP
bam-10847	72	56	the	the	DET
bam-10847	72	57	development	development	NOUN
bam-10847	72	58	and	and	CCONJ
bam-10847	72	59	progression	progression	NOUN
bam-10847	72	60	of	of	ADP
bam-10847	72	61	human	human	ADJ
bam-10847	72	62	malignancies	malignancy	NOUN
bam-10847	72	63	.	.	PUNCT
bam-10847	73	1	a	a	DET
bam-10847	73	2	subset	subset	NOUN
bam-10847	73	3	of	of	ADP
bam-10847	73	4	mutations	mutation	NOUN
bam-10847	73	5	occurring	occur	VERB
bam-10847	73	6	in	in	ADP
bam-10847	73	7	the	the	DET
bam-10847	73	8	wild	wild	ADJ
bam-10847	73	9	-	-	PUNCT
bam-10847	73	10	type	type	NOUN
bam-10847	73	11	tp53	tp53	PROPN
bam-10847	73	12	fig	fig	NOUN
bam-10847	73	13	1	1	NUM
bam-10847	73	14	.	.	PUNCT
bam-10847	74	1	the	the	DET
bam-10847	74	2	immunoexpression	immunoexpression	NOUN
bam-10847	74	3	of	of	ADP
bam-10847	74	4	p53	p53	NOUN
bam-10847	74	5	protein	protein	NOUN
bam-10847	74	6	in	in	ADP
bam-10847	74	7	oscc	oscc	ADJ
bam-10847	74	8	tissue	tissue	NOUN
bam-10847	74	9	.	.	PUNCT
bam-10847	75	1	a	a	DET
bam-10847	75	2	)	)	PUNCT
bam-10847	75	3	photomicrograph	photomicrograph	NOUN
bam-10847	75	4	showing	show	VERB
bam-10847	75	5	the	the	DET
bam-10847	75	6	p53	p53	NOUN
bam-10847	75	7	immunoexpression	immunoexpression	NOUN
bam-10847	75	8	in	in	ADP
bam-10847	75	9	dysplastic	dysplastic	ADJ
bam-10847	75	10	squamous	squamous	ADJ
bam-10847	75	11	epithelium	epithelium	NOUN
bam-10847	75	12	at	at	ADP
bam-10847	75	13	the	the	DET
bam-10847	75	14	vicinity	vicinity	NOUN
bam-10847	75	15	of	of	ADP
bam-10847	75	16	invasive	invasive	ADJ
bam-10847	75	17	oral	oral	ADJ
bam-10847	75	18	squamous	squamous	ADJ
bam-10847	75	19	cell	cell	NOUN
bam-10847	75	20	carcinoma	carcinoma	NOUN
bam-10847	75	21	(	(	PUNCT
bam-10847	75	22	ihc	ihc	NOUN
bam-10847	75	23	,	,	PUNCT
bam-10847	75	24	×250	×250	PROPN
bam-10847	75	25	)	)	PUNCT
bam-10847	75	26	;	;	PUNCT
bam-10847	75	27	b	b	X
bam-10847	75	28	)	)	PUNCT
bam-10847	75	29	the	the	DET
bam-10847	75	30	p53	p53	NOUN
bam-10847	75	31	negative	negative	ADJ
bam-10847	75	32	oral	oral	ADJ
bam-10847	75	33	squamous	squamous	ADJ
bam-10847	75	34	cell	cell	NOUN
bam-10847	75	35	carcinoma	carcinoma	NOUN
bam-10847	75	36	(	(	PUNCT
bam-10847	75	37	ihc	ihc	NOUN
bam-10847	75	38	,	,	PUNCT
bam-10847	75	39	×250	×250	PROPN
bam-10847	75	40	)	)	PUNCT
bam-10847	75	41	;	;	PUNCT
bam-10847	76	1	c	c	X
bam-10847	76	2	)	)	PUNCT
bam-10847	76	3	the	the	DET
bam-10847	76	4	p53	p53	NOUN
bam-10847	76	5	positive	positive	ADJ
bam-10847	76	6	oral	oral	ADJ
bam-10847	76	7	squamous	squamous	ADJ
bam-10847	76	8	cell	cell	NOUN
bam-10847	76	9	carcinoma	carcinoma	NOUN
bam-10847	76	10	(	(	PUNCT
bam-10847	76	11	ihc	ihc	PROPN
bam-10847	76	12	,	,	PUNCT
bam-10847	76	13	×400	×400	PROPN
bam-10847	76	14	)	)	PUNCT
bam-10847	76	15	non	non	PROPN
bam-10847	77	1	-co	-co	PROPN
bam-10847	77	2	mmerc	mmerc	PROPN
bam-10847	77	3	ial	ial	PROPN
bam-10847	77	4	us	us	PROPN
bam-10847	77	5	e	e	NOUN
bam-10847	77	6	o	o	NOUN
bam-10847	77	7	nly	nly	ADV
bam-10847	77	8	p53	p53	VERB
bam-10847	77	9	mutant	mutant	NOUN
bam-10847	77	10	-	-	PUNCT
bam-10847	77	11	type	type	NOUN
bam-10847	77	12	in	in	ADP
bam-10847	77	13	oral	oral	ADJ
bam-10847	77	14	squamous	squamous	ADJ
bam-10847	77	15	cell	cell	NOUN
bam-10847	77	16	carcinoma	carcinoma	NOUN
bam-10847	77	17	eur	eur	PROPN
bam-10847	77	18	j	j	PROPN
bam-10847	77	19	transl	transl	PROPN
bam-10847	77	20	myol	myol	ADV
bam-10847	77	21	33	33	NUM
bam-10847	77	22	(	(	PUNCT
bam-10847	77	23	1	1	NUM
bam-10847	77	24	)	)	PUNCT
bam-10847	77	25	10847	10847	NUM
bam-10847	77	26	,	,	PUNCT
bam-10847	77	27	2023	2023	NUM
bam-10847	77	28	doi	doi	NOUN
bam-10847	77	29	:	:	PUNCT
bam-10847	77	30	10.4081	10.4081	NUM
bam-10847	77	31	/	/	SYM
bam-10847	77	32	ejtm.2023.10847	ejtm.2023.10847	PROPN
bam-10847	77	33	4	4	NUM
bam-10847	77	34	gene	gene	NOUN
bam-10847	77	35	causes	cause	VERB
bam-10847	77	36	it	it	PRON
bam-10847	77	37	to	to	PART
bam-10847	77	38	lose	lose	VERB
bam-10847	77	39	its	its	PRON
bam-10847	77	40	tumor	tumor	NOUN
bam-10847	77	41	suppressor	suppressor	NOUN
bam-10847	77	42	activity	activity	NOUN
bam-10847	77	43	.	.	PUNCT
bam-10847	78	1	the	the	DET
bam-10847	78	2	overexpression	overexpression	NOUN
bam-10847	78	3	of	of	ADP
bam-10847	78	4	a	a	DET
bam-10847	78	5	mutant	mutant	ADJ
bam-10847	78	6	p53	p53	NOUN
bam-10847	78	7	protein	protein	NOUN
bam-10847	78	8	,	,	PUNCT
bam-10847	78	9	which	which	PRON
bam-10847	78	10	can	can	AUX
bam-10847	78	11	accumulate	accumulate	VERB
bam-10847	78	12	in	in	ADP
bam-10847	78	13	the	the	DET
bam-10847	78	14	nuclei	nucleus	NOUN
bam-10847	78	15	of	of	ADP
bam-10847	78	16	tumor	tumor	NOUN
bam-10847	78	17	cells	cell	NOUN
bam-10847	78	18	is	be	AUX
bam-10847	78	19	associated	associate	VERB
bam-10847	78	20	with	with	ADP
bam-10847	78	21	more	more	ADV
bam-10847	78	22	aggressive	aggressive	ADJ
bam-10847	78	23	behavior	behavior	NOUN
bam-10847	78	24	in	in	ADP
bam-10847	78	25	almost	almost	ADV
bam-10847	78	26	every	every	PRON
bam-10847	78	27	type	type	NOUN
bam-10847	78	28	of	of	ADP
bam-10847	78	29	cancers	cancer	NOUN
bam-10847	78	30	.	.	PUNCT
bam-10847	79	1	an	an	DET
bam-10847	79	2	increased	increase	VERB
bam-10847	79	3	p53	p53	NOUN
bam-10847	79	4	protein	protein	NOUN
bam-10847	79	5	immunoreactivity	immunoreactivity	NOUN
bam-10847	79	6	is	be	AUX
bam-10847	79	7	found	find	VERB
bam-10847	79	8	commonly	commonly	ADV
bam-10847	79	9	in	in	ADP
bam-10847	79	10	more	more	ADJ
bam-10847	79	11	than	than	ADP
bam-10847	79	12	50	50	NUM
bam-10847	79	13	%	%	NOUN
bam-10847	79	14	of	of	ADP
bam-10847	79	15	all	all	DET
bam-10847	79	16	human	human	ADJ
bam-10847	79	17	cancers	cancer	NOUN
bam-10847	79	18	;	;	PUNCT
bam-10847	79	19	therefore	therefore	ADV
bam-10847	79	20	,	,	PUNCT
bam-10847	79	21	considerable	considerable	ADJ
bam-10847	79	22	research	research	NOUN
bam-10847	79	23	effort	effort	NOUN
bam-10847	79	24	has	have	AUX
bam-10847	79	25	been	be	AUX
bam-10847	79	26	focused	focus	VERB
bam-10847	79	27	on	on	ADP
bam-10847	79	28	elucidating	elucidate	VERB
bam-10847	79	29	the	the	DET
bam-10847	79	30	key	key	ADJ
bam-10847	79	31	mechanisms	mechanism	NOUN
bam-10847	79	32	of	of	ADP
bam-10847	79	33	action	action	NOUN
bam-10847	79	34	of	of	ADP
bam-10847	79	35	p53	p53	NOUN
bam-10847	79	36	and	and	CCONJ
bam-10847	79	37	its	its	PRON
bam-10847	79	38	prognostic	prognostic	ADJ
bam-10847	79	39	significance	significance	NOUN
bam-10847	79	40	in	in	ADP
bam-10847	79	41	cancer	cancer	NOUN
bam-10847	79	42	patients.16,26	patients.16,26	NOUN
bam-10847	79	43	-	-	PUNCT
bam-10847	79	44	29	29	NUM
bam-10847	79	45	the	the	DET
bam-10847	79	46	findings	finding	NOUN
bam-10847	79	47	of	of	ADP
bam-10847	79	48	this	this	DET
bam-10847	79	49	study	study	NOUN
bam-10847	79	50	showed	show	VERB
bam-10847	79	51	a	a	DET
bam-10847	79	52	significant	significant	ADJ
bam-10847	79	53	difference	difference	NOUN
bam-10847	79	54	in	in	ADP
bam-10847	79	55	expression	expression	NOUN
bam-10847	79	56	of	of	ADP
bam-10847	79	57	p53mt	p53mt	NUM
bam-10847	79	58	protein	protein	NOUN
bam-10847	79	59	in	in	ADP
bam-10847	79	60	iranian	iranian	ADJ
bam-10847	80	1	oscc	oscc	PROPN
bam-10847	80	2	patients	patient	NOUN
bam-10847	80	3	and	and	CCONJ
bam-10847	80	4	the	the	DET
bam-10847	80	5	control	control	NOUN
bam-10847	80	6	group	group	NOUN
bam-10847	80	7	(	(	PUNCT
bam-10847	80	8	57.4	57.4	NUM
bam-10847	80	9	%	%	NOUN
bam-10847	80	10	vs.	vs.	ADP
bam-10847	80	11	0	0	NUM
bam-10847	80	12	%	%	NOUN
bam-10847	80	13	,	,	PUNCT
bam-10847	80	14	p<0.0001	p<0.0001	NOUN
bam-10847	80	15	)	)	PUNCT
bam-10847	80	16	.	.	PUNCT
bam-10847	81	1	our	our	PRON
bam-10847	81	2	observations	observation	NOUN
bam-10847	81	3	are	be	AUX
bam-10847	81	4	similar	similar	ADJ
bam-10847	81	5	to	to	ADP
bam-10847	81	6	the	the	DET
bam-10847	81	7	results	result	NOUN
bam-10847	81	8	obtained	obtain	VERB
bam-10847	81	9	from	from	ADP
bam-10847	81	10	previous	previous	ADJ
bam-10847	81	11	studies	study	NOUN
bam-10847	81	12	in	in	ADP
bam-10847	81	13	iran	iran	PROPN
bam-10847	81	14	.	.	PUNCT
bam-10847	82	1	fakhrjou	fakhrjou	VERB
bam-10847	82	2	a	a	PRON
bam-10847	82	3	,	,	PUNCT
bam-10847	82	4	toutounchi	toutounchi	X
bam-10847	82	5	sj	sj	INTJ
bam-10847	82	6	(	(	PUNCT
bam-10847	82	7	2012)18	2012)18	NUM
bam-10847	82	8	performed	perform	VERB
bam-10847	82	9	a	a	DET
bam-10847	82	10	study	study	NOUN
bam-10847	82	11	on	on	ADP
bam-10847	82	12	two	two	NUM
bam-10847	82	13	groups	group	NOUN
bam-10847	82	14	of	of	ADP
bam-10847	82	15	oscc	oscc	ADJ
bam-10847	82	16	lesions	lesion	NOUN
bam-10847	82	17	and	and	CCONJ
bam-10847	82	18	the	the	DET
bam-10847	82	19	buccal	buccal	ADJ
bam-10847	82	20	mucosa	mucosa	NOUN
bam-10847	82	21	of	of	ADP
bam-10847	82	22	normal	normal	ADJ
bam-10847	82	23	subjects	subject	NOUN
bam-10847	82	24	,	,	PUNCT
bam-10847	82	25	20	20	NUM
bam-10847	82	26	per	per	ADP
bam-10847	82	27	each	each	DET
bam-10847	82	28	group	group	NOUN
bam-10847	82	29	,	,	PUNCT
bam-10847	82	30	and	and	CCONJ
bam-10847	82	31	showed	show	VERB
bam-10847	82	32	a	a	DET
bam-10847	82	33	higher	high	ADJ
bam-10847	82	34	rate	rate	NOUN
bam-10847	82	35	of	of	ADP
bam-10847	82	36	p53	p53	NOUN
bam-10847	82	37	positivity	positivity	NOUN
bam-10847	82	38	in	in	ADP
bam-10847	82	39	oscc	oscc	ADJ
bam-10847	82	40	subjects	subject	NOUN
bam-10847	82	41	in	in	ADP
bam-10847	82	42	comparison	comparison	NOUN
bam-10847	82	43	to	to	ADP
bam-10847	82	44	the	the	DET
bam-10847	82	45	control	control	NOUN
bam-10847	82	46	group	group	NOUN
bam-10847	82	47	(	(	PUNCT
bam-10847	82	48	100	100	NUM
bam-10847	82	49	%	%	NOUN
bam-10847	82	50	vs.	vs.	ADP
bam-10847	82	51	40	40	NUM
bam-10847	82	52	%	%	NOUN
bam-10847	82	53	)	)	PUNCT
bam-10847	82	54	.	.	PUNCT
bam-10847	83	1	a	a	DET
bam-10847	83	2	case	case	NOUN
bam-10847	83	3	-	-	PUNCT
bam-10847	83	4	control	control	NOUN
bam-10847	83	5	study	study	NOUN
bam-10847	83	6	conducted	conduct	VERB
bam-10847	83	7	on	on	ADP
bam-10847	83	8	25	25	NUM
bam-10847	83	9	cases	case	NOUN
bam-10847	83	10	of	of	ADP
bam-10847	83	11	well	well	ADV
bam-10847	83	12	-	-	PUNCT
bam-10847	83	13	differentiated	differentiate	VERB
bam-10847	83	14	oscc	oscc	ADJ
bam-10847	83	15	and	and	CCONJ
bam-10847	83	16	22	22	NUM
bam-10847	83	17	samples	sample	NOUN
bam-10847	83	18	from	from	ADP
bam-10847	83	19	patients	patient	NOUN
bam-10847	83	20	with	with	ADP
bam-10847	83	21	erosive	erosive	ADJ
bam-10847	83	22	oral	oral	ADJ
bam-10847	83	23	lichen	lichen	NOUN
bam-10847	83	24	planus	planus	NOUN
bam-10847	83	25	(	(	PUNCT
bam-10847	83	26	olp	olp	PROPN
bam-10847	83	27	)	)	PUNCT
bam-10847	83	28	also	also	ADV
bam-10847	83	29	presented	present	VERB
bam-10847	83	30	a	a	DET
bam-10847	83	31	significant	significant	ADJ
bam-10847	83	32	difference	difference	NOUN
bam-10847	83	33	in	in	ADP
bam-10847	83	34	the	the	DET
bam-10847	83	35	expression	expression	NOUN
bam-10847	83	36	of	of	ADP
bam-10847	83	37	p53	p53	NOUN
bam-10847	83	38	protein	protein	NOUN
bam-10847	83	39	(	(	PUNCT
bam-10847	83	40	49.6±29.6	49.6±29.6	NUM
bam-10847	83	41	%	%	NOUN
bam-10847	83	42	in	in	ADP
bam-10847	83	43	oscc	oscc	ADJ
bam-10847	83	44	vs.	vs.	ADP
bam-10847	83	45	30.86±28.26	30.86±28.26	NUM
bam-10847	83	46	%	%	NOUN
bam-10847	83	47	in	in	ADP
bam-10847	83	48	olp).19	olp).19	ADJ
bam-10847	83	49	etemad	etemad	ADV
bam-10847	83	50	-	-	PUNCT
bam-10847	83	51	moghadam	moghadam	NOUN
bam-10847	83	52	et	et	PROPN
bam-10847	83	53	al	al	PROPN
bam-10847	83	54	.	.	PROPN
bam-10847	83	55	found	find	VERB
bam-10847	83	56	the	the	DET
bam-10847	83	57	immunoexpression	immunoexpression	NOUN
bam-10847	83	58	of	of	ADP
bam-10847	83	59	p53	p53	NOUN
bam-10847	83	60	protein	protein	NOUN
bam-10847	83	61	in	in	ADP
bam-10847	83	62	the	the	DET
bam-10847	83	63	primary	primary	ADJ
bam-10847	83	64	tumors	tumor	NOUN
bam-10847	83	65	of	of	ADP
bam-10847	83	66	28.57	28.57	NUM
bam-10847	83	67	%	%	NOUN
bam-10847	83	68	of	of	ADP
bam-10847	83	69	iranian	iranian	ADJ
bam-10847	83	70	oscc	oscc	PROPN
bam-10847	83	71	patients	patient	NOUN
bam-10847	83	72	(	(	PUNCT
bam-10847	83	73	8	8	NUM
bam-10847	83	74	out	out	ADP
bam-10847	83	75	of	of	ADP
bam-10847	83	76	28	28	NUM
bam-10847	83	77	cases).20	cases).20	VERB
bam-10847	83	78	the	the	DET
bam-10847	83	79	concentration	concentration	NOUN
bam-10847	83	80	of	of	ADP
bam-10847	83	81	p53	p53	NOUN
bam-10847	83	82	in	in	ADP
bam-10847	83	83	unstimulated	unstimulated	ADJ
bam-10847	83	84	whole	whole	ADJ
bam-10847	83	85	saliva	saliva	NOUN
bam-10847	83	86	of	of	ADP
bam-10847	83	87	patients	patient	NOUN
bam-10847	83	88	with	with	ADP
bam-10847	83	89	oscc	oscc	PROPN
bam-10847	83	90	was	be	AUX
bam-10847	83	91	significantly	significantly	ADV
bam-10847	83	92	higher	high	ADJ
bam-10847	83	93	than	than	ADP
bam-10847	83	94	patients	patient	NOUN
bam-10847	83	95	suffering	suffer	VERB
bam-10847	83	96	from	from	ADP
bam-10847	83	97	olp	olp	PROPN
bam-10847	83	98	or	or	CCONJ
bam-10847	83	99	healthy	healthy	ADJ
bam-10847	83	100	participant	participant	NOUN
bam-10847	83	101	(	(	PUNCT
bam-10847	83	102	5.36±1.08	5.36±1.08	PROPN
bam-10847	83	103	u	u	NOUN
bam-10847	83	104	/	/	SYM
bam-10847	83	105	ml	ml	NOUN
bam-10847	83	106	,	,	PUNCT
bam-10847	83	107	0.94±0.31	0.94±0.31	NOUN
bam-10847	83	108	u	u	NOUN
bam-10847	83	109	/	/	SYM
bam-10847	83	110	ml	ml	ADP
bam-10847	83	111	,	,	PUNCT
bam-10847	83	112	and	and	CCONJ
bam-10847	83	113	0.41±0.04	0.41±0.04	PROPN
bam-10847	83	114	u	u	NOUN
bam-10847	83	115	/	/	SYM
bam-10847	83	116	ml	ml	PROPN
bam-10847	83	117	,	,	PUNCT
bam-10847	83	118	respectively).21	respectively).21	PROPN
bam-10847	83	119	it	it	PRON
bam-10847	83	120	was	be	AUX
bam-10847	83	121	also	also	ADV
bam-10847	83	122	observed	observe	VERB
bam-10847	83	123	by	by	ADP
bam-10847	83	124	immunohistochemical	immunohistochemical	ADJ
bam-10847	83	125	analysis	analysis	NOUN
bam-10847	83	126	in	in	ADP
bam-10847	83	127	28.8	28.8	NUM
bam-10847	83	128	%	%	NOUN
bam-10847	83	129	(	(	PUNCT
bam-10847	83	130	17	17	NUM
bam-10847	83	131	of	of	ADP
bam-10847	83	132	59	59	NUM
bam-10847	83	133	)	)	PUNCT
bam-10847	83	134	,	,	PUNCT
bam-10847	83	135	52.7	52.7	NUM
bam-10847	83	136	%	%	NOUN
bam-10847	83	137	(	(	PUNCT
bam-10847	83	138	48	48	NUM
bam-10847	83	139	of	of	ADP
bam-10847	83	140	91	91	NUM
bam-10847	83	141	)	)	PUNCT
bam-10847	83	142	,	,	PUNCT
bam-10847	83	143	61.6	61.6	NUM
bam-10847	83	144	%	%	NOUN
bam-10847	83	145	(	(	PUNCT
bam-10847	83	146	40	40	NUM
bam-10847	83	147	of	of	ADP
bam-10847	83	148	65	65	NUM
bam-10847	83	149	)	)	PUNCT
bam-10847	83	150	,	,	PUNCT
bam-10847	83	151	63.3	63.3	NUM
bam-10847	83	152	%	%	NOUN
bam-10847	83	153	(	(	PUNCT
bam-10847	83	154	19	19	NUM
bam-10847	83	155	of	of	ADP
bam-10847	83	156	30	30	NUM
bam-10847	83	157	)	)	PUNCT
bam-10847	83	158	,	,	PUNCT
bam-10847	83	159	and	and	CCONJ
bam-10847	83	160	100	100	NUM
bam-10847	83	161	%	%	NOUN
bam-10847	83	162	(	(	PUNCT
bam-10847	83	163	70	70	NUM
bam-10847	83	164	cases	case	NOUN
bam-10847	83	165	with	with	ADP
bam-10847	83	166	low	low	ADJ
bam-10847	83	167	expression	expression	NOUN
bam-10847	83	168	and	and	CCONJ
bam-10847	83	169	42	42	NUM
bam-10847	83	170	cases	case	NOUN
bam-10847	83	171	with	with	ADP
bam-10847	83	172	high	high	ADJ
bam-10847	83	173	expression	expression	NOUN
bam-10847	83	174	)	)	PUNCT
bam-10847	83	175	of	of	ADP
bam-10847	83	176	patients	patient	NOUN
bam-10847	83	177	with	with	ADP
bam-10847	83	178	the	the	DET
bam-10847	83	179	primary	primary	NOUN
bam-10847	83	180	oscc	oscc	ADV
bam-10847	83	181	in	in	ADP
bam-10847	83	182	japan,30	japan,30	PROPN
bam-10847	83	183	spain,31,22	spain,31,22	PROPN
bam-10847	83	184	brazil,33	brazil,33	NOUN
bam-10847	83	185	and	and	CCONJ
bam-10847	83	186	taiwan,34	taiwan,34	NOUN
bam-10847	83	187	respectively	respectively	ADV
bam-10847	83	188	.	.	PUNCT
bam-10847	84	1	although	although	SCONJ
bam-10847	84	2	in	in	ADP
bam-10847	84	3	all	all	DET
bam-10847	84	4	studies	study	NOUN
bam-10847	84	5	,	,	PUNCT
bam-10847	84	6	the	the	DET
bam-10847	84	7	expression	expression	NOUN
bam-10847	84	8	of	of	ADP
bam-10847	84	9	p53	p53	NOUN
bam-10847	84	10	protein	protein	NOUN
bam-10847	84	11	in	in	ADP
bam-10847	84	12	oscc	oscc	PROPN
bam-10847	84	13	group	group	NOUN
bam-10847	84	14	was	be	AUX
bam-10847	84	15	higher	high	ADJ
bam-10847	84	16	than	than	ADP
bam-10847	84	17	the	the	DET
bam-10847	84	18	control	control	NOUN
bam-10847	84	19	group	group	NOUN
bam-10847	84	20	,	,	PUNCT
bam-10847	84	21	possible	possible	ADJ
bam-10847	84	22	reasons	reason	NOUN
bam-10847	84	23	for	for	ADP
bam-10847	84	24	the	the	DET
bam-10847	84	25	discrepancy	discrepancy	NOUN
bam-10847	84	26	between	between	ADP
bam-10847	84	27	the	the	DET
bam-10847	84	28	results	result	NOUN
bam-10847	84	29	may	may	AUX
bam-10847	84	30	include	include	VERB
bam-10847	84	31	the	the	DET
bam-10847	84	32	study	study	NOUN
bam-10847	84	33	population	population	NOUN
bam-10847	84	34	,	,	PUNCT
bam-10847	84	35	sample	sample	NOUN
bam-10847	84	36	size	size	NOUN
bam-10847	84	37	,	,	PUNCT
bam-10847	84	38	type	type	NOUN
bam-10847	84	39	of	of	ADP
bam-10847	84	40	the	the	DET
bam-10847	84	41	tumor	tumor	NOUN
bam-10847	84	42	sample	sample	NOUN
bam-10847	84	43	(	(	PUNCT
bam-10847	84	44	biopsy	biopsy	NOUN
bam-10847	84	45	vs.	vs.	ADP
bam-10847	84	46	surgery	surgery	NOUN
bam-10847	84	47	)	)	PUNCT
bam-10847	84	48	,	,	PUNCT
bam-10847	84	49	size	size	NOUN
bam-10847	84	50	and	and	CCONJ
bam-10847	84	51	location	location	NOUN
bam-10847	84	52	of	of	ADP
bam-10847	84	53	the	the	DET
bam-10847	84	54	tumor	tumor	NOUN
bam-10847	84	55	,	,	PUNCT
bam-10847	84	56	and	and	CCONJ
bam-10847	84	57	the	the	DET
bam-10847	84	58	follow	follow	VERB
bam-10847	84	59	-	-	PUNCT
bam-10847	84	60	up	up	ADP
bam-10847	84	61	periods	period	NOUN
bam-10847	84	62	,	,	PUNCT
bam-10847	84	63	which	which	PRON
bam-10847	84	64	reduces	reduce	VERB
bam-10847	84	65	the	the	DET
bam-10847	84	66	accuracy	accuracy	NOUN
bam-10847	84	67	of	of	ADP
bam-10847	84	68	statistical	statistical	ADJ
bam-10847	84	69	analysis	analysis	NOUN
bam-10847	84	70	.	.	PUNCT
bam-10847	85	1	according	accord	VERB
bam-10847	85	2	to	to	ADP
bam-10847	85	3	the	the	DET
bam-10847	85	4	findings	finding	NOUN
bam-10847	85	5	of	of	ADP
bam-10847	85	6	present	present	ADJ
bam-10847	85	7	study	study	NOUN
bam-10847	85	8	,	,	PUNCT
bam-10847	85	9	most	most	ADJ
bam-10847	85	10	of	of	ADP
bam-10847	85	11	the	the	DET
bam-10847	85	12	oscc	oscc	ADJ
bam-10847	85	13	patients	patient	NOUN
bam-10847	85	14	were	be	AUX
bam-10847	85	15	poorly	poorly	ADV
bam-10847	85	16	differentiated	differentiate	VERB
bam-10847	85	17	and	and	CCONJ
bam-10847	85	18	no	no	DET
bam-10847	85	19	significant	significant	ADJ
bam-10847	85	20	association	association	NOUN
bam-10847	85	21	was	be	AUX
bam-10847	85	22	observed	observe	VERB
bam-10847	85	23	between	between	ADP
bam-10847	85	24	the	the	DET
bam-10847	85	25	expression	expression	NOUN
bam-10847	85	26	of	of	ADP
bam-10847	85	27	mutant	mutant	ADJ
bam-10847	85	28	p53	p53	NOUN
bam-10847	85	29	protein	protein	NOUN
bam-10847	85	30	and	and	CCONJ
bam-10847	85	31	the	the	DET
bam-10847	85	32	tumor	tumor	NOUN
bam-10847	85	33	grade	grade	NOUN
bam-10847	85	34	.	.	PUNCT
bam-10847	86	1	mutations	mutation	NOUN
bam-10847	86	2	in	in	ADP
bam-10847	86	3	the	the	DET
bam-10847	86	4	tp53	tp53	PROPN
bam-10847	86	5	gene	gene	NOUN
bam-10847	86	6	are	be	AUX
bam-10847	86	7	the	the	DET
bam-10847	86	8	most	most	ADV
bam-10847	86	9	common	common	ADJ
bam-10847	86	10	molecular	molecular	ADJ
bam-10847	86	11	defects	defect	NOUN
bam-10847	86	12	in	in	ADP
bam-10847	86	13	oscc	oscc	ADV
bam-10847	87	1	and	and	CCONJ
bam-10847	87	2	it	it	PRON
bam-10847	87	3	is	be	AUX
bam-10847	87	4	essential	essential	ADJ
bam-10847	87	5	for	for	ADP
bam-10847	87	6	the	the	DET
bam-10847	87	7	initial	initial	ADJ
bam-10847	87	8	phase	phase	NOUN
bam-10847	87	9	of	of	ADP
bam-10847	87	10	oral	oral	ADJ
bam-10847	87	11	cancers.18	cancers.18	NOUN
bam-10847	87	12	-	-	PUNCT
bam-10847	87	13	22	22	NUM
bam-10847	87	14	the	the	DET
bam-10847	87	15	lack	lack	NOUN
bam-10847	87	16	of	of	ADP
bam-10847	87	17	correlation	correlation	NOUN
bam-10847	87	18	between	between	ADP
bam-10847	87	19	the	the	DET
bam-10847	87	20	oscc	oscc	ADJ
bam-10847	87	21	tumor	tumor	NOUN
bam-10847	87	22	grade	grade	NOUN
bam-10847	87	23	and	and	CCONJ
bam-10847	87	24	the	the	DET
bam-10847	87	25	p53	p53	NOUN
bam-10847	87	26	expression	expression	NOUN
bam-10847	87	27	in	in	ADP
bam-10847	87	28	the	the	DET
bam-10847	87	29	current	current	ADJ
bam-10847	87	30	study	study	NOUN
bam-10847	87	31	can	can	AUX
bam-10847	87	32	be	be	AUX
bam-10847	87	33	attributed	attribute	VERB
bam-10847	87	34	to	to	ADP
bam-10847	87	35	their	their	PRON
bam-10847	87	36	poorly	poorly	ADJ
bam-10847	87	37	differentiation	differentiation	NOUN
bam-10847	87	38	.	.	PUNCT
bam-10847	88	1	however	however	ADV
bam-10847	88	2	,	,	PUNCT
bam-10847	88	3	patients	patient	NOUN
bam-10847	88	4	in	in	ADP
bam-10847	88	5	previous	previous	ADJ
bam-10847	88	6	studies	study	NOUN
bam-10847	88	7	were	be	AUX
bam-10847	88	8	predominantly	predominantly	ADV
bam-10847	88	9	well	well	ADV
bam-10847	88	10	and	and	CCONJ
bam-10847	88	11	moderately	moderately	ADV
bam-10847	88	12	differentiated.30	differentiated.30	NOUN
bam-10847	88	13	-	-	PUNCT
bam-10847	88	14	34	34	NUM
bam-10847	88	15	younger	young	ADJ
bam-10847	88	16	patients	patient	NOUN
bam-10847	88	17	in	in	ADP
bam-10847	88	18	this	this	DET
bam-10847	88	19	study	study	NOUN
bam-10847	88	20	(	(	PUNCT
bam-10847	88	21	aged	age	VERB
bam-10847	88	22	below	below	ADP
bam-10847	88	23	50	50	NUM
bam-10847	88	24	years	year	NOUN
bam-10847	88	25	)	)	PUNCT
bam-10847	88	26	are	be	AUX
bam-10847	88	27	4.52	4.52	NUM
bam-10847	88	28	-	-	PUNCT
bam-10847	88	29	times	time	NOUN
bam-10847	88	30	more	more	ADV
bam-10847	88	31	likely	likely	ADJ
bam-10847	88	32	to	to	PART
bam-10847	88	33	express	express	VERB
bam-10847	88	34	the	the	DET
bam-10847	88	35	mutant	mutant	ADJ
bam-10847	88	36	p53	p53	NOUN
bam-10847	88	37	protein	protein	NOUN
bam-10847	88	38	than	than	ADP
bam-10847	88	39	the	the	DET
bam-10847	88	40	older	old	ADJ
bam-10847	88	41	ones	one	NOUN
bam-10847	88	42	(	(	PUNCT
bam-10847	88	43	aged	aged	ADJ
bam-10847	88	44	over	over	ADP
bam-10847	88	45	50	50	NUM
bam-10847	88	46	years	year	NOUN
bam-10847	88	47	)	)	PUNCT
bam-10847	88	48	.	.	PUNCT
bam-10847	89	1	oscc	oscc	ADV
bam-10847	89	2	occasionally	occasionally	ADV
bam-10847	89	3	occurs	occur	VERB
bam-10847	89	4	in	in	ADP
bam-10847	89	5	young	young	ADJ
bam-10847	89	6	patients	patient	NOUN
bam-10847	89	7	with	with	ADP
bam-10847	89	8	more	more	ADV
bam-10847	89	9	aggressive	aggressive	ADJ
bam-10847	89	10	behavior	behavior	NOUN
bam-10847	89	11	and	and	CCONJ
bam-10847	89	12	poor	poor	ADJ
bam-10847	89	13	prognosis	prognosis	NOUN
bam-10847	89	14	,	,	PUNCT
bam-10847	89	15	and	and	CCONJ
bam-10847	89	16	is	be	AUX
bam-10847	89	17	likely	likely	ADJ
bam-10847	89	18	to	to	PART
bam-10847	89	19	be	be	AUX
bam-10847	89	20	distinct	distinct	ADJ
bam-10847	89	21	from	from	ADP
bam-10847	89	22	oscc	oscc	ADV
bam-10847	89	23	in	in	ADP
bam-10847	89	24	older	old	ADJ
bam-10847	89	25	patients.35	patients.35	NOUN
bam-10847	89	26	,	,	PUNCT
bam-10847	89	27	36	36	NUM
bam-10847	89	28	since	since	SCONJ
bam-10847	89	29	the	the	DET
bam-10847	89	30	p53	p53	NOUN
bam-10847	89	31	is	be	AUX
bam-10847	89	32	a	a	DET
bam-10847	89	33	genome	genome	NOUN
bam-10847	89	34	guardian	guardian	NOUN
bam-10847	89	35	protein	protein	NOUN
bam-10847	89	36	and	and	CCONJ
bam-10847	89	37	plays	play	VERB
bam-10847	89	38	an	an	DET
bam-10847	89	39	important	important	ADJ
bam-10847	89	40	role	role	NOUN
bam-10847	89	41	in	in	ADP
bam-10847	89	42	the	the	DET
bam-10847	89	43	prevention	prevention	NOUN
bam-10847	89	44	of	of	ADP
bam-10847	89	45	malignancies	malignancy	NOUN
bam-10847	89	46	,	,	PUNCT
bam-10847	89	47	the	the	DET
bam-10847	89	48	higher	high	ADJ
bam-10847	89	49	rate	rate	NOUN
bam-10847	89	50	of	of	ADP
bam-10847	89	51	p53	p53	NOUN
bam-10847	89	52	immunopositivity	immunopositivity	NOUN
bam-10847	89	53	in	in	ADP
bam-10847	89	54	younger	young	ADJ
bam-10847	89	55	patients	patient	NOUN
bam-10847	89	56	can	can	AUX
bam-10847	89	57	explain	explain	VERB
bam-10847	89	58	the	the	DET
bam-10847	89	59	more	more	ADV
bam-10847	89	60	aggressive	aggressive	ADJ
bam-10847	89	61	types	type	NOUN
bam-10847	89	62	of	of	ADP
bam-10847	89	63	osccs	osccs	NOUN
bam-10847	89	64	.	.	PUNCT
bam-10847	90	1	patients	patient	NOUN
bam-10847	90	2	with	with	ADP
bam-10847	90	3	osccs	osccs	PROPN
bam-10847	90	4	have	have	VERB
bam-10847	90	5	a	a	DET
bam-10847	90	6	high	high	ADJ
bam-10847	90	7	incidence	incidence	NOUN
bam-10847	90	8	of	of	ADP
bam-10847	90	9	recurrences	recurrence	NOUN
bam-10847	90	10	,	,	PUNCT
bam-10847	90	11	and	and	CCONJ
bam-10847	90	12	it	it	PRON
bam-10847	90	13	is	be	AUX
bam-10847	90	14	an	an	DET
bam-10847	90	15	important	important	ADJ
bam-10847	90	16	prognostic	prognostic	ADJ
bam-10847	90	17	factor	factor	NOUN
bam-10847	90	18	in	in	ADP
bam-10847	90	19	these	these	DET
bam-10847	90	20	patients.7	patients.7	NOUN
bam-10847	90	21	in	in	ADP
bam-10847	90	22	the	the	DET
bam-10847	90	23	present	present	ADJ
bam-10847	90	24	study	study	NOUN
bam-10847	90	25	,	,	PUNCT
bam-10847	90	26	the	the	DET
bam-10847	90	27	pattern	pattern	NOUN
bam-10847	90	28	of	of	ADP
bam-10847	90	29	p53mt	p53mt	NUM
bam-10847	90	30	protein	protein	NOUN
bam-10847	90	31	expression	expression	NOUN
bam-10847	90	32	in	in	ADP
bam-10847	90	33	cases	case	NOUN
bam-10847	90	34	of	of	ADP
bam-10847	90	35	oscc	oscc	ADJ
bam-10847	90	36	recurrence	recurrence	NOUN
bam-10847	90	37	was	be	AUX
bam-10847	90	38	the	the	DET
bam-10847	90	39	same	same	ADJ
bam-10847	90	40	as	as	ADP
bam-10847	90	41	in	in	ADP
bam-10847	90	42	the	the	DET
bam-10847	90	43	matched	match	VERB
bam-10847	90	44	primary	primary	ADJ
bam-10847	90	45	tumors	tumor	NOUN
bam-10847	90	46	.	.	PUNCT
bam-10847	91	1	to	to	ADP
bam-10847	91	2	the	the	DET
bam-10847	91	3	best	good	ADJ
bam-10847	91	4	of	of	ADP
bam-10847	91	5	our	our	PRON
bam-10847	91	6	knowledge	knowledge	NOUN
bam-10847	91	7	the	the	DET
bam-10847	91	8	current	current	ADJ
bam-10847	91	9	study	study	NOUN
bam-10847	91	10	is	be	AUX
bam-10847	91	11	the	the	DET
bam-10847	91	12	first	first	ADJ
bam-10847	91	13	investigation	investigation	NOUN
bam-10847	91	14	regarding	regard	VERB
bam-10847	91	15	the	the	DET
bam-10847	91	16	possible	possible	ADJ
bam-10847	91	17	changes	change	NOUN
bam-10847	91	18	in	in	ADP
bam-10847	91	19	the	the	DET
bam-10847	91	20	expression	expression	NOUN
bam-10847	91	21	of	of	ADP
bam-10847	91	22	mutant	mutant	ADJ
bam-10847	91	23	p53	p53	NOUN
bam-10847	91	24	protein	protein	NOUN
bam-10847	91	25	between	between	ADP
bam-10847	91	26	iranian	iranian	ADJ
bam-10847	91	27	oscc	oscc	PROPN
bam-10847	91	28	patients	patient	NOUN
bam-10847	91	29	with	with	ADP
bam-10847	91	30	the	the	DET
bam-10847	91	31	primary	primary	ADJ
bam-10847	91	32	and	and	CCONJ
bam-10847	91	33	recurrence	recurrence	NOUN
bam-10847	91	34	tumors	tumor	NOUN
bam-10847	91	35	.	.	PUNCT
bam-10847	92	1	although	although	SCONJ
bam-10847	92	2	we	we	PRON
bam-10847	92	3	did	do	AUX
bam-10847	92	4	not	not	PART
bam-10847	92	5	evaluate	evaluate	VERB
bam-10847	92	6	the	the	DET
bam-10847	92	7	prognosis	prognosis	NOUN
bam-10847	92	8	of	of	ADP
bam-10847	92	9	oscc	oscc	ADJ
bam-10847	92	10	patients	patient	NOUN
bam-10847	92	11	in	in	ADP
bam-10847	92	12	this	this	DET
bam-10847	92	13	study	study	NOUN
bam-10847	92	14	,	,	PUNCT
bam-10847	92	15	a	a	DET
bam-10847	92	16	considerable	considerable	ADJ
bam-10847	92	17	number	number	NOUN
bam-10847	92	18	of	of	ADP
bam-10847	92	19	former	former	ADJ
bam-10847	92	20	investigations	investigation	NOUN
bam-10847	92	21	performed	perform	VERB
bam-10847	92	22	on	on	ADP
bam-10847	92	23	patients	patient	NOUN
bam-10847	92	24	with	with	ADP
bam-10847	92	25	hnsccs,37	hnsccs,37	NOUN
bam-10847	92	26	,	,	PUNCT
bam-10847	92	27	38	38	NUM
bam-10847	92	28	oral	oral	ADJ
bam-10847	92	29	and	and	CCONJ
bam-10847	92	30	oropharyngeal	oropharyngeal	NOUN
bam-10847	92	31	scc,39	scc,39	NOUN
bam-10847	92	32	and	and	CCONJ
bam-10847	92	33	hypopharyngeal	hypopharyngeal	NOUN
bam-10847	92	34	scc,40	scc,40	VERB
bam-10847	92	35	showed	show	VERB
bam-10847	92	36	no	no	DET
bam-10847	92	37	significant	significant	ADJ
bam-10847	92	38	correlation	correlation	NOUN
bam-10847	92	39	between	between	ADP
bam-10847	92	40	the	the	DET
bam-10847	92	41	expression	expression	NOUN
bam-10847	92	42	of	of	ADP
bam-10847	92	43	p53	p53	NOUN
bam-10847	92	44	protein	protein	NOUN
bam-10847	92	45	and	and	CCONJ
bam-10847	92	46	the	the	DET
bam-10847	92	47	patients	patient	NOUN
bam-10847	92	48	'	'	PART
bam-10847	92	49	survival	survival	NOUN
bam-10847	92	50	.	.	PUNCT
bam-10847	93	1	in	in	ADP
bam-10847	93	2	contrast	contrast	NOUN
bam-10847	93	3	,	,	PUNCT
bam-10847	93	4	some	some	DET
bam-10847	93	5	reports	report	NOUN
bam-10847	93	6	in	in	ADP
bam-10847	93	7	literature	literature	NOUN
bam-10847	93	8	stated	state	VERB
bam-10847	93	9	a	a	DET
bam-10847	93	10	negative	negative	ADJ
bam-10847	93	11	prognostic	prognostic	ADJ
bam-10847	93	12	value	value	NOUN
bam-10847	93	13	of	of	ADP
bam-10847	93	14	p53	p53	NOUN
bam-10847	93	15	protein	protein	NOUN
bam-10847	93	16	expression	expression	NOUN
bam-10847	93	17	in	in	ADP
bam-10847	93	18	laryngeal	laryngeal	ADJ
bam-10847	93	19	scc	scc	NOUN
bam-10847	93	20	,	,	PUNCT
bam-10847	93	21	oscc	oscc	ADJ
bam-10847	93	22	,	,	PUNCT
bam-10847	93	23	and	and	CCONJ
bam-10847	93	24	hnsccs.30,41,42	hnsccs.30,41,42	PRON
bam-10847	93	25	the	the	DET
bam-10847	93	26	discrepancy	discrepancy	NOUN
bam-10847	93	27	between	between	ADP
bam-10847	93	28	the	the	DET
bam-10847	93	29	results	result	NOUN
bam-10847	93	30	may	may	AUX
bam-10847	93	31	be	be	AUX
bam-10847	93	32	due	due	ADJ
bam-10847	93	33	to	to	ADP
bam-10847	93	34	the	the	DET
bam-10847	93	35	differences	difference	NOUN
bam-10847	93	36	in	in	ADP
bam-10847	93	37	surgical	surgical	ADJ
bam-10847	93	38	techniques	technique	NOUN
bam-10847	93	39	,	,	PUNCT
bam-10847	93	40	types	type	NOUN
bam-10847	93	41	of	of	ADP
bam-10847	93	42	adjuvant	adjuvant	ADJ
bam-10847	93	43	therapy	therapy	NOUN
bam-10847	93	44	,	,	PUNCT
bam-10847	93	45	method	method	NOUN
bam-10847	93	46	of	of	ADP
bam-10847	93	47	ihc	ihc	PROPN
bam-10847	93	48	staining	staining	NOUN
bam-10847	93	49	,	,	PUNCT
bam-10847	93	50	and	and	CCONJ
bam-10847	93	51	other	other	ADJ
bam-10847	93	52	interference	interference	NOUN
bam-10847	93	53	factors	factor	NOUN
bam-10847	93	54	.	.	PUNCT
bam-10847	94	1	mutations	mutation	NOUN
bam-10847	94	2	are	be	AUX
bam-10847	94	3	likely	likely	ADJ
bam-10847	94	4	to	to	PART
bam-10847	94	5	affect	affect	VERB
bam-10847	94	6	protein	protein	NOUN
bam-10847	94	7	synthesis	synthesis	NOUN
bam-10847	94	8	/	/	SYM
bam-10847	94	9	function	function	NOUN
bam-10847	94	10	,	,	PUNCT
bam-10847	94	11	depending	depend	VERB
bam-10847	94	12	on	on	ADP
bam-10847	94	13	their	their	PRON
bam-10847	94	14	context	context	NOUN
bam-10847	94	15	and	and	CCONJ
bam-10847	94	16	location	location	NOUN
bam-10847	94	17	.	.	PUNCT
bam-10847	95	1	immunohistochemistry	immunohistochemistry	PROPN
bam-10847	95	2	is	be	AUX
bam-10847	95	3	a	a	DET
bam-10847	95	4	cheap	cheap	ADJ
bam-10847	95	5	and	and	CCONJ
bam-10847	95	6	simple	simple	ADJ
bam-10847	95	7	method	method	NOUN
bam-10847	95	8	to	to	PART
bam-10847	95	9	detect	detect	VERB
bam-10847	95	10	the	the	DET
bam-10847	95	11	inactivated	inactivated	ADJ
bam-10847	95	12	p53	p53	NOUN
bam-10847	95	13	protein	protein	NOUN
bam-10847	95	14	,	,	PUNCT
bam-10847	95	15	either	either	CCONJ
bam-10847	95	16	directly	directly	ADV
bam-10847	95	17	as	as	ADP
bam-10847	95	18	a	a	DET
bam-10847	95	19	result	result	NOUN
bam-10847	95	20	of	of	ADP
bam-10847	95	21	mutations	mutation	NOUN
bam-10847	95	22	in	in	ADP
bam-10847	95	23	tp53	tp53	PROPN
bam-10847	95	24	gene	gene	NOUN
bam-10847	95	25	or	or	CCONJ
bam-10847	95	26	indirectly	indirectly	ADV
bam-10847	95	27	through	through	ADP
bam-10847	95	28	binding	bind	VERB
bam-10847	95	29	to	to	ADP
bam-10847	95	30	viral	viral	ADJ
bam-10847	95	31	proteins	protein	NOUN
bam-10847	95	32	and	and	CCONJ
bam-10847	95	33	cellular	cellular	ADJ
bam-10847	95	34	oncogenes	oncogene	NOUN
bam-10847	95	35	.	.	PUNCT
bam-10847	96	1	however	however	ADV
bam-10847	96	2	,	,	PUNCT
bam-10847	96	3	the	the	DET
bam-10847	96	4	p53	p53	NOUN
bam-10847	96	5	alterations	alteration	NOUN
bam-10847	96	6	was	be	AUX
bam-10847	96	7	not	not	PART
bam-10847	96	8	evaluated	evaluate	VERB
bam-10847	96	9	in	in	ADP
bam-10847	96	10	previous	previous	ADJ
bam-10847	96	11	studies.30	studies.30	NOUN
bam-10847	96	12	-	-	PUNCT
bam-10847	96	13	34	34	NUM
bam-10847	96	14	although	although	SCONJ
bam-10847	96	15	the	the	DET
bam-10847	96	16	vast	vast	ADJ
bam-10847	96	17	majority	majority	NOUN
bam-10847	96	18	of	of	ADP
bam-10847	96	19	p53	p53	NOUN
bam-10847	96	20	mutations	mutation	NOUN
bam-10847	96	21	in	in	ADP
bam-10847	96	22	cancers	cancer	NOUN
bam-10847	96	23	are	be	AUX
bam-10847	96	24	missense	missense	NOUN
bam-10847	96	25	mutations	mutation	NOUN
bam-10847	96	26	that	that	PRON
bam-10847	96	27	able	able	ADJ
bam-10847	96	28	to	to	PART
bam-10847	96	29	produce	produce	VERB
bam-10847	96	30	the	the	DET
bam-10847	96	31	full	full	ADJ
bam-10847	96	32	-	-	PUNCT
bam-10847	96	33	length	length	NOUN
bam-10847	96	34	p53mt	p53mt	NUM
bam-10847	96	35	protein	protein	NOUN
bam-10847	96	36	with	with	ADP
bam-10847	96	37	single	single	ADJ
bam-10847	96	38	amino	amino	NOUN
bam-10847	96	39	acid	acid	NOUN
bam-10847	96	40	substitutions	substitution	NOUN
bam-10847	96	41	within	within	ADP
bam-10847	96	42	the	the	DET
bam-10847	96	43	dna	dna	NOUN
bam-10847	96	44	binding	bind	VERB
bam-10847	96	45	domain	domain	NOUN
bam-10847	96	46	(	(	PUNCT
bam-10847	96	47	only	only	ADV
bam-10847	96	48	one	one	NUM
bam-10847	96	49	amino	amino	NOUN
bam-10847	96	50	acid	acid	NOUN
bam-10847	96	51	difference	difference	NOUN
bam-10847	96	52	from	from	ADP
bam-10847	96	53	p53wt	p53wt	ADJ
bam-10847	96	54	protein	protein	NOUN
bam-10847	96	55	)	)	PUNCT
bam-10847	96	56	,	,	PUNCT
bam-10847	96	57	nonsense	nonsense	NOUN
bam-10847	96	58	mutations	mutation	NOUN
bam-10847	96	59	or	or	CCONJ
bam-10847	96	60	loss	loss	NOUN
bam-10847	96	61	of	of	ADP
bam-10847	96	62	both	both	DET
bam-10847	96	63	alleles	allele	NOUN
bam-10847	96	64	can	can	AUX
bam-10847	96	65	lead	lead	VERB
bam-10847	96	66	to	to	ADP
bam-10847	96	67	a	a	DET
bam-10847	96	68	lack	lack	NOUN
bam-10847	96	69	of	of	ADP
bam-10847	96	70	p53	p53	NOUN
bam-10847	96	71	protein	protein	NOUN
bam-10847	96	72	production	production	NOUN
bam-10847	96	73	/	/	SYM
bam-10847	96	74	detection.30,43	detection.30,43	NOUN
bam-10847	96	75	-	-	PUNCT
bam-10847	96	76	45	45	NUM
bam-10847	96	77	therefore	therefore	ADV
bam-10847	96	78	,	,	PUNCT
bam-10847	96	79	determining	determine	VERB
bam-10847	96	80	the	the	DET
bam-10847	96	81	type	type	NOUN
bam-10847	96	82	of	of	ADP
bam-10847	96	83	inactivated	inactivated	ADJ
bam-10847	96	84	p53	p53	NOUN
bam-10847	96	85	protein	protein	NOUN
bam-10847	96	86	is	be	AUX
bam-10847	96	87	so	so	ADV
bam-10847	96	88	important	important	ADJ
bam-10847	96	89	and	and	CCONJ
bam-10847	96	90	could	could	AUX
bam-10847	96	91	clarify	clarify	VERB
bam-10847	96	92	the	the	DET
bam-10847	96	93	limited	limited	ADJ
bam-10847	96	94	prognostic	prognostic	ADJ
bam-10847	96	95	significance	significance	NOUN
bam-10847	96	96	of	of	ADP
bam-10847	96	97	p53	p53	NOUN
bam-10847	96	98	immunoexpression	immunoexpression	NOUN
bam-10847	96	99	in	in	ADP
bam-10847	96	100	some	some	DET
bam-10847	96	101	human	human	ADJ
bam-10847	96	102	cancers	cancer	NOUN
bam-10847	96	103	.	.	PUNCT
bam-10847	97	1	this	this	DET
bam-10847	97	2	study	study	NOUN
bam-10847	97	3	also	also	ADV
bam-10847	97	4	has	have	VERB
bam-10847	97	5	some	some	DET
bam-10847	97	6	limitations	limitation	NOUN
bam-10847	97	7	due	due	ADP
bam-10847	97	8	to	to	ADP
bam-10847	97	9	the	the	DET
bam-10847	97	10	methodological	methodological	ADJ
bam-10847	97	11	flaws	flaw	NOUN
bam-10847	97	12	and	and	CCONJ
bam-10847	97	13	potential	potential	ADJ
bam-10847	97	14	unmeasured	unmeasured	ADJ
bam-10847	97	15	confounding	confounding	NOUN
bam-10847	97	16	,	,	PUNCT
bam-10847	97	17	which	which	PRON
bam-10847	97	18	can	can	AUX
bam-10847	97	19	be	be	AUX
bam-10847	97	20	addressed	address	VERB
bam-10847	97	21	in	in	ADP
bam-10847	97	22	future	future	ADJ
bam-10847	97	23	studies	study	NOUN
bam-10847	97	24	.	.	PUNCT
bam-10847	98	1	firstly	firstly	ADV
bam-10847	98	2	,	,	PUNCT
bam-10847	98	3	it	it	PRON
bam-10847	98	4	is	be	AUX
bam-10847	98	5	possible	possible	ADJ
bam-10847	98	6	that	that	SCONJ
bam-10847	98	7	imbalance	imbalance	NOUN
bam-10847	98	8	between	between	ADP
bam-10847	98	9	oscc	oscc	NOUN
bam-10847	98	10	and	and	CCONJ
bam-10847	98	11	control	control	VERB
bam-10847	98	12	participants	participant	NOUN
bam-10847	98	13	could	could	AUX
bam-10847	98	14	lead	lead	VERB
bam-10847	98	15	to	to	ADP
bam-10847	98	16	residual	residual	ADJ
bam-10847	98	17	confounding	confounding	NOUN
bam-10847	98	18	,	,	PUNCT
bam-10847	98	19	which	which	PRON
bam-10847	98	20	can	can	AUX
bam-10847	98	21	explain	explain	VERB
bam-10847	98	22	our	our	PRON
bam-10847	98	23	findings	finding	NOUN
bam-10847	98	24	.	.	PUNCT
bam-10847	99	1	the	the	DET
bam-10847	99	2	second	second	ADJ
bam-10847	99	3	limitation	limitation	NOUN
bam-10847	99	4	was	be	AUX
bam-10847	99	5	small	small	ADJ
bam-10847	99	6	sample	sample	NOUN
bam-10847	99	7	size	size	NOUN
bam-10847	99	8	of	of	ADP
bam-10847	99	9	patients	patient	NOUN
bam-10847	99	10	in	in	ADP
bam-10847	99	11	different	different	ADJ
bam-10847	99	12	stages	stage	NOUN
bam-10847	99	13	of	of	ADP
bam-10847	99	14	oscc	oscc	ADJ
bam-10847	99	15	,	,	PUNCT
bam-10847	99	16	which	which	PRON
bam-10847	99	17	lead	lead	VERB
bam-10847	99	18	to	to	ADP
bam-10847	99	19	no	no	DET
bam-10847	99	20	correlation	correlation	NOUN
bam-10847	99	21	between	between	ADP
bam-10847	99	22	the	the	DET
bam-10847	99	23	p53	p53	NOUN
bam-10847	99	24	expression	expression	NOUN
bam-10847	99	25	and	and	CCONJ
bam-10847	99	26	tumor	tumor	NOUN
bam-10847	99	27	grading	grading	NOUN
bam-10847	99	28	.	.	PUNCT
bam-10847	100	1	therefore	therefore	ADV
bam-10847	100	2	,	,	PUNCT
bam-10847	100	3	further	further	ADJ
bam-10847	100	4	studies	study	NOUN
bam-10847	100	5	with	with	ADP
bam-10847	100	6	larger	large	ADJ
bam-10847	100	7	sample	sample	NOUN
bam-10847	100	8	non	non	ADJ
bam-10847	100	9	-co	-co	PROPN
bam-10847	100	10	mmerc	mmerc	PROPN
bam-10847	100	11	ial	ial	PROPN
bam-10847	100	12	us	us	PROPN
bam-10847	100	13	e	e	NOUN
bam-10847	100	14	o	o	NOUN
bam-10847	100	15	nly	nly	ADV
bam-10847	100	16	p53	p53	VERB
bam-10847	100	17	mutant	mutant	NOUN
bam-10847	100	18	-	-	PUNCT
bam-10847	100	19	type	type	NOUN
bam-10847	100	20	in	in	ADP
bam-10847	100	21	oral	oral	ADJ
bam-10847	100	22	squamous	squamous	ADJ
bam-10847	100	23	cell	cell	NOUN
bam-10847	100	24	carcinoma	carcinoma	NOUN
bam-10847	100	25	eur	eur	PROPN
bam-10847	100	26	j	j	PROPN
bam-10847	100	27	transl	transl	PROPN
bam-10847	100	28	myol	myol	ADV
bam-10847	100	29	33	33	NUM
bam-10847	100	30	(	(	PUNCT
bam-10847	100	31	1	1	NUM
bam-10847	100	32	)	)	PUNCT
bam-10847	100	33	10847	10847	NUM
bam-10847	100	34	,	,	PUNCT
bam-10847	100	35	2023	2023	NUM
bam-10847	100	36	doi	doi	NOUN
bam-10847	100	37	:	:	PUNCT
bam-10847	100	38	10.4081	10.4081	NUM
bam-10847	100	39	/	/	SYM
bam-10847	100	40	ejtm.2023.10847	ejtm.2023.10847	PROPN
bam-10847	100	41	5	5	NUM
bam-10847	100	42	size	size	NOUN
bam-10847	100	43	,	,	PUNCT
bam-10847	100	44	much	much	ADJ
bam-10847	100	45	cases	case	NOUN
bam-10847	100	46	in	in	ADP
bam-10847	100	47	each	each	DET
bam-10847	100	48	tumor	tumor	NOUN
bam-10847	100	49	grade	grade	NOUN
bam-10847	100	50	,	,	PUNCT
bam-10847	100	51	and	and	CCONJ
bam-10847	100	52	longer	long	ADV
bam-10847	100	53	follow	follow	VERB
bam-10847	100	54	-	-	PUNCT
bam-10847	100	55	ups	up	NOUN
bam-10847	100	56	are	be	AUX
bam-10847	100	57	highly	highly	ADV
bam-10847	100	58	recommendable	recommendable	ADJ
bam-10847	100	59	.	.	PUNCT
bam-10847	101	1	finally	finally	ADV
bam-10847	101	2	,	,	PUNCT
bam-10847	101	3	the	the	DET
bam-10847	101	4	unification	unification	NOUN
bam-10847	101	5	of	of	ADP
bam-10847	101	6	clinical	clinical	ADJ
bam-10847	101	7	laboratory	laboratory	NOUN
bam-10847	101	8	methods	method	NOUN
bam-10847	101	9	and	and	CCONJ
bam-10847	101	10	the	the	DET
bam-10847	101	11	standardization	standardization	NOUN
bam-10847	101	12	of	of	ADP
bam-10847	101	13	detection	detection	NOUN
bam-10847	101	14	techniques	technique	NOUN
bam-10847	101	15	might	might	AUX
bam-10847	101	16	be	be	AUX
bam-10847	101	17	beneficial	beneficial	ADJ
bam-10847	101	18	to	to	PART
bam-10847	101	19	reduce	reduce	VERB
bam-10847	101	20	the	the	DET
bam-10847	101	21	differences	difference	NOUN
bam-10847	101	22	between	between	ADP
bam-10847	101	23	the	the	DET
bam-10847	101	24	laboratories	laboratory	NOUN
bam-10847	101	25	in	in	ADP
bam-10847	101	26	analysis	analysis	NOUN
bam-10847	101	27	of	of	ADP
bam-10847	101	28	the	the	DET
bam-10847	101	29	ihc	ihc	PROPN
bam-10847	101	30	results	result	NOUN
bam-10847	101	31	.	.	PUNCT
bam-10847	102	1	in	in	ADP
bam-10847	102	2	conclusion	conclusion	NOUN
bam-10847	102	3	,	,	PUNCT
bam-10847	102	4	this	this	DET
bam-10847	102	5	study	study	NOUN
bam-10847	102	6	showed	show	VERB
bam-10847	102	7	a	a	DET
bam-10847	102	8	significant	significant	ADJ
bam-10847	102	9	difference	difference	NOUN
bam-10847	102	10	in	in	ADP
bam-10847	102	11	the	the	DET
bam-10847	102	12	expression	expression	NOUN
bam-10847	102	13	of	of	ADP
bam-10847	102	14	mutant	mutant	ADJ
bam-10847	102	15	p53	p53	NOUN
bam-10847	102	16	protein	protein	NOUN
bam-10847	102	17	between	between	ADP
bam-10847	102	18	oscc	oscc	ADJ
bam-10847	102	19	patients	patient	NOUN
bam-10847	102	20	and	and	CCONJ
bam-10847	102	21	the	the	DET
bam-10847	102	22	control	control	NOUN
bam-10847	102	23	.	.	PUNCT
bam-10847	103	1	hence	hence	ADV
bam-10847	103	2	,	,	PUNCT
bam-10847	103	3	monitoring	monitoring	NOUN
bam-10847	103	4	of	of	ADP
bam-10847	103	5	individuals	individual	NOUN
bam-10847	103	6	with	with	ADP
bam-10847	103	7	higher	high	ADJ
bam-10847	103	8	risk	risk	NOUN
bam-10847	103	9	of	of	ADP
bam-10847	103	10	oscc	oscc	PROPN
bam-10847	103	11	development	development	NOUN
bam-10847	103	12	,	,	PUNCT
bam-10847	103	13	especially	especially	ADV
bam-10847	103	14	younger	young	ADJ
bam-10847	103	15	patients	patient	NOUN
bam-10847	103	16	,	,	PUNCT
bam-10847	103	17	can	can	AUX
bam-10847	103	18	be	be	AUX
bam-10847	103	19	performed	perform	VERB
bam-10847	103	20	by	by	ADP
bam-10847	103	21	this	this	DET
bam-10847	103	22	valuable	valuable	ADJ
bam-10847	103	23	marker	marker	NOUN
bam-10847	103	24	to	to	PART
bam-10847	103	25	prevent	prevent	VERB
bam-10847	103	26	malignant	malignant	ADJ
bam-10847	103	27	transformation	transformation	NOUN
bam-10847	103	28	and	and	CCONJ
bam-10847	103	29	distant	distant	ADJ
bam-10847	103	30	metastasis	metastasis	NOUN
bam-10847	103	31	,	,	PUNCT
bam-10847	103	32	i.e.	i.e.	X
bam-10847	103	33	,	,	PUNCT
bam-10847	103	34	for	for	ADP
bam-10847	103	35	timely	timely	ADJ
bam-10847	103	36	intervention	intervention	NOUN
bam-10847	103	37	.	.	PUNCT
bam-10847	104	1	despite	despite	SCONJ
bam-10847	104	2	in	in	ADP
bam-10847	104	3	our	our	PRON
bam-10847	104	4	study	study	NOUN
bam-10847	104	5	the	the	DET
bam-10847	104	6	immunoexpression	immunoexpression	NOUN
bam-10847	104	7	of	of	ADP
bam-10847	104	8	the	the	DET
bam-10847	104	9	p53	p53	NOUN
bam-10847	104	10	mutant	mutant	NOUN
bam-10847	104	11	had	have	VERB
bam-10847	104	12	no	no	DET
bam-10847	104	13	prognostic	prognostic	ADJ
bam-10847	104	14	value	value	NOUN
bam-10847	104	15	for	for	ADP
bam-10847	104	16	relapses	relapse	NOUN
bam-10847	104	17	,	,	PUNCT
bam-10847	104	18	further	further	ADJ
bam-10847	104	19	indepth	indepth	ADJ
bam-10847	104	20	studies	study	NOUN
bam-10847	104	21	could	could	AUX
bam-10847	104	22	provide	provide	VERB
bam-10847	104	23	useful	useful	ADJ
bam-10847	104	24	information	information	NOUN
bam-10847	104	25	in	in	ADP
bam-10847	104	26	this	this	DET
bam-10847	104	27	domain	domain	NOUN
bam-10847	104	28	.	.	PUNCT
bam-10847	105	1	list	list	NOUN
bam-10847	105	2	of	of	ADP
bam-10847	105	3	acronyms	acronym	NOUN
bam-10847	105	4	95%ci	95%ci	NUM
bam-10847	105	5	95	95	NUM
bam-10847	105	6	%	%	NOUN
bam-10847	105	7	confidence	confidence	NOUN
bam-10847	105	8	interval	interval	NOUN
bam-10847	105	9	ajcc	ajcc	PROPN
bam-10847	105	10	american	american	PROPN
bam-10847	105	11	joint	joint	PROPN
bam-10847	105	12	committee	committee	PROPN
bam-10847	105	13	on	on	ADP
bam-10847	105	14	cancer	cancer	NOUN
bam-10847	105	15	dna	dna	PROPN
bam-10847	105	16	deoxyribonucleic	deoxyribonucleic	VERB
bam-10847	105	17	acid	acid	NOUN
bam-10847	105	18	egfr	egfr	VERB
bam-10847	105	19	epidermal	epidermal	ADJ
bam-10847	105	20	growth	growth	NOUN
bam-10847	105	21	factor	factor	NOUN
bam-10847	105	22	receptor	receptor	NOUN
bam-10847	105	23	h	h	PROPN
bam-10847	105	24	&	&	CCONJ
bam-10847	105	25	e	e	PROPN
bam-10847	105	26	hematoxylin	hematoxylin	PROPN
bam-10847	105	27	and	and	CCONJ
bam-10847	105	28	eosin	eosin	PROPN
bam-10847	105	29	hnscc	hnscc	NOUN
bam-10847	105	30	head	head	NOUN
bam-10847	105	31	and	and	CCONJ
bam-10847	105	32	neck	neck	VERB
bam-10847	105	33	squamous	squamous	ADJ
bam-10847	105	34	cell	cell	NOUN
bam-10847	105	35	carcinoma	carcinoma	NOUN
bam-10847	105	36	hr	hr	PROPN
bam-10847	105	37	hazard	hazard	NOUN
bam-10847	105	38	regression	regression	NOUN
bam-10847	105	39	and	and	CCONJ
bam-10847	105	40	hazard	hazard	NOUN
bam-10847	105	41	ratio	ratio	NOUN
bam-10847	105	42	ihc	ihc	PROPN
bam-10847	105	43	immunohistochemistry	immunohistochemistry	PROPN
bam-10847	105	44	olp	olp	PROPN
bam-10847	105	45	oral	oral	ADJ
bam-10847	105	46	lichen	lichen	NOUN
bam-10847	105	47	planus	planus	NOUN
bam-10847	105	48	or	or	CCONJ
bam-10847	105	49	odds	odd	NOUN
bam-10847	105	50	ratio	ratio	NOUN
bam-10847	105	51	oscc	oscc	ADJ
bam-10847	105	52	oral	oral	ADJ
bam-10847	105	53	squamous	squamous	ADJ
bam-10847	105	54	cell	cell	NOUN
bam-10847	105	55	carcinoma	carcinoma	NOUN
bam-10847	105	56	p53mt	p53mt	NUM
bam-10847	105	57	p53	p53	NOUN
bam-10847	105	58	mutant	mutant	ADJ
bam-10847	105	59	-	-	PUNCT
bam-10847	105	60	type	type	NOUN
bam-10847	105	61	p53null	p53null	NOUN
bam-10847	105	62	p53	p53	NOUN
bam-10847	105	63	null	null	ADJ
bam-10847	105	64	-	-	PUNCT
bam-10847	105	65	type	type	NOUN
bam-10847	105	66	p53wt	p53wt	PROPN
bam-10847	105	67	p53	p53	NOUN
bam-10847	105	68	wild	wild	ADJ
bam-10847	105	69	-	-	PUNCT
bam-10847	105	70	type	type	NOUN
bam-10847	105	71	ros	ros	PROPN
bam-10847	105	72	reactive	reactive	ADJ
bam-10847	105	73	oxygen	oxygen	NOUN
bam-10847	105	74	species	specie	NOUN
bam-10847	105	75	tnm	tnm	PROPN
bam-10847	105	76	tumor	tumor	PROPN
bam-10847	105	77	,	,	PUNCT
bam-10847	105	78	node	node	NOUN
bam-10847	105	79	,	,	PUNCT
bam-10847	105	80	and	and	CCONJ
bam-10847	105	81	metastasis	metastasis	NOUN
bam-10847	105	82	tp53	tp53	PROPN
bam-10847	105	83	–	–	PUNCT
bam-10847	105	84	tumor	tumor	NOUN
bam-10847	105	85	-	-	PUNCT
bam-10847	105	86	suppressor	suppressor	NOUN
bam-10847	105	87	protein	protein	NOUN
bam-10847	105	88	53	53	NUM
bam-10847	105	89	who	who	PRON
bam-10847	105	90	world	world	NOUN
bam-10847	105	91	health	health	NOUN
bam-10847	105	92	organization	organization	NOUN
bam-10847	105	93	contributions	contribution	NOUN
bam-10847	105	94	of	of	ADP
bam-10847	105	95	authors	author	NOUN
bam-10847	105	96	all	all	DET
bam-10847	105	97	authors	author	NOUN
bam-10847	105	98	have	have	AUX
bam-10847	105	99	read	read	VERB
bam-10847	105	100	and	and	CCONJ
bam-10847	105	101	approved	approve	VERB
bam-10847	105	102	the	the	DET
bam-10847	105	103	final	final	ADJ
bam-10847	105	104	edited	edited	ADJ
bam-10847	105	105	typescript	typescript	NOUN
bam-10847	105	106	.	.	PUNCT
bam-10847	106	1	acknowledgments	acknowledgment	NOUN
bam-10847	106	2	the	the	DET
bam-10847	106	3	authors	author	NOUN
bam-10847	106	4	thank	thank	VERB
bam-10847	106	5	the	the	DET
bam-10847	106	6	patients	patient	NOUN
bam-10847	106	7	who	who	PRON
bam-10847	106	8	volunteered	volunteer	VERB
bam-10847	106	9	for	for	ADP
bam-10847	106	10	the	the	DET
bam-10847	106	11	study	study	NOUN
bam-10847	106	12	.	.	PUNCT
bam-10847	107	1	funding	fund	VERB
bam-10847	107	2	this	this	DET
bam-10847	107	3	study	study	NOUN
bam-10847	107	4	was	be	AUX
bam-10847	107	5	financially	financially	ADV
bam-10847	107	6	supported	support	VERB
bam-10847	107	7	by	by	ADP
bam-10847	107	8	grant	grant	NOUN
bam-10847	107	9	no	no	NOUN
bam-10847	107	10	.	.	PROPN
bam-10847	107	11	24958	24958	NUM
bam-10847	107	12	from	from	ADP
bam-10847	107	13	the	the	DET
bam-10847	107	14	vice	vice	NOUN
bam-10847	107	15	-	-	NOUN
bam-10847	107	16	chancellor	chancellor	NOUN
bam-10847	107	17	for	for	ADP
bam-10847	107	18	research	research	NOUN
bam-10847	107	19	affairs	affair	NOUN
bam-10847	107	20	of	of	ADP
bam-10847	107	21	shiraz	shiraz	PROPN
bam-10847	107	22	university	university	PROPN
bam-10847	107	23	of	of	ADP
bam-10847	107	24	medical	medical	ADJ
bam-10847	107	25	sciences	sciences	PROPN
bam-10847	107	26	,	,	PUNCT
bam-10847	107	27	shiraz	shiraz	PROPN
bam-10847	107	28	,	,	PUNCT
bam-10847	107	29	iran	iran	PROPN
bam-10847	107	30	.	.	PUNCT
bam-10847	108	1	conflict	conflict	NOUN
bam-10847	108	2	of	of	ADP
bam-10847	108	3	interest	interest	NOUN
bam-10847	108	4	the	the	DET
bam-10847	108	5	authors	author	NOUN
bam-10847	108	6	declare	declare	VERB
bam-10847	108	7	no	no	DET
bam-10847	108	8	financial	financial	ADJ
bam-10847	108	9	,	,	PUNCT
bam-10847	108	10	personal	personal	ADJ
bam-10847	108	11	,	,	PUNCT
bam-10847	108	12	or	or	CCONJ
bam-10847	108	13	other	other	ADJ
bam-10847	108	14	conflicts	conflict	NOUN
bam-10847	108	15	of	of	ADP
bam-10847	108	16	interest	interest	NOUN
bam-10847	108	17	.	.	PUNCT
bam-10847	109	1	ethical	ethical	ADJ
bam-10847	109	2	publication	publication	NOUN
bam-10847	109	3	statement	statement	NOUN
bam-10847	109	4	we	we	PRON
bam-10847	109	5	confirm	confirm	VERB
bam-10847	109	6	that	that	SCONJ
bam-10847	109	7	we	we	PRON
bam-10847	109	8	have	have	AUX
bam-10847	109	9	read	read	VERB
bam-10847	109	10	the	the	DET
bam-10847	109	11	journal	journal	NOUN
bam-10847	109	12	’s	’s	PART
bam-10847	109	13	position	position	NOUN
bam-10847	109	14	on	on	ADP
bam-10847	109	15	issues	issue	NOUN
bam-10847	109	16	involved	involve	VERB
bam-10847	109	17	in	in	ADP
bam-10847	109	18	ethical	ethical	ADJ
bam-10847	109	19	publication	publication	NOUN
bam-10847	109	20	and	and	CCONJ
bam-10847	109	21	affirm	affirm	NOUN
bam-10847	109	22	that	that	SCONJ
bam-10847	109	23	this	this	DET
bam-10847	109	24	report	report	NOUN
bam-10847	109	25	is	be	AUX
bam-10847	109	26	consistent	consistent	ADJ
bam-10847	109	27	with	with	ADP
bam-10847	109	28	those	those	DET
bam-10847	109	29	guidelines	guideline	NOUN
bam-10847	109	30	.	.	PUNCT
bam-10847	110	1	corresponding	correspond	VERB
bam-10847	110	2	author	author	NOUN
bam-10847	110	3	azita	azita	NOUN
bam-10847	110	4	sadeghzadeh	sadeghzadeh	NOUN
bam-10847	110	5	,	,	PUNCT
bam-10847	110	6	oral	oral	ADJ
bam-10847	110	7	and	and	CCONJ
bam-10847	110	8	dental	dental	ADJ
bam-10847	110	9	disease	disease	NOUN
bam-10847	110	10	research	research	NOUN
bam-10847	110	11	center	center	NOUN
bam-10847	110	12	,	,	PUNCT
bam-10847	110	13	department	department	NOUN
bam-10847	110	14	of	of	ADP
bam-10847	110	15	oral	oral	ADJ
bam-10847	110	16	and	and	CCONJ
bam-10847	110	17	maxillofacial	maxillofacial	ADJ
bam-10847	110	18	medicine	medicine	NOUN
bam-10847	110	19	,	,	PUNCT
bam-10847	110	20	school	school	NOUN
bam-10847	110	21	of	of	ADP
bam-10847	110	22	dentistry	dentistry	NOUN
bam-10847	110	23	,	,	PUNCT
bam-10847	110	24	shiraz	shiraz	PROPN
bam-10847	110	25	university	university	PROPN
bam-10847	110	26	of	of	ADP
bam-10847	110	27	medical	medical	ADJ
bam-10847	110	28	sciences	sciences	PROPN
bam-10847	110	29	,	,	PUNCT
bam-10847	110	30	shiraz	shiraz	PROPN
bam-10847	110	31	,	,	PUNCT
bam-10847	110	32	iran	iran	PROPN
bam-10847	110	33	.	.	PUNCT
bam-10847	111	1	orcid	orcid	NOUN
bam-10847	112	1	i	i	PRON
bam-10847	112	2	d	d	NOUN
bam-10847	112	3	:	:	PUNCT
bam-10847	112	4	0000	0000	NUM
bam-10847	112	5	-	-	PUNCT
bam-10847	112	6	0002	0002	NUM
bam-10847	112	7	-	-	PUNCT
bam-10847	112	8	2601	2601	NUM
bam-10847	112	9	-	-	SYM
bam-10847	112	10	4254	4254	NUM
bam-10847	112	11	e	e	NOUN
bam-10847	112	12	-	-	NOUN
bam-10847	112	13	mail	mail	NOUN
bam-10847	112	14	:	:	PUNCT
bam-10847	113	1	azitasadeghzadeh48@yandex.com	azitasadeghzadeh48@yandex.com	X
bam-10847	113	2	e	e	NOUN
bam-10847	113	3	-	-	NOUN
bam-10847	113	4	mails	mail	NOUN
bam-10847	113	5	and	and	CCONJ
bam-10847	113	6	orcid	orcid	NOUN
bam-10847	113	7	i	i	INTJ
bam-10847	113	8	d	d	PROPN
bam-10847	113	9	of	of	ADP
bam-10847	113	10	co	co	NOUN
bam-10847	113	11	-	-	NOUN
bam-10847	113	12	authors	author	NOUN
bam-10847	113	13	hossein	hossein	PROPN
bam-10847	113	14	daneste	daneste	PROPN
bam-10847	113	15	:	:	PUNCT
bam-10847	114	1	hd80_2003@yahoo.com	hd80_2003@yahoo.com	X
bam-10847	114	2	orcid	orcid	NOUN
bam-10847	115	1	i	i	INTJ
bam-10847	115	2	d	d	NOUN
bam-10847	115	3	:	:	PUNCT
bam-10847	115	4	0000	0000	NUM
bam-10847	115	5	-	-	PUNCT
bam-10847	115	6	0002	0002	NUM
bam-10847	115	7	-	-	PUNCT
bam-10847	115	8	5711	5711	NUM
bam-10847	115	9	-	-	PUNCT
bam-10847	115	10	0564	0564	NUM
bam-10847	115	11	maral	maral	ADJ
bam-10847	115	12	mokhtari	mokhtari	NOUN
bam-10847	115	13	:	:	PUNCT
bam-10847	115	14	maral_mokhtari@yahoo.com	maral_mokhtari@yahoo.com	X
bam-10847	115	15	orcid	orcid	PROPN
bam-10847	116	1	i	i	PRON
bam-10847	116	2	d	d	NOUN
bam-10847	116	3	:	:	PUNCT
bam-10847	116	4	0000	0000	NUM
bam-10847	116	5	-	-	PUNCT
bam-10847	116	6	0002	0002	NUM
bam-10847	116	7	-	-	PUNCT
bam-10847	116	8	4815	4815	NUM
bam-10847	116	9	-	-	PUNCT
bam-10847	116	10	2631	2631	NUM
bam-10847	116	11	hossein	hossein	PROPN
bam-10847	116	12	mohammadkhani	mohammadkhani	PROPN
bam-10847	116	13	:	:	PUNCT
bam-10847	117	1	hossein.m.khani@gmail.com	hossein.m.khani@gmail.com	PROPN
bam-10847	117	2	orcid	orcid	PROPN
bam-10847	117	3	i	i	PRON
bam-10847	117	4	d	d	NOUN
bam-10847	117	5	:	:	PUNCT
bam-10847	117	6	0000	0000	NUM
bam-10847	117	7	-	-	PUNCT
bam-10847	117	8	0002	0002	NUM
bam-10847	117	9	-	-	PUNCT
bam-10847	117	10	8012	8012	NUM
bam-10847	117	11	-	-	SYM
bam-10847	117	12	8658	8658	NUM
bam-10847	117	13	fatemeh	fatemeh	NOUN
bam-10847	117	14	lavaee	lavaee	ADJ
bam-10847	117	15	:	:	PUNCT
bam-10847	117	16	fatemeh.lavaee@gmail.com	fatemeh.lavaee@gmail.com	X
bam-10847	117	17	orcid	orcid	NOUN
bam-10847	118	1	i	i	NOUN
bam-10847	118	2	d	d	NOUN
bam-10847	118	3	:	:	PUNCT
bam-10847	118	4	0000	0000	NUM
bam-10847	118	5	-	-	PUNCT
bam-10847	118	6	0001	0001	NUM
bam-10847	118	7	-	-	PUNCT
bam-10847	118	8	8896	8896	NUM
bam-10847	118	9	-	-	PUNCT
bam-10847	118	10	1225	1225	NUM
bam-10847	118	11	javad	javad	PROPN
bam-10847	118	12	moayedi	moayedi	PROPN
bam-10847	118	13	:	:	PUNCT
bam-10847	119	1	javad.moayedi88@gmail.com	javad.moayedi88@gmail.com	PROPN
bam-10847	119	2	orcid	orcid	PROPN
bam-10847	120	1	i	i	PRON
bam-10847	120	2	d	d	NOUN
bam-10847	120	3	:	:	PUNCT
bam-10847	120	4	0000	0000	NUM
bam-10847	120	5	-	-	PUNCT
bam-10847	120	6	0001	0001	NUM
bam-10847	120	7	-	-	PUNCT
bam-10847	120	8	6154	6154	NUM
bam-10847	120	9	-	-	SYM
bam-10847	120	10	9468	9468	NUM
bam-10847	120	11	references	reference	NOUN
bam-10847	120	12	1	1	NUM
bam-10847	120	13	.	.	PUNCT
bam-10847	120	14	wang	wang	PROPN
bam-10847	120	15	sw	sw	PROPN
bam-10847	120	16	,	,	PUNCT
bam-10847	120	17	chan	chan	PROPN
bam-10847	120	18	lp	lp	PROPN
bam-10847	120	19	,	,	PUNCT
bam-10847	120	20	wang	wang	PROPN
bam-10847	120	21	lf	lf	PROPN
bam-10847	120	22	,	,	PUNCT
bam-10847	120	23	wu	wu	PROPN
bam-10847	120	24	cw	cw	PROPN
bam-10847	120	25	,	,	PUNCT
bam-10847	120	26	lin	lin	PROPN
bam-10847	120	27	sh	sh	PROPN
bam-10847	120	28	,	,	PUNCT
bam-10847	120	29	huang	huang	PROPN
bam-10847	120	30	ty	ty	PROPN
bam-10847	120	31	,	,	PUNCT
bam-10847	120	32	lee	lee	PROPN
bam-10847	120	33	kw	kw	PROPN
bam-10847	120	34	.	.	PUNCT
bam-10847	121	1	secondary	secondary	ADJ
bam-10847	121	2	primary	primary	ADJ
bam-10847	121	3	malignancy	malignancy	NOUN
bam-10847	121	4	in	in	ADP
bam-10847	121	5	patients	patient	NOUN
bam-10847	121	6	with	with	ADP
bam-10847	121	7	head	head	NOUN
bam-10847	121	8	and	and	CCONJ
bam-10847	121	9	neck	neck	VERB
bam-10847	121	10	squamous	squamous	ADJ
bam-10847	121	11	cell	cell	NOUN
bam-10847	121	12	carcinoma	carcinoma	NOUN
bam-10847	121	13	:	:	PUNCT
bam-10847	121	14	27	27	NUM
bam-10847	121	15	-	-	PUNCT
bam-10847	121	16	year	year	NOUN
bam-10847	121	17	experience	experience	NOUN
bam-10847	121	18	from	from	ADP
bam-10847	121	19	the	the	DET
bam-10847	121	20	perspective	perspective	NOUN
bam-10847	121	21	of	of	ADP
bam-10847	121	22	diagnostic	diagnostic	ADJ
bam-10847	121	23	tools	tool	NOUN
bam-10847	121	24	.	.	PUNCT
bam-10847	122	1	plos	plos	PROPN
bam-10847	122	2	one	one	NUM
bam-10847	122	3	.	.	PUNCT
bam-10847	123	1	2022	2022	NUM
bam-10847	123	2	feb	feb	PROPN
bam-10847	123	3	15;17(2):e0263773	15;17(2):e0263773	NUM
bam-10847	123	4	.	.	PUNCT
bam-10847	124	1	doi	doi	NOUN
bam-10847	124	2	:	:	PUNCT
bam-10847	124	3	10.1371/	10.1371/	NUM
bam-10847	124	4	journal.pone.0263773	journal.pone.0263773	PROPN
bam-10847	124	5	.	.	PROPN
bam-10847	125	1	2	2	NUM
bam-10847	125	2	.	.	X
bam-10847	125	3	chow	chow	PROPN
bam-10847	125	4	lqm	lqm	PROPN
bam-10847	125	5	.	.	PUNCT
bam-10847	126	1	head	head	NOUN
bam-10847	126	2	and	and	CCONJ
bam-10847	126	3	neck	neck	NOUN
bam-10847	126	4	cancer	cancer	NOUN
bam-10847	126	5	.	.	PUNCT
bam-10847	127	1	n	n	PROPN
bam-10847	127	2	engl	engl	PROPN
bam-10847	127	3	j	j	PROPN
bam-10847	127	4	med	med	PROPN
bam-10847	127	5	.	.	PUNCT
bam-10847	128	1	2020	2020	NUM
bam-10847	128	2	jan	jan	PROPN
bam-10847	128	3	2;382(1):60	2;382(1):60	NUM
bam-10847	128	4	-	-	SYM
bam-10847	128	5	72	72	NUM
bam-10847	128	6	.	.	PUNCT
bam-10847	129	1	doi	doi	NOUN
bam-10847	129	2	:	:	PUNCT
bam-10847	129	3	10.1056	10.1056	NUM
bam-10847	129	4	/	/	SYM
bam-10847	129	5	nejmra1715715	nejmra1715715	PROPN
bam-10847	129	6	.	.	PUNCT
bam-10847	130	1	3	3	X
bam-10847	130	2	.	.	X
bam-10847	130	3	sun	sun	PROPN
bam-10847	130	4	z	z	PROPN
bam-10847	130	5	,	,	PUNCT
bam-10847	130	6	sun	sun	PROPN
bam-10847	130	7	x	x	PROPN
bam-10847	130	8	,	,	PUNCT
bam-10847	130	9	chen	chen	PROPN
bam-10847	130	10	z	z	PROPN
bam-10847	130	11	,	,	PUNCT
bam-10847	130	12	du	du	PROPN
bam-10847	130	13	j	j	PROPN
bam-10847	130	14	,	,	PUNCT
bam-10847	130	15	wu	wu	PROPN
bam-10847	130	16	y.	y.	PROPN
bam-10847	130	17	head	head	PROPN
bam-10847	130	18	and	and	CCONJ
bam-10847	130	19	neck	neck	VERB
bam-10847	130	20	squamous	squamous	ADJ
bam-10847	130	21	cell	cell	NOUN
bam-10847	130	22	carcinoma	carcinoma	NOUN
bam-10847	130	23	:	:	PUNCT
bam-10847	130	24	risk	risk	NOUN
bam-10847	130	25	factors	factor	NOUN
bam-10847	130	26	,	,	PUNCT
bam-10847	130	27	molecular	molecular	ADJ
bam-10847	130	28	alterations	alteration	NOUN
bam-10847	130	29	,	,	PUNCT
bam-10847	130	30	immunology	immunology	NOUN
bam-10847	130	31	and	and	CCONJ
bam-10847	130	32	peptide	peptide	ADJ
bam-10847	130	33	vaccines	vaccine	NOUN
bam-10847	130	34	.	.	PUNCT
bam-10847	131	1	int	int	NOUN
bam-10847	131	2	j	j	PROPN
bam-10847	131	3	pept	pept	NOUN
bam-10847	131	4	res	re	NOUN
bam-10847	131	5	ther	ther	ADV
bam-10847	131	6	.	.	PUNCT
bam-10847	132	1	2022;28(1):19	2022;28(1):19	NUM
bam-10847	132	2	.	.	PUNCT
bam-10847	132	3	doi	doi	NOUN
bam-10847	132	4	:	:	PUNCT
bam-10847	132	5	10.1007	10.1007	NUM
bam-10847	132	6	/	/	SYM
bam-10847	132	7	s10989	s10989	PROPN
bam-10847	132	8	-	-	PUNCT
bam-10847	132	9	021	021	NUM
bam-10847	132	10	-	-	PUNCT
bam-10847	132	11	10334	10334	NUM
bam-10847	132	12	-	-	SYM
bam-10847	132	13	5	5	NUM
bam-10847	132	14	.	.	PUNCT
bam-10847	133	1	epub	epub	NOUN
bam-10847	133	2	2021	2021	NUM
bam-10847	133	3	dec	dec	PROPN
bam-10847	133	4	8	8	NUM
bam-10847	133	5	.	.	X
bam-10847	133	6	4	4	X
bam-10847	133	7	.	.	X
bam-10847	133	8	singh	singh	PROPN
bam-10847	133	9	mp	mp	PROPN
bam-10847	133	10	,	,	PUNCT
bam-10847	133	11	kumar	kumar	PROPN
bam-10847	133	12	v	v	PROPN
bam-10847	133	13	,	,	PUNCT
bam-10847	133	14	agarwal	agarwal	PROPN
bam-10847	133	15	a	a	PROPN
bam-10847	133	16	,	,	PUNCT
bam-10847	133	17	kumar	kumar	PROPN
bam-10847	133	18	r	r	PROPN
bam-10847	133	19	,	,	PUNCT
bam-10847	133	20	bhatt	bhatt	PROPN
bam-10847	133	21	ml	ml	PROPN
bam-10847	133	22	,	,	PUNCT
bam-10847	133	23	misra	misra	PROPN
bam-10847	133	24	s.	s.	PROPN
bam-10847	133	25	clinico	clinico	PROPN
bam-10847	133	26	-	-	PUNCT
bam-10847	133	27	epidemiological	epidemiological	ADJ
bam-10847	133	28	study	study	NOUN
bam-10847	133	29	of	of	ADP
bam-10847	133	30	oral	oral	ADJ
bam-10847	133	31	squamous	squamous	ADJ
bam-10847	133	32	cell	cell	NOUN
bam-10847	133	33	carcinoma	carcinoma	NOUN
bam-10847	133	34	:	:	PUNCT
bam-10847	133	35	a	a	DET
bam-10847	133	36	tertiary	tertiary	ADJ
bam-10847	133	37	care	care	NOUN
bam-10847	133	38	centre	centre	NOUN
bam-10847	133	39	study	study	NOUN
bam-10847	133	40	in	in	ADP
bam-10847	133	41	north	north	PROPN
bam-10847	133	42	india	india	PROPN
bam-10847	133	43	.	.	PUNCT
bam-10847	134	1	j	j	PROPN
bam-10847	134	2	oral	oral	ADJ
bam-10847	134	3	biol	biol	PROPN
bam-10847	134	4	craniofac	craniofac	NOUN
bam-10847	134	5	res	re	NOUN
bam-10847	134	6	.	.	PUNCT
bam-10847	135	1	2016	2016	NUM
bam-10847	135	2	jan	jan	PROPN
bam-10847	135	3	-	-	PUNCT
bam-10847	135	4	apr;6(1):31	apr;6(1):31	NOUN
bam-10847	135	5	-	-	PUNCT
bam-10847	135	6	4	4	NUM
bam-10847	135	7	.	.	PUNCT
bam-10847	135	8	doi	doi	NOUN
bam-10847	135	9	:	:	PUNCT
bam-10847	135	10	10.1016	10.1016	NUM
bam-10847	135	11	/	/	SYM
bam-10847	135	12	j.jobcr.2015.11.002	j.jobcr.2015.11.002	PROPN
bam-10847	135	13	.	.	PUNCT
bam-10847	136	1	epub	epub	PROPN
bam-10847	136	2	2015	2015	NUM
bam-10847	136	3	dec	dec	PROPN
bam-10847	136	4	4	4	NUM
bam-10847	136	5	.	.	NOUN
bam-10847	136	6	5	5	NUM
bam-10847	136	7	.	.	NUM
bam-10847	136	8	taghavi	taghavi	VERB
bam-10847	136	9	n	n	CCONJ
bam-10847	136	10	,	,	PUNCT
bam-10847	136	11	yazdi	yazdi	PROPN
bam-10847	136	12	i.	i.	PROPN
bam-10847	136	13	prognostic	prognostic	PROPN
bam-10847	136	14	factors	factor	NOUN
bam-10847	136	15	of	of	ADP
bam-10847	136	16	survival	survival	NOUN
bam-10847	136	17	rate	rate	NOUN
bam-10847	136	18	in	in	ADP
bam-10847	136	19	oral	oral	ADJ
bam-10847	136	20	squamous	squamous	ADJ
bam-10847	136	21	cell	cell	NOUN
bam-10847	136	22	carcinoma	carcinoma	NOUN
bam-10847	136	23	:	:	PUNCT
bam-10847	136	24	clinical	clinical	ADJ
bam-10847	136	25	,	,	PUNCT
bam-10847	136	26	histologic	histologic	ADJ
bam-10847	136	27	,	,	PUNCT
bam-10847	136	28	genetic	genetic	ADJ
bam-10847	136	29	and	and	CCONJ
bam-10847	136	30	molecular	molecular	ADJ
bam-10847	136	31	concepts	concept	NOUN
bam-10847	136	32	.	.	PUNCT
bam-10847	137	1	arch	arch	VERB
bam-10847	137	2	iran	iran	PROPN
bam-10847	137	3	med	me	VERB
bam-10847	137	4	.	.	PUNCT
bam-10847	138	1	2015	2015	NUM
bam-10847	138	2	may;18(5):314	may;18(5):314	NUM
bam-10847	138	3	-	-	PUNCT
bam-10847	138	4	9	9	NUM
bam-10847	138	5	.	.	NOUN
bam-10847	138	6	6	6	NUM
bam-10847	138	7	.	.	PUNCT
bam-10847	138	8	markopoulos	markopoulos	PROPN
bam-10847	138	9	ak	ak	PROPN
bam-10847	138	10	.	.	PROPN
bam-10847	138	11	current	current	ADJ
bam-10847	138	12	aspects	aspect	NOUN
bam-10847	138	13	on	on	ADP
bam-10847	138	14	oral	oral	ADJ
bam-10847	138	15	squamous	squamous	ADJ
bam-10847	138	16	cell	cell	NOUN
bam-10847	138	17	carcinoma	carcinoma	NOUN
bam-10847	138	18	.	.	PUNCT
bam-10847	139	1	open	open	ADJ
bam-10847	139	2	dent	dent	PROPN
bam-10847	139	3	j.	j.	PROPN
bam-10847	139	4	2012;6:126	2012;6:126	PROPN
bam-10847	139	5	-	-	PUNCT
bam-10847	139	6	30	30	NUM
bam-10847	139	7	.	.	PUNCT
bam-10847	140	1	doi	doi	NOUN
bam-10847	140	2	:	:	PUNCT
bam-10847	140	3	10.2174/18742106012060	10.2174/18742106012060	NUM
bam-10847	140	4	10126	10126	NUM
bam-10847	140	5	.	.	PUNCT
bam-10847	141	1	epub	epub	PROPN
bam-10847	141	2	2012	2012	NUM
bam-10847	141	3	aug	aug	PROPN
bam-10847	141	4	10	10	NUM
bam-10847	141	5	.	.	PUNCT
bam-10847	142	1	7	7	X
bam-10847	142	2	.	.	X
bam-10847	143	1	wang	wang	PROPN
bam-10847	143	2	b	b	PROPN
bam-10847	143	3	,	,	PUNCT
bam-10847	143	4	zhang	zhang	PROPN
bam-10847	143	5	s	s	PROPN
bam-10847	143	6	,	,	PUNCT
bam-10847	143	7	yue	yue	PROPN
bam-10847	143	8	k	k	PROPN
bam-10847	143	9	,	,	PUNCT
bam-10847	143	10	wang	wang	PROPN
bam-10847	143	11	xd	xd	PROPN
bam-10847	143	12	.	.	PUNCT
bam-10847	144	1	the	the	DET
bam-10847	144	2	recurrence	recurrence	NOUN
bam-10847	144	3	and	and	CCONJ
bam-10847	144	4	survival	survival	NOUN
bam-10847	144	5	of	of	ADP
bam-10847	144	6	oral	oral	ADJ
bam-10847	144	7	squamous	squamous	ADJ
bam-10847	144	8	cell	cell	NOUN
bam-10847	144	9	carcinoma	carcinoma	NOUN
bam-10847	144	10	:	:	PUNCT
bam-10847	144	11	a	a	DET
bam-10847	144	12	report	report	NOUN
bam-10847	144	13	of	of	ADP
bam-10847	144	14	275	275	NUM
bam-10847	144	15	cases	case	NOUN
bam-10847	144	16	.	.	PUNCT
bam-10847	145	1	chin	chin	PROPN
bam-10847	145	2	j	j	PROPN
bam-10847	145	3	cancer	cancer	NOUN
bam-10847	145	4	.	.	PUNCT
bam-10847	146	1	2013	2013	NUM
bam-10847	146	2	nov;32(11):614	nov;32(11):614	PROPN
bam-10847	146	3	-	-	X
bam-10847	146	4	8	8	NUM
bam-10847	146	5	.	.	PUNCT
bam-10847	147	1	doi	doi	NOUN
bam-10847	147	2	:	:	PUNCT
bam-10847	147	3	10.5732	10.5732	NUM
bam-10847	147	4	/	/	SYM
bam-10847	147	5	cjc.012	cjc.012	NOUN
bam-10847	147	6	.	.	PUNCT
bam-10847	148	1	10219	10219	NUM
bam-10847	148	2	.	.	PUNCT
bam-10847	149	1	epub	epub	NOUN
bam-10847	149	2	2013	2013	NUM
bam-10847	149	3	apr	apr	NOUN
bam-10847	149	4	19	19	NUM
bam-10847	149	5	.	.	NOUN
bam-10847	149	6	8	8	NUM
bam-10847	149	7	.	.	X
bam-10847	149	8	beck	beck	PROPN
bam-10847	149	9	tn	tn	PROPN
bam-10847	149	10	,	,	PUNCT
bam-10847	149	11	golemis	golemis	PROPN
bam-10847	149	12	ea	ea	PROPN
bam-10847	149	13	.	.	PUNCT
bam-10847	150	1	genomic	genomic	ADJ
bam-10847	150	2	insights	insight	NOUN
bam-10847	150	3	into	into	ADP
bam-10847	150	4	head	head	NOUN
bam-10847	150	5	and	and	CCONJ
bam-10847	150	6	neck	neck	NOUN
bam-10847	150	7	cancer	cancer	NOUN
bam-10847	150	8	.	.	PUNCT
bam-10847	151	1	cancers	cancer	NOUN
bam-10847	151	2	head	head	VERB
bam-10847	151	3	neck	neck	NOUN
bam-10847	151	4	.	.	PUNCT
bam-10847	152	1	non	non	ADJ
bam-10847	153	1	-co	-co	PROPN
bam-10847	153	2	mmerc	mmerc	PROPN
bam-10847	153	3	ial	ial	PROPN
bam-10847	153	4	us	us	PROPN
bam-10847	153	5	e	e	NOUN
bam-10847	153	6	o	o	NOUN
bam-10847	153	7	nly	nly	ADV
bam-10847	153	8	mailto:azitasadeghzadeh48@yandex.com	mailto:azitasadeghzadeh48@yandex.com	PROPN
bam-10847	153	9	mailto:azitasadeghzadeh48@yandex.com	mailto:azitasadeghzadeh48@yandex.com	PROPN
bam-10847	153	10	mailto:hd80_2003@yahoo.com	mailto:hd80_2003@yahoo.com	PROPN
bam-10847	153	11	mailto:maral_mokhtari@yahoo.com	mailto:maral_mokhtari@yahoo.com	X
bam-10847	154	1	mailto:hossein.m.khani@gmail.com	mailto:hossein.m.khani@gmail.com	PROPN
bam-10847	154	2	mailto:fatemeh.lavaee@gmail.com	mailto:fatemeh.lavaee@gmail.com	X
bam-10847	155	1	mailto:javad.moayedi88@gmail.com	mailto:javad.moayedi88@gmail.com	X
bam-10847	155	2	p53	p53	NOUN
bam-10847	155	3	mutant	mutant	NOUN
bam-10847	155	4	-	-	PUNCT
bam-10847	155	5	type	type	NOUN
bam-10847	155	6	in	in	ADP
bam-10847	155	7	oral	oral	ADJ
bam-10847	155	8	squamous	squamous	ADJ
bam-10847	155	9	cell	cell	NOUN
bam-10847	155	10	carcinoma	carcinoma	NOUN
bam-10847	156	1	eur	eur	PROPN
bam-10847	156	2	j	j	PROPN
bam-10847	156	3	transl	transl	PROPN
bam-10847	156	4	myol	myol	ADV
bam-10847	156	5	33	33	NUM
bam-10847	156	6	(	(	PUNCT
bam-10847	156	7	1	1	NUM
bam-10847	156	8	)	)	PUNCT
bam-10847	156	9	10847	10847	NUM
bam-10847	156	10	,	,	PUNCT
bam-10847	156	11	2023	2023	NUM
bam-10847	156	12	doi	doi	NOUN
bam-10847	156	13	:	:	PUNCT
bam-10847	156	14	10.4081	10.4081	NUM
bam-10847	156	15	/	/	SYM
bam-10847	156	16	ejtm.2023.10847	ejtm.2023.10847	PROPN
bam-10847	156	17	6	6	NUM
bam-10847	156	18	2016;1:1	2016;1:1	NUM
bam-10847	156	19	.	.	PUNCT
bam-10847	157	1	doi	doi	NOUN
bam-10847	157	2	:	:	PUNCT
bam-10847	157	3	10.1186	10.1186	NUM
bam-10847	157	4	/	/	SYM
bam-10847	157	5	s41199	s41199	NOUN
bam-10847	157	6	-	-	PUNCT
bam-10847	157	7	016	016	NUM
bam-10847	157	8	-	-	PUNCT
bam-10847	157	9	0003	0003	NUM
bam-10847	157	10	-	-	PUNCT
bam-10847	157	11	z.	z.	PROPN
bam-10847	157	12	epub	epub	PROPN
bam-10847	157	13	2016	2016	NUM
bam-10847	157	14	jun	jun	PROPN
bam-10847	157	15	3	3	NUM
bam-10847	157	16	.	.	NOUN
bam-10847	157	17	9	9	NUM
bam-10847	157	18	.	.	PUNCT
bam-10847	158	1	pai	pai	PROPN
bam-10847	158	2	si	si	PROPN
bam-10847	158	3	,	,	PUNCT
bam-10847	158	4	westra	westra	PROPN
bam-10847	158	5	wh	wh	PROPN
bam-10847	158	6	.	.	PROPN
bam-10847	158	7	molecular	molecular	ADJ
bam-10847	158	8	pathology	pathology	NOUN
bam-10847	158	9	of	of	ADP
bam-10847	158	10	head	head	NOUN
bam-10847	158	11	and	and	CCONJ
bam-10847	158	12	neck	neck	NOUN
bam-10847	158	13	cancer	cancer	NOUN
bam-10847	158	14	:	:	PUNCT
bam-10847	158	15	implications	implication	NOUN
bam-10847	158	16	for	for	ADP
bam-10847	158	17	diagnosis	diagnosis	NOUN
bam-10847	158	18	,	,	PUNCT
bam-10847	158	19	prognosis	prognosis	NOUN
bam-10847	158	20	,	,	PUNCT
bam-10847	158	21	and	and	CCONJ
bam-10847	158	22	treatment	treatment	NOUN
bam-10847	158	23	.	.	PUNCT
bam-10847	159	1	annu	annu	PROPN
bam-10847	159	2	rev	rev	PROPN
bam-10847	159	3	pathol	pathol	PROPN
bam-10847	159	4	.	.	PUNCT
bam-10847	160	1	2009;4:49	2009;4:49	NUM
bam-10847	160	2	-	-	PUNCT
bam-10847	160	3	70	70	NUM
bam-10847	160	4	.	.	PUNCT
bam-10847	161	1	doi	doi	NOUN
bam-10847	161	2	:	:	PUNCT
bam-10847	161	3	10.1146	10.1146	NUM
bam-10847	161	4	/	/	SYM
bam-10847	161	5	annurev.pathol.4.110807.092158	annurev.pathol.4.110807.092158	PROPN
bam-10847	161	6	.	.	PROPN
bam-10847	161	7	10	10	NUM
bam-10847	161	8	.	.	PUNCT
bam-10847	162	1	perdomo	perdomo	PROPN
bam-10847	162	2	s	s	PROPN
bam-10847	162	3	,	,	PUNCT
bam-10847	162	4	anantharaman	anantharaman	NOUN
bam-10847	162	5	d	d	PROPN
bam-10847	162	6	,	,	PUNCT
bam-10847	162	7	foll	foll	PROPN
bam-10847	162	8	m	m	PROPN
bam-10847	162	9	,	,	PUNCT
bam-10847	162	10	abediardekani	abediardekani	PROPN
bam-10847	162	11	b	b	PROPN
bam-10847	162	12	,	,	PUNCT
bam-10847	162	13	durand	durand	NOUN
bam-10847	162	14	g	g	PROPN
bam-10847	162	15	,	,	PUNCT
bam-10847	162	16	reis	reis	NOUN
bam-10847	162	17	rosa	rosa	PROPN
bam-10847	162	18	la	la	PROPN
bam-10847	162	19	,	,	PUNCT
bam-10847	162	20	holmila	holmila	ADJ
bam-10847	162	21	r	r	NOUN
bam-10847	162	22	,	,	PUNCT
bam-10847	162	23	le	le	X
bam-10847	162	24	calvez	calvez	NOUN
bam-10847	162	25	-	-	PUNCT
bam-10847	162	26	kelm	kelm	PROPN
bam-10847	162	27	f	f	PROPN
bam-10847	162	28	,	,	PUNCT
bam-10847	162	29	tajara	tajara	PROPN
bam-10847	162	30	eh	eh	INTJ
bam-10847	162	31	,	,	PUNCT
bam-10847	162	32	wünsch	wünsch	NOUN
bam-10847	162	33	-	-	PUNCT
bam-10847	162	34	filho	filho	PROPN
bam-10847	162	35	v	v	NOUN
bam-10847	162	36	,	,	PUNCT
bam-10847	162	37	levi	levi	PROPN
bam-10847	162	38	je	je	PROPN
bam-10847	162	39	,	,	PUNCT
bam-10847	162	40	vilensky	vilensky	PROPN
bam-10847	162	41	m	m	PROPN
bam-10847	162	42	,	,	PUNCT
bam-10847	162	43	polesel	polesel	PROPN
bam-10847	162	44	j	j	PROPN
bam-10847	162	45	,	,	PUNCT
bam-10847	162	46	holcatova	holcatova	PROPN
bam-10847	163	1	i	i	PRON
bam-10847	163	2	,	,	PUNCT
bam-10847	163	3	simonato	simonato	PROPN
bam-10847	163	4	l	l	NOUN
bam-10847	163	5	,	,	PUNCT
bam-10847	163	6	canova	canova	PROPN
bam-10847	163	7	c	c	X
bam-10847	163	8	,	,	PUNCT
bam-10847	163	9	lagiou	lagiou	NOUN
bam-10847	163	10	p	p	X
bam-10847	163	11	,	,	PUNCT
bam-10847	163	12	mckay	mckay	PROPN
bam-10847	163	13	jd	jd	PROPN
bam-10847	163	14	,	,	PUNCT
bam-10847	163	15	brennan	brennan	PROPN
bam-10847	163	16	p.	p.	PROPN
bam-10847	164	1	genomic	genomic	NOUN
bam-10847	164	2	analysis	analysis	NOUN
bam-10847	164	3	of	of	ADP
bam-10847	164	4	head	head	NOUN
bam-10847	164	5	and	and	CCONJ
bam-10847	164	6	neck	neck	NOUN
bam-10847	164	7	cancer	cancer	NOUN
bam-10847	164	8	cases	case	NOUN
bam-10847	164	9	from	from	ADP
bam-10847	164	10	two	two	NUM
bam-10847	164	11	high	high	ADJ
bam-10847	164	12	incidence	incidence	NOUN
bam-10847	164	13	regions	region	NOUN
bam-10847	164	14	.	.	PUNCT
bam-10847	165	1	plos	plos	PROPN
bam-10847	165	2	one	one	NUM
bam-10847	165	3	.	.	PUNCT
bam-10847	166	1	2018	2018	NUM
bam-10847	166	2	jan	jan	PROPN
bam-10847	166	3	29;13(1):e0191701	29;13(1):e0191701	NUM
bam-10847	166	4	.	.	PUNCT
bam-10847	167	1	doi	doi	NOUN
bam-10847	167	2	:	:	PUNCT
bam-10847	167	3	10.1371	10.1371	NUM
bam-10847	167	4	/	/	SYM
bam-10847	167	5	journal.pone.0191701	journal.pone.0191701	PROPN
bam-10847	167	6	.	.	PROPN
bam-10847	167	7	11	11	NUM
bam-10847	167	8	.	.	PUNCT
bam-10847	168	1	zhou	zhou	PROPN
bam-10847	168	2	g	g	PROPN
bam-10847	168	3	,	,	PUNCT
bam-10847	168	4	liu	liu	PROPN
bam-10847	168	5	z	z	PROPN
bam-10847	168	6	,	,	PUNCT
bam-10847	168	7	myers	myers	PROPN
bam-10847	168	8	jn	jn	PROPN
bam-10847	168	9	.	.	PUNCT
bam-10847	169	1	tp53	tp53	PROPN
bam-10847	169	2	mutations	mutation	NOUN
bam-10847	169	3	in	in	ADP
bam-10847	169	4	head	head	NOUN
bam-10847	169	5	and	and	CCONJ
bam-10847	169	6	neck	neck	VERB
bam-10847	169	7	squamous	squamous	ADJ
bam-10847	169	8	cell	cell	NOUN
bam-10847	169	9	carcinoma	carcinoma	NOUN
bam-10847	169	10	and	and	CCONJ
bam-10847	169	11	their	their	PRON
bam-10847	169	12	impact	impact	NOUN
bam-10847	169	13	on	on	ADP
bam-10847	169	14	disease	disease	NOUN
bam-10847	169	15	progression	progression	NOUN
bam-10847	169	16	and	and	CCONJ
bam-10847	169	17	treatment	treatment	NOUN
bam-10847	169	18	response	response	NOUN
bam-10847	169	19	.	.	PUNCT
bam-10847	170	1	j	j	PROPN
bam-10847	170	2	cell	cell	PROPN
bam-10847	170	3	biochem	biochem	PROPN
bam-10847	170	4	.	.	PUNCT
bam-10847	171	1	2016	2016	NUM
bam-10847	171	2	dec;117(12):2682	dec;117(12):2682	NOUN
bam-10847	171	3	-	-	PUNCT
bam-10847	171	4	2692	2692	NUM
bam-10847	171	5	.	.	PUNCT
bam-10847	172	1	doi	doi	NOUN
bam-10847	172	2	:	:	PUNCT
bam-10847	172	3	10.1002	10.1002	NUM
bam-10847	172	4	/	/	SYM
bam-10847	172	5	jcb.25592	jcb.25592	PROPN
bam-10847	172	6	.	.	PUNCT
bam-10847	173	1	epub	epub	PROPN
bam-10847	173	2	2016	2016	NUM
bam-10847	173	3	jun	jun	PROPN
bam-10847	173	4	3	3	NUM
bam-10847	173	5	.	.	NOUN
bam-10847	173	6	12	12	NUM
bam-10847	173	7	.	.	PUNCT
bam-10847	174	1	feroz	feroz	PROPN
bam-10847	174	2	w	w	PROPN
bam-10847	174	3	,	,	PUNCT
bam-10847	174	4	sheikh	sheikh	PROPN
bam-10847	174	5	ama	ama	PROPN
bam-10847	174	6	.	.	PUNCT
bam-10847	175	1	exploring	explore	VERB
bam-10847	175	2	the	the	DET
bam-10847	175	3	multiple	multiple	ADJ
bam-10847	175	4	roles	role	NOUN
bam-10847	175	5	of	of	ADP
bam-10847	175	6	guardian	guardian	NOUN
bam-10847	175	7	of	of	ADP
bam-10847	175	8	the	the	DET
bam-10847	175	9	genome	genome	NOUN
bam-10847	175	10	:	:	PUNCT
bam-10847	175	11	p53	p53	NOUN
bam-10847	175	12	.	.	PUNCT
bam-10847	176	1	egyptian	egyptian	PROPN
bam-10847	176	2	j	j	PROPN
bam-10847	176	3	med	med	PROPN
bam-10847	176	4	human	human	PROPN
bam-10847	176	5	gen	gen	PROPN
bam-10847	176	6	.	.	PROPN
bam-10847	176	7	2020;21(1):49	2020;21(1):49	NUM
bam-10847	176	8	.	.	PUNCT
bam-10847	177	1	https://doi.org/10.1186/s43042-020-00089-x	https://doi.org/10.1186/s43042-020-00089-x	NOUN
bam-10847	177	2	13	13	NUM
bam-10847	177	3	.	.	PUNCT
bam-10847	178	1	mijit	mijit	PROPN
bam-10847	178	2	m	m	PROPN
bam-10847	178	3	,	,	PUNCT
bam-10847	178	4	caracciolo	caracciolo	PROPN
bam-10847	178	5	v	v	PROPN
bam-10847	178	6	,	,	PUNCT
bam-10847	178	7	melillo	melillo	PROPN
bam-10847	178	8	a	a	X
bam-10847	178	9	,	,	PUNCT
bam-10847	178	10	amicarelli	amicarelli	PROPN
bam-10847	178	11	f	f	PROPN
bam-10847	178	12	,	,	PUNCT
bam-10847	178	13	giordano	giordano	PROPN
bam-10847	178	14	a.	a.	NOUN
bam-10847	178	15	role	role	NOUN
bam-10847	178	16	of	of	ADP
bam-10847	178	17	p53	p53	NOUN
bam-10847	178	18	in	in	ADP
bam-10847	178	19	the	the	DET
bam-10847	178	20	regulation	regulation	NOUN
bam-10847	178	21	of	of	ADP
bam-10847	178	22	cellular	cellular	ADJ
bam-10847	178	23	senescence	senescence	NOUN
bam-10847	178	24	.	.	PUNCT
bam-10847	179	1	biomolecules	biomolecule	NOUN
bam-10847	179	2	.	.	PUNCT
bam-10847	180	1	2020	2020	NUM
bam-10847	180	2	mar	mar	PROPN
bam-10847	180	3	8;10(3):420	8;10(3):420	NUM
bam-10847	180	4	.	.	PUNCT
bam-10847	181	1	doi	doi	NOUN
bam-10847	181	2	:	:	PUNCT
bam-10847	181	3	10.3390	10.3390	NUM
bam-10847	181	4	/	/	SYM
bam-10847	181	5	biom10030420	biom10030420	PROPN
bam-10847	181	6	.	.	PUNCT
bam-10847	182	1	14	14	NUM
bam-10847	182	2	.	.	PUNCT
bam-10847	183	1	chen	chen	PROPN
bam-10847	183	2	j.	j.	PROPN
bam-10847	183	3	the	the	DET
bam-10847	183	4	cell	cell	NOUN
bam-10847	183	5	-	-	PUNCT
bam-10847	183	6	cycle	cycle	NOUN
bam-10847	183	7	arrest	arrest	NOUN
bam-10847	183	8	and	and	CCONJ
bam-10847	183	9	apoptotic	apoptotic	ADJ
bam-10847	183	10	functions	function	NOUN
bam-10847	183	11	of	of	ADP
bam-10847	183	12	p53	p53	NOUN
bam-10847	183	13	in	in	ADP
bam-10847	183	14	tumor	tumor	NOUN
bam-10847	183	15	initiation	initiation	NOUN
bam-10847	183	16	and	and	CCONJ
bam-10847	183	17	progression	progression	NOUN
bam-10847	183	18	.	.	PUNCT
bam-10847	184	1	cold	cold	ADJ
bam-10847	184	2	spring	spring	NOUN
bam-10847	184	3	harb	harb	PROPN
bam-10847	184	4	perspect	perspect	PROPN
bam-10847	184	5	med	med	PROPN
bam-10847	184	6	.	.	PUNCT
bam-10847	185	1	2016	2016	NUM
bam-10847	185	2	mar	mar	PROPN
bam-10847	185	3	1;6(3):a026104	1;6(3):a026104	PROPN
bam-10847	185	4	.	.	PUNCT
bam-10847	186	1	doi	doi	PROPN
bam-10847	186	2	:	:	PUNCT
bam-10847	186	3	10.1101	10.1101	NUM
bam-10847	186	4	/	/	SYM
bam-10847	186	5	csh	csh	PROPN
bam-10847	186	6	perspect.a026104	perspect.a026104	PROPN
bam-10847	186	7	.	.	PUNCT
bam-10847	187	1	15	15	X
bam-10847	187	2	.	.	PUNCT
bam-10847	188	1	castellanos	castellanos	PROPN
bam-10847	188	2	mr	mr	PROPN
bam-10847	188	3	,	,	PUNCT
bam-10847	188	4	pan	pan	PROPN
bam-10847	188	5	q.	q.	PROPN
bam-10847	188	6	novel	novel	PROPN
bam-10847	188	7	p53	p53	NOUN
bam-10847	188	8	therapies	therapy	NOUN
bam-10847	188	9	for	for	ADP
bam-10847	188	10	head	head	NOUN
bam-10847	188	11	and	and	CCONJ
bam-10847	188	12	neck	neck	NOUN
bam-10847	188	13	cancer	cancer	NOUN
bam-10847	188	14	.	.	PUNCT
bam-10847	189	1	world	world	PROPN
bam-10847	189	2	j	j	PROPN
bam-10847	189	3	otorhinolaryngol	otorhinolaryngol	PROPN
bam-10847	189	4	head	head	VERB
bam-10847	189	5	neck	neck	NOUN
bam-10847	189	6	surg	surg	NOUN
bam-10847	189	7	.	.	PUNCT
bam-10847	190	1	2016	2016	NUM
bam-10847	190	2	jul	jul	PROPN
bam-10847	190	3	19;2(2):68	19;2(2):68	NUM
bam-10847	190	4	-	-	SYM
bam-10847	190	5	75	75	NUM
bam-10847	190	6	.	.	PUNCT
bam-10847	191	1	doi	doi	NOUN
bam-10847	191	2	:	:	PUNCT
bam-10847	191	3	10.1016	10.1016	NUM
bam-10847	191	4	/	/	SYM
bam-10847	191	5	j.wjorl.2016.05.005	j.wjorl.2016.05.005	PROPN
bam-10847	191	6	.	.	PUNCT
bam-10847	192	1	16	16	NUM
bam-10847	192	2	.	.	PUNCT
bam-10847	192	3	de	de	PROPN
bam-10847	192	4	bakker	bakker	PROPN
bam-10847	192	5	t	t	PROPN
bam-10847	192	6	,	,	PUNCT
bam-10847	192	7	journe	journe	NOUN
bam-10847	192	8	f	f	AUX
bam-10847	192	9	,	,	PUNCT
bam-10847	192	10	descamps	descamp	VERB
bam-10847	192	11	g	g	NOUN
bam-10847	192	12	,	,	PUNCT
bam-10847	192	13	saussez	saussez	VERB
bam-10847	192	14	s	s	PART
bam-10847	192	15	,	,	PUNCT
bam-10847	192	16	dragan	dragan	PROPN
bam-10847	192	17	t	t	PROPN
bam-10847	192	18	,	,	PUNCT
bam-10847	192	19	ghanem	ghanem	PROPN
bam-10847	192	20	g	g	PROPN
bam-10847	192	21	,	,	PUNCT
bam-10847	192	22	krayem	krayem	PROPN
bam-10847	192	23	m	m	PROPN
bam-10847	192	24	,	,	PUNCT
bam-10847	192	25	van	van	PROPN
bam-10847	192	26	gestel	gestel	PROPN
bam-10847	192	27	d.	d.	PROPN
bam-10847	192	28	restoring	restore	VERB
bam-10847	192	29	p53	p53	NOUN
bam-10847	192	30	function	function	NOUN
bam-10847	192	31	in	in	ADP
bam-10847	192	32	head	head	NOUN
bam-10847	192	33	and	and	CCONJ
bam-10847	192	34	neck	neck	VERB
bam-10847	192	35	squamous	squamous	ADJ
bam-10847	192	36	cell	cell	NOUN
bam-10847	192	37	carcinoma	carcinoma	NOUN
bam-10847	192	38	to	to	PART
bam-10847	192	39	improve	improve	VERB
bam-10847	192	40	treatments	treatment	NOUN
bam-10847	192	41	.	.	PUNCT
bam-10847	193	1	front	front	ADJ
bam-10847	193	2	oncol	oncol	ADJ
bam-10847	193	3	.	.	PUNCT
bam-10847	194	1	2022	2022	NUM
bam-10847	194	2	jan	jan	PROPN
bam-10847	194	3	6;11:799993	6;11:799993	NUM
bam-10847	194	4	.	.	PUNCT
bam-10847	195	1	doi	doi	NOUN
bam-10847	195	2	:	:	PUNCT
bam-10847	195	3	10.3389	10.3389	NUM
bam-10847	195	4	/	/	SYM
bam-10847	195	5	fonc.2021.799993	fonc.2021.799993	NOUN
bam-10847	195	6	.	.	PUNCT
bam-10847	196	1	pmid	pmid	NOUN
bam-10847	196	2	:	:	PUNCT
bam-10847	196	3	35071005	35071005	NUM
bam-10847	196	4	;	;	PUNCT
bam-10847	196	5	pmcid	pmcid	PROPN
bam-10847	196	6	:	:	PUNCT
bam-10847	196	7	pmc8770810	pmc8770810	PROPN
bam-10847	196	8	.	.	PUNCT
bam-10847	197	1	17	17	NUM
bam-10847	197	2	.	.	PUNCT
bam-10847	198	1	chin	chin	PROPN
bam-10847	198	2	d	d	PROPN
bam-10847	198	3	,	,	PUNCT
bam-10847	198	4	boyle	boyle	PROPN
bam-10847	198	5	gm	gm	PROPN
bam-10847	198	6	,	,	PUNCT
bam-10847	198	7	theile	theile	ADJ
bam-10847	198	8	dr	dr	PROPN
bam-10847	198	9	,	,	PUNCT
bam-10847	198	10	parsons	parsons	PROPN
bam-10847	198	11	pg	pg	PROPN
bam-10847	198	12	,	,	PUNCT
bam-10847	198	13	coman	coman	PROPN
bam-10847	198	14	wb	wb	PROPN
bam-10847	198	15	.	.	PROPN
bam-10847	198	16	molecular	molecular	ADJ
bam-10847	198	17	introduction	introduction	NOUN
bam-10847	198	18	to	to	PART
bam-10847	198	19	head	head	VERB
bam-10847	198	20	and	and	CCONJ
bam-10847	198	21	neck	neck	NOUN
bam-10847	198	22	cancer	cancer	NOUN
bam-10847	198	23	(	(	PUNCT
bam-10847	198	24	hnscc	hnscc	NOUN
bam-10847	198	25	)	)	PUNCT
bam-10847	198	26	carcinogenesis	carcinogenesis	NOUN
bam-10847	198	27	.	.	PUNCT
bam-10847	199	1	br	br	PROPN
bam-10847	199	2	j	j	PROPN
bam-10847	199	3	plast	plast	PROPN
bam-10847	199	4	surg	surg	PROPN
bam-10847	199	5	.	.	PUNCT
bam-10847	200	1	2004	2004	NUM
bam-10847	200	2	oct;57(7):595	oct;57(7):595	NOUN
bam-10847	200	3	-	-	PUNCT
bam-10847	200	4	602	602	NUM
bam-10847	200	5	.	.	PUNCT
bam-10847	201	1	doi	doi	NOUN
bam-10847	201	2	:	:	PUNCT
bam-10847	201	3	10.1016	10.1016	NUM
bam-10847	201	4	/	/	SYM
bam-10847	201	5	j.bjps.2004.06.010	j.bjps.2004.06.010	PROPN
bam-10847	201	6	.	.	PUNCT
bam-10847	202	1	pmid	pmid	NOUN
bam-10847	202	2	:	:	PUNCT
bam-10847	202	3	15380692	15380692	NUM
bam-10847	202	4	.	.	PUNCT
bam-10847	203	1	18	18	NUM
bam-10847	203	2	.	.	PUNCT
bam-10847	203	3	fakhrjou	fakhrjou	VERB
bam-10847	203	4	a	a	DET
bam-10847	203	5	,	,	PUNCT
bam-10847	203	6	seyed	seyed	PROPN
bam-10847	203	7	outounchi	outounchi	PROPN
bam-10847	203	8	sj	sj	PROPN
bam-10847	203	9	.	.	PUNCT
bam-10847	203	10	morphologic	morphologic	ADJ
bam-10847	203	11	evaluation	evaluation	NOUN
bam-10847	203	12	of	of	ADP
bam-10847	203	13	p53	p53	NOUN
bam-10847	203	14	apoptotic	apoptotic	ADJ
bam-10847	203	15	signaling	signal	VERB
bam-10847	203	16	responses	response	NOUN
bam-10847	203	17	and	and	CCONJ
bam-10847	203	18	proliferative	proliferative	ADJ
bam-10847	203	19	activity	activity	NOUN
bam-10847	203	20	of	of	ADP
bam-10847	203	21	ki-67	ki-67	ADJ
bam-10847	203	22	in	in	ADP
bam-10847	203	23	oral	oral	ADJ
bam-10847	203	24	lichen	lichen	NOUN
bam-10847	203	25	planus	planus	NOUN
bam-10847	203	26	,	,	PUNCT
bam-10847	203	27	oral	oral	ADJ
bam-10847	203	28	squamous	squamous	ADJ
bam-10847	203	29	cell	cell	NOUN
bam-10847	203	30	carcinoma	carcinoma	NOUN
bam-10847	203	31	and	and	CCONJ
bam-10847	203	32	normal	normal	ADJ
bam-10847	203	33	specimens	specimen	NOUN
bam-10847	203	34	.	.	PUNCT
bam-10847	204	1	j	j	PROPN
bam-10847	204	2	med	med	PROPN
bam-10847	204	3	sci	sci	PROPN
bam-10847	204	4	.	.	PUNCT
bam-10847	205	1	2012;12(2):51	2012;12(2):51	NUM
bam-10847	205	2	-	-	SYM
bam-10847	205	3	6	6	NUM
bam-10847	205	4	.	.	PUNCT
bam-10847	205	5	doi	doi	NOUN
bam-10847	205	6	:	:	PUNCT
bam-10847	205	7	10.3923	10.3923	NUM
bam-10847	205	8	/	/	SYM
bam-10847	205	9	jms.2012.51.56	jms.2012.51.56	PROPN
bam-10847	205	10	19	19	NUM
bam-10847	205	11	.	.	PUNCT
bam-10847	205	12	farhadi	farhadi	PROPN
bam-10847	205	13	s	s	PROPN
bam-10847	205	14	,	,	PUNCT
bam-10847	205	15	shahsavari	shahsavari	NOUN
bam-10847	205	16	f	f	PROPN
bam-10847	205	17	,	,	PUNCT
bam-10847	205	18	alf	alf	PROPN
bam-10847	205	19	k.	k.	PROPN
bam-10847	205	20	comparison	comparison	NOUN
bam-10847	205	21	of	of	ADP
bam-10847	205	22	expression	expression	NOUN
bam-10847	205	23	of	of	ADP
bam-10847	205	24	p53	p53	NOUN
bam-10847	205	25	and	and	CCONJ
bam-10847	205	26	bcl-2	bcl-2	NOUN
bam-10847	205	27	markers	marker	NOUN
bam-10847	205	28	in	in	ADP
bam-10847	205	29	oral	oral	ADJ
bam-10847	205	30	lichen	lichen	NOUN
bam-10847	205	31	planus	planus	NOUN
bam-10847	205	32	and	and	CCONJ
bam-10847	205	33	oral	oral	ADJ
bam-10847	205	34	squamous	squamous	ADJ
bam-10847	205	35	cell	cell	NOUN
bam-10847	205	36	carcinoma	carcinoma	NOUN
bam-10847	205	37	.	.	PUNCT
bam-10847	206	1	j	j	PROPN
bam-10847	206	2	res	re	NOUN
bam-10847	206	3	dent	dent	NOUN
bam-10847	206	4	maxillofac	maxillofac	NOUN
bam-10847	206	5	sci	sci	PROPN
bam-10847	206	6	2018	2018	NUM
bam-10847	206	7	;	;	PUNCT
bam-10847	206	8	3	3	NUM
bam-10847	206	9	(	(	PUNCT
bam-10847	206	10	2	2	NUM
bam-10847	206	11	)	)	PUNCT
bam-10847	207	1	:	:	PUNCT
bam-10847	207	2	37	37	NUM
bam-10847	207	3	-	-	SYM
bam-10847	207	4	45	45	NUM
bam-10847	207	5	.	.	PUNCT
bam-10847	207	6	url	url	PROPN
bam-10847	207	7	:	:	PUNCT
bam-10847	207	8	http://jrdms.dentaliau.ac.ir/article-1206-en.html	http://jrdms.dentaliau.ac.ir/article-1206-en.html	PROPN
bam-10847	207	9	20	20	NUM
bam-10847	207	10	.	.	PUNCT
bam-10847	208	1	etemad	etemad	PROPN
bam-10847	208	2	-	-	PUNCT
bam-10847	208	3	moghadam	moghadam	NOUN
bam-10847	208	4	s	s	PROPN
bam-10847	208	5	,	,	PUNCT
bam-10847	208	6	keyhani	keyhani	X
bam-10847	208	7	a	a	PRON
bam-10847	208	8	,	,	PUNCT
bam-10847	208	9	yazdani	yazdani	PROPN
bam-10847	208	10	k	k	PROPN
bam-10847	208	11	,	,	PUNCT
bam-10847	208	12	alaeddini	alaeddini	PROPN
bam-10847	208	13	m.	m.	NOUN
bam-10847	208	14	status	status	NOUN
bam-10847	208	15	of	of	ADP
bam-10847	208	16	p53	p53	NOUN
bam-10847	208	17	and	and	CCONJ
bam-10847	208	18	p27(kip1	p27(kip1	PROPN
bam-10847	208	19	)	)	PUNCT
bam-10847	208	20	in	in	ADP
bam-10847	208	21	iranian	iranian	ADJ
bam-10847	208	22	patients	patient	NOUN
bam-10847	208	23	with	with	ADP
bam-10847	208	24	oral	oral	ADJ
bam-10847	208	25	squamous	squamous	ADJ
bam-10847	208	26	cell	cell	NOUN
bam-10847	208	27	carcinoma	carcinoma	NOUN
bam-10847	208	28	.	.	PUNCT
bam-10847	209	1	iran	iran	PROPN
bam-10847	209	2	red	red	PROPN
bam-10847	209	3	crescent	crescent	PROPN
bam-10847	209	4	med	med	PROPN
bam-10847	209	5	j.	j.	PROPN
bam-10847	209	6	2015	2015	NUM
bam-10847	209	7	oct	oct	PROPN
bam-10847	209	8	19;17(10):e19359	19;17(10):e19359	NUM
bam-10847	209	9	.	.	PUNCT
bam-10847	210	1	doi	doi	NOUN
bam-10847	210	2	:	:	PUNCT
bam-10847	210	3	10.5812	10.5812	NUM
bam-10847	210	4	/	/	SYM
bam-10847	210	5	ircmj.19359	ircmj.19359	PROPN
bam-10847	210	6	.	.	PROPN
bam-10847	210	7	21	21	NUM
bam-10847	210	8	.	.	X
bam-10847	211	1	agha	agha	PROPN
bam-10847	211	2	-	-	PUNCT
bam-10847	211	3	hosseini	hosseini	PROPN
bam-10847	211	4	f	f	PROPN
bam-10847	211	5	,	,	PUNCT
bam-10847	211	6	mirzaii	mirzaii	PROPN
bam-10847	211	7	-	-	PUNCT
bam-10847	211	8	dizgah	dizgah	NOUN
bam-10847	211	9	i	i	PROPN
bam-10847	211	10	,	,	PUNCT
bam-10847	211	11	miri	miri	PROPN
bam-10847	211	12	-	-	PUNCT
bam-10847	211	13	zarandi	zarandi	PROPN
bam-10847	211	14	n.	n.	PROPN
bam-10847	211	15	unstimulated	unstimulated	ADJ
bam-10847	211	16	salivary	salivary	ADJ
bam-10847	211	17	p53	p53	NOUN
bam-10847	211	18	in	in	ADP
bam-10847	211	19	patients	patient	NOUN
bam-10847	211	20	with	with	ADP
bam-10847	211	21	oral	oral	ADJ
bam-10847	211	22	lichen	lichen	NOUN
bam-10847	211	23	planus	planus	NOUN
bam-10847	211	24	and	and	CCONJ
bam-10847	211	25	squamous	squamous	ADJ
bam-10847	211	26	cell	cell	NOUN
bam-10847	211	27	carcinoma	carcinoma	NOUN
bam-10847	211	28	.	.	PUNCT
bam-10847	212	1	acta	acta	PROPN
bam-10847	212	2	med	med	PROPN
bam-10847	212	3	iran	iran	PROPN
bam-10847	212	4	.	.	PUNCT
bam-10847	213	1	2015	2015	NUM
bam-10847	213	2	jul;53(7):439	jul;53(7):439	PROPN
bam-10847	213	3	-	-	PUNCT
bam-10847	213	4	43	43	NUM
bam-10847	213	5	.	.	PUNCT
bam-10847	214	1	22	22	NUM
bam-10847	214	2	.	.	PUNCT
bam-10847	215	1	sina	sina	PROPN
bam-10847	215	2	m	m	PROPN
bam-10847	215	3	,	,	PUNCT
bam-10847	215	4	pedram	pedram	PROPN
bam-10847	215	5	m	m	PROPN
bam-10847	215	6	,	,	PUNCT
bam-10847	215	7	ghojazadeh	ghojazadeh	PROPN
bam-10847	215	8	m	m	PROPN
bam-10847	215	9	,	,	PUNCT
bam-10847	215	10	kochaki	kochaki	PROPN
bam-10847	215	11	a	a	PRON
bam-10847	215	12	,	,	PUNCT
bam-10847	215	13	aghbali	aghbali	ADJ
bam-10847	215	14	a.	a.	NOUN
bam-10847	215	15	p53	p53	NOUN
bam-10847	215	16	gene	gene	NOUN
bam-10847	215	17	codon	codon	NOUN
bam-10847	215	18	72	72	NUM
bam-10847	215	19	polymorphism	polymorphism	NOUN
bam-10847	215	20	in	in	ADP
bam-10847	215	21	patients	patient	NOUN
bam-10847	215	22	with	with	ADP
bam-10847	215	23	oral	oral	ADJ
bam-10847	215	24	squamous	squamous	ADJ
bam-10847	215	25	cell	cell	NOUN
bam-10847	215	26	carcinoma	carcinoma	NOUN
bam-10847	215	27	in	in	ADP
bam-10847	215	28	the	the	DET
bam-10847	215	29	population	population	NOUN
bam-10847	215	30	of	of	ADP
bam-10847	215	31	northern	northern	ADJ
bam-10847	215	32	iran	iran	PROPN
bam-10847	215	33	.	.	PUNCT
bam-10847	216	1	med	med	ADJ
bam-10847	216	2	oral	oral	ADJ
bam-10847	216	3	patol	patol	NOUN
bam-10847	216	4	oral	oral	ADJ
bam-10847	216	5	cir	cir	NOUN
bam-10847	216	6	bucal	bucal	NOUN
bam-10847	216	7	.	.	PUNCT
bam-10847	217	1	2014	2014	NUM
bam-10847	217	2	nov	nov	NOUN
bam-10847	217	3	1;19(6):e550	1;19(6):e550	NUM
bam-10847	217	4	-	-	SYM
bam-10847	217	5	5	5	NUM
bam-10847	217	6	.	.	PUNCT
bam-10847	217	7	doi	doi	NOUN
bam-10847	217	8	:	:	PUNCT
bam-10847	217	9	10.4317	10.4317	NUM
bam-10847	217	10	/	/	SYM
bam-10847	217	11	medoral.19794	medoral.19794	PROPN
bam-10847	217	12	.	.	PROPN
bam-10847	217	13	23	23	NUM
bam-10847	217	14	.	.	PUNCT
bam-10847	218	1	pinholt	pinholt	NOUN
bam-10847	218	2	em	em	PRON
bam-10847	218	3	,	,	PUNCT
bam-10847	218	4	rindum	rindum	PROPN
bam-10847	218	5	j	j	PROPN
bam-10847	218	6	,	,	PUNCT
bam-10847	218	7	pindborg	pindborg	PROPN
bam-10847	218	8	jj	jj	PROPN
bam-10847	218	9	.	.	PROPN
bam-10847	218	10	oral	oral	ADJ
bam-10847	218	11	cancer	cancer	NOUN
bam-10847	218	12	:	:	PUNCT
bam-10847	218	13	a	a	DET
bam-10847	218	14	retrospective	retrospective	ADJ
bam-10847	218	15	study	study	NOUN
bam-10847	218	16	of	of	ADP
bam-10847	218	17	100	100	NUM
bam-10847	218	18	danish	danish	ADJ
bam-10847	218	19	cases	case	NOUN
bam-10847	218	20	.	.	PUNCT
bam-10847	219	1	br	br	PROPN
bam-10847	219	2	j	j	PROPN
bam-10847	219	3	oral	oral	ADJ
bam-10847	219	4	maxillofac	maxillofac	NOUN
bam-10847	219	5	surg	surg	NOUN
bam-10847	219	6	.	.	PUNCT
bam-10847	220	1	1997	1997	NUM
bam-10847	220	2	apr;35(2):77	apr;35(2):77	PROPN
bam-10847	220	3	-	-	PUNCT
bam-10847	220	4	80	80	NUM
bam-10847	220	5	.	.	PUNCT
bam-10847	221	1	doi	doi	NOUN
bam-10847	221	2	:	:	PUNCT
bam-10847	221	3	10.1016	10.1016	NUM
bam-10847	221	4	/	/	SYM
bam-10847	221	5	s0266	s0266	PROPN
bam-10847	221	6	-	-	PUNCT
bam-10847	221	7	4356(97)90679	4356(97)90679	NOUN
bam-10847	221	8	-	-	SYM
bam-10847	221	9	3	3	NUM
bam-10847	221	10	.	.	NOUN
bam-10847	221	11	24	24	NUM
bam-10847	221	12	.	.	PUNCT
bam-10847	222	1	anneroth	anneroth	PROPN
bam-10847	222	2	g	g	PROPN
bam-10847	222	3	,	,	PUNCT
bam-10847	222	4	batsakis	batsakis	PROPN
bam-10847	222	5	j	j	PROPN
bam-10847	222	6	,	,	PUNCT
bam-10847	222	7	luna	luna	PROPN
bam-10847	222	8	m.	m.	PROPN
bam-10847	222	9	review	review	PROPN
bam-10847	222	10	of	of	ADP
bam-10847	222	11	the	the	DET
bam-10847	222	12	literature	literature	NOUN
bam-10847	222	13	and	and	CCONJ
bam-10847	222	14	a	a	DET
bam-10847	222	15	recommended	recommend	VERB
bam-10847	222	16	system	system	NOUN
bam-10847	222	17	of	of	ADP
bam-10847	222	18	malignancy	malignancy	NOUN
bam-10847	222	19	grading	grade	VERB
bam-10847	222	20	in	in	ADP
bam-10847	222	21	oral	oral	ADJ
bam-10847	222	22	squamous	squamous	ADJ
bam-10847	222	23	cell	cell	NOUN
bam-10847	222	24	carcinomas	carcinoma	NOUN
bam-10847	222	25	.	.	PUNCT
bam-10847	223	1	scand	scand	PROPN
bam-10847	223	2	j	j	PROPN
bam-10847	223	3	dent	dent	PROPN
bam-10847	223	4	res	re	NOUN
bam-10847	223	5	.	.	PUNCT
bam-10847	223	6	1987	1987	NUM
bam-10847	223	7	jun;95(3):229	jun;95(3):229	PROPN
bam-10847	223	8	-	-	SYM
bam-10847	223	9	49	49	NUM
bam-10847	223	10	.	.	PUNCT
bam-10847	224	1	doi	doi	NOUN
bam-10847	224	2	:	:	PUNCT
bam-10847	224	3	10.1111	10.1111	NUM
bam-10847	224	4	/	/	SYM
bam-10847	224	5	j.16000722.1987.tb01836.x	j.16000722.1987.tb01836.x	PROPN
bam-10847	224	6	.	.	PROPN
bam-10847	225	1	25	25	NUM
bam-10847	225	2	.	.	PUNCT
bam-10847	226	1	casalini	casalini	PROPN
bam-10847	226	2	p	p	PROPN
bam-10847	226	3	,	,	PUNCT
bam-10847	226	4	iorio	iorio	PROPN
bam-10847	226	5	mv	mv	PROPN
bam-10847	226	6	,	,	PUNCT
bam-10847	226	7	berno	berno	NOUN
bam-10847	226	8	v	v	NOUN
bam-10847	226	9	,	,	PUNCT
bam-10847	226	10	bergamaschi	bergamaschi	NOUN
bam-10847	226	11	a	a	PRON
bam-10847	226	12	,	,	PUNCT
bam-10847	226	13	børresen	børresen	PROPN
bam-10847	226	14	dale	dale	PROPN
bam-10847	226	15	al	al	PROPN
bam-10847	226	16	,	,	PUNCT
bam-10847	226	17	gasparini	gasparini	NOUN
bam-10847	226	18	p	p	NOUN
bam-10847	226	19	,	,	PUNCT
bam-10847	226	20	orlandi	orlandi	VERB
bam-10847	226	21	r	r	NOUN
bam-10847	226	22	,	,	PUNCT
bam-10847	226	23	casati	casati	NOUN
bam-10847	226	24	b	b	PROPN
bam-10847	226	25	,	,	PUNCT
bam-10847	226	26	tagliabue	tagliabue	NOUN
bam-10847	226	27	e	e	NOUN
bam-10847	226	28	,	,	PUNCT
bam-10847	226	29	ménard	ménard	PROPN
bam-10847	226	30	s.	s.	PROPN
bam-10847	226	31	relationship	relationship	NOUN
bam-10847	226	32	between	between	ADP
bam-10847	226	33	p53	p53	NOUN
bam-10847	226	34	and	and	CCONJ
bam-10847	226	35	p27	p27	NOUN
bam-10847	226	36	expression	expression	NOUN
bam-10847	226	37	following	follow	VERB
bam-10847	226	38	her2	her2	PROPN
bam-10847	226	39	signaling	signal	VERB
bam-10847	226	40	.	.	PUNCT
bam-10847	227	1	breast	breast	NOUN
bam-10847	227	2	.	.	PUNCT
bam-10847	228	1	2007	2007	NUM
bam-10847	228	2	dec;16(6):597	dec;16(6):597	NOUN
bam-10847	228	3	-	-	PUNCT
bam-10847	228	4	605	605	NUM
bam-10847	228	5	.	.	PUNCT
bam-10847	229	1	doi	doi	NOUN
bam-10847	229	2	:	:	PUNCT
bam-10847	229	3	10.1016/	10.1016/	NUM
bam-10847	229	4	j.breast.2007.05.007	j.breast.2007.05.007	PROPN
bam-10847	229	5	.	.	PUNCT
bam-10847	230	1	epub	epub	PROPN
bam-10847	230	2	2007	2007	NUM
bam-10847	230	3	jun	jun	PROPN
bam-10847	230	4	28	28	NUM
bam-10847	230	5	.	.	PUNCT
bam-10847	231	1	26	26	NUM
bam-10847	231	2	.	.	PUNCT
bam-10847	232	1	sarr	sarr	PROPN
bam-10847	232	2	p	p	PROPN
bam-10847	232	3	,	,	PUNCT
bam-10847	232	4	a	a	DET
bam-10847	232	5	d	d	NOUN
bam-10847	232	6	,	,	PUNCT
bam-10847	232	7	faye	faye	PROPN
bam-10847	232	8	o	o	PROPN
bam-10847	232	9	,	,	PUNCT
bam-10847	232	10	m	m	PROPN
bam-10847	232	11	s	s	PROPN
bam-10847	232	12	,	,	PUNCT
bam-10847	232	13	b	b	PROPN
bam-10847	232	14	m	m	PROPN
bam-10847	232	15	,	,	PUNCT
bam-10847	232	16	kane	kane	PROPN
bam-10847	232	17	y	y	PROPN
bam-10847	232	18	,	,	PUNCT
bam-10847	232	19	et	et	PROPN
bam-10847	232	20	al	al	PROPN
bam-10847	232	21	.	.	PROPN
bam-10847	232	22	association	association	PROPN
bam-10847	232	23	of	of	ADP
bam-10847	232	24	the	the	DET
bam-10847	232	25	tp53	tp53	PROPN
bam-10847	232	26	arg72pro	arg72pro	ADJ
bam-10847	232	27	polymorphism	polymorphism	NOUN
bam-10847	232	28	with	with	ADP
bam-10847	232	29	oral	oral	ADJ
bam-10847	232	30	squamous	squamous	ADJ
bam-10847	232	31	cell	cell	NOUN
bam-10847	232	32	carcinoma	carcinoma	NOUN
bam-10847	232	33	:	:	PUNCT
bam-10847	232	34	a	a	DET
bam-10847	232	35	metaanalysis	metaanalysis	NOUN
bam-10847	232	36	.	.	PUNCT
bam-10847	233	1	j	j	PROPN
bam-10847	233	2	mol	mol	PROPN
bam-10847	233	3	genet	genet	PROPN
bam-10847	233	4	med	med	PROPN
bam-10847	233	5	.	.	PUNCT
bam-10847	234	1	2020;14(3):455	2020;14(3):455	NUM
bam-10847	234	2	.	.	PUNCT
bam-10847	235	1	doi	doi	NOUN
bam-10847	235	2	:	:	PUNCT
bam-10847	235	3	10.37421	10.37421	NUM
bam-10847	235	4	/	/	SYM
bam-10847	235	5	jmgm.2020.14.455	jmgm.2020.14.455	PRON
bam-10847	235	6	27	27	NUM
bam-10847	235	7	.	.	PUNCT
bam-10847	236	1	liu	liu	PROPN
bam-10847	236	2	r	r	PROPN
bam-10847	236	3	,	,	PUNCT
bam-10847	236	4	sun	sun	PROPN
bam-10847	236	5	k	k	PROPN
bam-10847	236	6	,	,	PUNCT
bam-10847	236	7	wang	wang	PROPN
bam-10847	236	8	y	y	PROPN
bam-10847	236	9	,	,	PUNCT
bam-10847	236	10	jiang	jiang	PROPN
bam-10847	236	11	y	y	PROPN
bam-10847	236	12	,	,	PUNCT
bam-10847	236	13	kang	kang	PROPN
bam-10847	236	14	j	j	PROPN
bam-10847	236	15	,	,	PUNCT
bam-10847	236	16	ma	ma	PROPN
bam-10847	236	17	h.	h.	PROPN
bam-10847	236	18	the	the	DET
bam-10847	236	19	effects	effect	NOUN
bam-10847	236	20	of	of	ADP
bam-10847	236	21	proliferating	proliferate	VERB
bam-10847	236	22	cell	cell	NOUN
bam-10847	236	23	nuclear	nuclear	ADJ
bam-10847	236	24	antigen	antigen	NOUN
bam-10847	236	25	and	and	CCONJ
bam-10847	236	26	p53	p53	VERB
bam-10847	236	27	in	in	ADP
bam-10847	236	28	patients	patient	NOUN
bam-10847	236	29	with	with	ADP
bam-10847	236	30	oral	oral	ADJ
bam-10847	236	31	squamous	squamous	ADJ
bam-10847	236	32	cell	cell	NOUN
bam-10847	236	33	carcinoma	carcinoma	NOUN
bam-10847	236	34	:	:	PUNCT
bam-10847	236	35	a	a	DET
bam-10847	236	36	systematic	systematic	ADJ
bam-10847	236	37	review	review	NOUN
bam-10847	236	38	and	and	CCONJ
bam-10847	236	39	meta	meta	ADJ
bam-10847	236	40	-	-	PUNCT
bam-10847	236	41	analysis	analysis	NOUN
bam-10847	236	42	.	.	PUNCT
bam-10847	237	1	ann	ann	PROPN
bam-10847	237	2	transl	transl	PROPN
bam-10847	237	3	med	med	PROPN
bam-10847	237	4	.	.	PUNCT
bam-10847	238	1	2021	2021	NUM
bam-10847	238	2	dec;9(23):1739	dec;9(23):1739	X
bam-10847	238	3	.	.	PUNCT
bam-10847	238	4	doi	doi	NOUN
bam-10847	238	5	:	:	PUNCT
bam-10847	238	6	10.21037	10.21037	NUM
bam-10847	238	7	/	/	SYM
bam-10847	238	8	atm-21	atm-21	PROPN
bam-10847	238	9	-	-	PUNCT
bam-10847	238	10	6133	6133	NUM
bam-10847	238	11	.	.	PUNCT
bam-10847	239	1	28	28	NUM
bam-10847	239	2	.	.	PUNCT
bam-10847	240	1	ozaki	ozaki	PROPN
bam-10847	240	2	t	t	PROPN
bam-10847	240	3	,	,	PUNCT
bam-10847	240	4	nakagawara	nakagawara	NOUN
bam-10847	240	5	a.	a.	NOUN
bam-10847	240	6	role	role	NOUN
bam-10847	240	7	of	of	ADP
bam-10847	240	8	p53	p53	NOUN
bam-10847	240	9	in	in	ADP
bam-10847	240	10	cell	cell	NOUN
bam-10847	240	11	death	death	NOUN
bam-10847	240	12	and	and	CCONJ
bam-10847	240	13	human	human	ADJ
bam-10847	240	14	cancers	cancer	NOUN
bam-10847	240	15	.	.	PUNCT
bam-10847	241	1	cancers	cancer	NOUN
bam-10847	241	2	(	(	PUNCT
bam-10847	241	3	basel	basel	PROPN
bam-10847	241	4	)	)	PUNCT
bam-10847	241	5	.	.	PUNCT
bam-10847	242	1	2011	2011	NUM
bam-10847	242	2	mar	mar	PROPN
bam-10847	242	3	3;3(1):994	3;3(1):994	PROPN
bam-10847	242	4	-	-	PUNCT
bam-10847	242	5	1013	1013	NUM
bam-10847	242	6	.	.	PUNCT
bam-10847	243	1	doi	doi	NOUN
bam-10847	243	2	:	:	PUNCT
bam-10847	243	3	10.3390	10.3390	NUM
bam-10847	243	4	/	/	SYM
bam-10847	243	5	cancers3010994	cancers3010994	PROPN
bam-10847	243	6	.	.	PUNCT
bam-10847	244	1	29	29	NUM
bam-10847	244	2	.	.	PUNCT
bam-10847	245	1	marei	marei	VERB
bam-10847	245	2	he	he	PRON
bam-10847	245	3	,	,	PUNCT
bam-10847	245	4	althani	althani	PROPN
bam-10847	245	5	a	a	PRON
bam-10847	245	6	,	,	PUNCT
bam-10847	245	7	afifi	afifi	PROPN
bam-10847	245	8	n	n	CCONJ
bam-10847	245	9	,	,	PUNCT
bam-10847	245	10	hasan	hasan	PROPN
bam-10847	245	11	a	a	X
bam-10847	245	12	,	,	PUNCT
bam-10847	245	13	caceci	caceci	PROPN
bam-10847	245	14	t	t	PROPN
bam-10847	245	15	,	,	PUNCT
bam-10847	245	16	pozzoli	pozzoli	NOUN
bam-10847	245	17	g	g	NOUN
bam-10847	245	18	,	,	PUNCT
bam-10847	245	19	morrione	morrione	NOUN
bam-10847	245	20	a	a	NOUN
bam-10847	245	21	,	,	PUNCT
bam-10847	245	22	giordano	giordano	PROPN
bam-10847	245	23	a	a	DET
bam-10847	245	24	,	,	PUNCT
bam-10847	245	25	cenciarelli	cenciarelli	PROPN
bam-10847	245	26	c.	c.	PROPN
bam-10847	245	27	p53	p53	PROPN
bam-10847	245	28	signaling	signal	VERB
bam-10847	245	29	in	in	ADP
bam-10847	245	30	cancer	cancer	NOUN
bam-10847	245	31	progression	progression	NOUN
bam-10847	245	32	and	and	CCONJ
bam-10847	245	33	therapy	therapy	NOUN
bam-10847	245	34	.	.	PUNCT
bam-10847	246	1	cancer	cancer	NOUN
bam-10847	246	2	cell	cell	NOUN
bam-10847	246	3	int	int	NOUN
bam-10847	246	4	.	.	PUNCT
bam-10847	247	1	2021	2021	NUM
bam-10847	247	2	dec	dec	PROPN
bam-10847	247	3	24;21(1):703	24;21(1):703	NUM
bam-10847	247	4	.	.	PUNCT
bam-10847	248	1	doi	doi	NOUN
bam-10847	248	2	:	:	PUNCT
bam-10847	248	3	10.1186	10.1186	NUM
bam-10847	248	4	/	/	SYM
bam-10847	248	5	s12935	s12935	PROPN
bam-10847	248	6	-	-	PUNCT
bam-10847	248	7	021	021	NUM
bam-10847	248	8	-	-	PUNCT
bam-10847	248	9	02396	02396	NUM
bam-10847	248	10	-	-	SYM
bam-10847	248	11	8	8	NUM
bam-10847	248	12	.	.	NUM
bam-10847	248	13	30	30	NUM
bam-10847	248	14	.	.	PUNCT
bam-10847	249	1	kato	kato	PROPN
bam-10847	249	2	k	k	PROPN
bam-10847	249	3	,	,	PUNCT
bam-10847	249	4	kawashiri	kawashiri	PROPN
bam-10847	249	5	s	s	PROPN
bam-10847	249	6	,	,	PUNCT
bam-10847	249	7	yoshizawa	yoshizawa	PROPN
bam-10847	249	8	k	k	PROPN
bam-10847	249	9	,	,	PUNCT
bam-10847	249	10	kitahara	kitahara	PROPN
bam-10847	249	11	h	h	PROPN
bam-10847	249	12	,	,	PUNCT
bam-10847	249	13	okamune	okamune	VERB
bam-10847	249	14	a	a	DET
bam-10847	249	15	,	,	PUNCT
bam-10847	249	16	sugiura	sugiura	NOUN
bam-10847	249	17	s	s	PROPN
bam-10847	249	18	,	,	PUNCT
bam-10847	249	19	noguchi	noguchi	PROPN
bam-10847	249	20	n	n	CCONJ
bam-10847	249	21	,	,	PUNCT
bam-10847	249	22	yamamoto	yamamoto	PROPN
bam-10847	249	23	e.	e.	PROPN
bam-10847	249	24	non	non	PROPN
bam-10847	250	1	-co	-co	PROPN
bam-10847	250	2	mmerc	mmerc	PROPN
bam-10847	250	3	ial	ial	PROPN
bam-10847	250	4	us	us	PROPN
bam-10847	250	5	e	e	NOUN
bam-10847	250	6	o	o	NOUN
bam-10847	250	7	nly	nly	ADV
bam-10847	250	8	p53	p53	VERB
bam-10847	250	9	mutant	mutant	NOUN
bam-10847	250	10	-	-	PUNCT
bam-10847	250	11	type	type	NOUN
bam-10847	250	12	in	in	ADP
bam-10847	250	13	oral	oral	ADJ
bam-10847	250	14	squamous	squamous	ADJ
bam-10847	250	15	cell	cell	NOUN
bam-10847	250	16	carcinoma	carcinoma	NOUN
bam-10847	250	17	eur	eur	PROPN
bam-10847	250	18	j	j	PROPN
bam-10847	250	19	transl	transl	PROPN
bam-10847	250	20	myol	myol	ADV
bam-10847	250	21	33	33	NUM
bam-10847	250	22	(	(	PUNCT
bam-10847	250	23	1	1	NUM
bam-10847	250	24	)	)	PUNCT
bam-10847	250	25	10847	10847	NUM
bam-10847	250	26	,	,	PUNCT
bam-10847	250	27	2023	2023	NUM
bam-10847	250	28	doi	doi	NOUN
bam-10847	250	29	:	:	PUNCT
bam-10847	250	30	10.4081	10.4081	NUM
bam-10847	250	31	/	/	SYM
bam-10847	250	32	ejtm.2023.10847	ejtm.2023.10847	PROPN
bam-10847	250	33	7	7	NUM
bam-10847	250	34	expression	expression	NOUN
bam-10847	250	35	form	form	NOUN
bam-10847	250	36	of	of	ADP
bam-10847	250	37	p53	p53	NOUN
bam-10847	250	38	and	and	CCONJ
bam-10847	250	39	pcna	pcna	NOUN
bam-10847	250	40	at	at	ADP
bam-10847	250	41	the	the	DET
bam-10847	250	42	invasive	invasive	ADJ
bam-10847	250	43	front	front	NOUN
bam-10847	250	44	in	in	ADP
bam-10847	250	45	oral	oral	ADJ
bam-10847	250	46	squamous	squamous	ADJ
bam-10847	250	47	cell	cell	NOUN
bam-10847	250	48	carcinoma	carcinoma	NOUN
bam-10847	250	49	:	:	PUNCT
bam-10847	250	50	correlation	correlation	NOUN
bam-10847	250	51	with	with	ADP
bam-10847	250	52	clinicopathological	clinicopathological	ADJ
bam-10847	250	53	features	feature	NOUN
bam-10847	250	54	and	and	CCONJ
bam-10847	250	55	prognosis	prognosis	NOUN
bam-10847	250	56	.	.	PUNCT
bam-10847	251	1	j	j	PROPN
bam-10847	251	2	oral	oral	ADJ
bam-10847	251	3	pathol	pathol	NOUN
bam-10847	251	4	med	me	VERB
bam-10847	251	5	.	.	PUNCT
bam-10847	251	6	2011	2011	NUM
bam-10847	251	7	oct;40(9):693	oct;40(9):693	NOUN
bam-10847	251	8	-	-	SYM
bam-10847	251	9	8	8	NUM
bam-10847	251	10	.	.	PUNCT
bam-10847	252	1	doi	doi	NOUN
bam-10847	252	2	:	:	PUNCT
bam-10847	252	3	10.1111	10.1111	NUM
bam-10847	252	4	/	/	SYM
bam-10847	252	5	j.1600	j.1600	PROPN
bam-10847	252	6	-	-	PUNCT
bam-10847	252	7	0714.2011.01032.x	0714.2011.01032.x	PROPN
bam-10847	252	8	.	.	PUNCT
bam-10847	253	1	epub	epub	PROPN
bam-10847	253	2	2011	2011	NUM
bam-10847	253	3	apr	apr	PROPN
bam-10847	253	4	18	18	NUM
bam-10847	253	5	.	.	PUNCT
bam-10847	253	6	31	31	NUM
bam-10847	253	7	.	.	PUNCT
bam-10847	254	1	carlos	carlos	PROPN
bam-10847	254	2	de	de	PROPN
bam-10847	254	3	vicente	vicente	PROPN
bam-10847	254	4	j	j	PROPN
bam-10847	254	5	,	,	PUNCT
bam-10847	254	6	junquera	junquera	PROPN
bam-10847	254	7	gutiérrez	gutiérrez	PROPN
bam-10847	254	8	lm	lm	PROPN
bam-10847	254	9	,	,	PUNCT
bam-10847	254	10	zapatero	zapatero	PROPN
bam-10847	254	11	ah	ah	INTJ
bam-10847	254	12	,	,	PUNCT
bam-10847	254	13	fresno	fresno	PROPN
bam-10847	254	14	forcelledo	forcelledo	PROPN
bam-10847	254	15	mf	mf	PROPN
bam-10847	254	16	,	,	PUNCT
bam-10847	254	17	hernándezvallejo	hernándezvallejo	NOUN
bam-10847	254	18	g	g	NOUN
bam-10847	254	19	,	,	PUNCT
bam-10847	254	20	lópez	lópez	PROPN
bam-10847	254	21	arranz	arranz	PROPN
bam-10847	254	22	js	js	PROPN
bam-10847	254	23	.	.	PUNCT
bam-10847	255	1	prognostic	prognostic	ADJ
bam-10847	255	2	significance	significance	NOUN
bam-10847	255	3	of	of	ADP
bam-10847	255	4	p53	p53	NOUN
bam-10847	255	5	expression	expression	NOUN
bam-10847	255	6	in	in	ADP
bam-10847	255	7	oral	oral	ADJ
bam-10847	255	8	squamous	squamous	ADJ
bam-10847	255	9	cell	cell	NOUN
bam-10847	255	10	carcinoma	carcinoma	NOUN
bam-10847	255	11	without	without	ADP
bam-10847	255	12	neck	neck	NOUN
bam-10847	255	13	node	node	NOUN
bam-10847	255	14	metastases	metastasis	NOUN
bam-10847	255	15	.	.	PUNCT
bam-10847	256	1	head	head	NOUN
bam-10847	256	2	neck	neck	NOUN
bam-10847	256	3	.	.	PUNCT
bam-10847	257	1	2004	2004	NUM
bam-10847	257	2	jan;26(1):22	jan;26(1):22	PROPN
bam-10847	257	3	-	-	SYM
bam-10847	257	4	30	30	NUM
bam-10847	257	5	.	.	PUNCT
bam-10847	258	1	doi	doi	NOUN
bam-10847	258	2	:	:	PUNCT
bam-10847	258	3	10.1002	10.1002	NUM
bam-10847	258	4	/	/	SYM
bam-10847	258	5	hed.10339	hed.10339	PROPN
bam-10847	258	6	.	.	PROPN
bam-10847	258	7	32	32	NUM
bam-10847	258	8	.	.	PUNCT
bam-10847	259	1	monteiro	monteiro	PROPN
bam-10847	259	2	ls	ls	PROPN
bam-10847	259	3	,	,	PUNCT
bam-10847	259	4	diniz	diniz	PROPN
bam-10847	259	5	-	-	PUNCT
bam-10847	259	6	freitas	freitas	PROPN
bam-10847	259	7	m	m	PROPN
bam-10847	259	8	,	,	PUNCT
bam-10847	259	9	garcia	garcia	PROPN
bam-10847	259	10	-	-	PUNCT
bam-10847	259	11	caballero	caballero	PROPN
bam-10847	259	12	t	t	PROPN
bam-10847	259	13	,	,	PUNCT
bam-10847	259	14	warnakulasuriya	warnakulasuriya	NOUN
bam-10847	259	15	s	s	PROPN
bam-10847	259	16	,	,	PUNCT
bam-10847	259	17	forteza	forteza	PRON
bam-10847	259	18	j	j	PROPN
bam-10847	259	19	,	,	PUNCT
bam-10847	259	20	fraga	fraga	NOUN
bam-10847	259	21	m.	m.	NOUN
bam-10847	259	22	combined	combine	VERB
bam-10847	259	23	cytoplasmic	cytoplasmic	ADJ
bam-10847	259	24	and	and	CCONJ
bam-10847	259	25	membranous	membranous	ADJ
bam-10847	259	26	egfr	egfr	NOUN
bam-10847	259	27	and	and	CCONJ
bam-10847	259	28	p53	p53	NOUN
bam-10847	259	29	overexpression	overexpression	NOUN
bam-10847	259	30	is	be	AUX
bam-10847	259	31	a	a	DET
bam-10847	259	32	poor	poor	ADJ
bam-10847	259	33	prognostic	prognostic	ADJ
bam-10847	259	34	marker	marker	NOUN
bam-10847	259	35	in	in	ADP
bam-10847	259	36	early	early	ADJ
bam-10847	259	37	stage	stage	NOUN
bam-10847	259	38	oral	oral	ADJ
bam-10847	259	39	squamous	squamous	ADJ
bam-10847	259	40	cell	cell	NOUN
bam-10847	259	41	carcinoma	carcinoma	NOUN
bam-10847	259	42	.	.	PUNCT
bam-10847	260	1	j	j	PROPN
bam-10847	260	2	oral	oral	ADJ
bam-10847	260	3	pathol	pathol	NOUN
bam-10847	260	4	med	me	VERB
bam-10847	260	5	.	.	PUNCT
bam-10847	260	6	2012	2012	NUM
bam-10847	260	7	aug;41(7):559	aug;41(7):559	NOUN
bam-10847	260	8	-	-	PUNCT
bam-10847	260	9	67	67	PROPN
bam-10847	260	10	.	.	PUNCT
bam-10847	261	1	doi	doi	NOUN
bam-10847	261	2	:	:	PUNCT
bam-10847	261	3	10.1111	10.1111	NUM
bam-10847	261	4	/	/	SYM
bam-10847	261	5	j.1600	j.1600	NOUN
bam-10847	261	6	-	-	PUNCT
bam-10847	261	7	0714.2012.01142.x	0714.2012.01142.x	NOUN
bam-10847	261	8	.	.	PUNCT
bam-10847	262	1	epub	epub	PROPN
bam-10847	262	2	2012	2012	NUM
bam-10847	262	3	mar	mar	PROPN
bam-10847	262	4	14	14	NUM
bam-10847	262	5	.	.	PUNCT
bam-10847	263	1	33	33	NUM
bam-10847	263	2	.	.	PUNCT
bam-10847	264	1	abrahao	abrahao	PROPN
bam-10847	264	2	ac	ac	PROPN
bam-10847	264	3	,	,	PUNCT
bam-10847	264	4	bonelli	bonelli	PROPN
bam-10847	264	5	bv	bv	PROPN
bam-10847	264	6	,	,	PUNCT
bam-10847	264	7	nunes	nunes	PROPN
bam-10847	264	8	fd	fd	PROPN
bam-10847	264	9	,	,	PUNCT
bam-10847	264	10	dias	dias	PROPN
bam-10847	264	11	ep	ep	PROPN
bam-10847	264	12	,	,	PUNCT
bam-10847	264	13	cabral	cabral	PROPN
bam-10847	264	14	mg	mg	PROPN
bam-10847	264	15	.	.	PUNCT
bam-10847	265	1	immunohistochemical	immunohistochemical	ADJ
bam-10847	265	2	expression	expression	NOUN
bam-10847	265	3	of	of	ADP
bam-10847	265	4	p53	p53	NOUN
bam-10847	265	5	,	,	PUNCT
bam-10847	265	6	p16	p16	NOUN
bam-10847	265	7	and	and	CCONJ
bam-10847	265	8	htert	htert	NOUN
bam-10847	265	9	in	in	ADP
bam-10847	265	10	oral	oral	ADJ
bam-10847	265	11	squamous	squamous	ADJ
bam-10847	265	12	cell	cell	NOUN
bam-10847	265	13	carcinoma	carcinoma	NOUN
bam-10847	265	14	and	and	CCONJ
bam-10847	265	15	potentially	potentially	ADV
bam-10847	265	16	malignant	malignant	ADJ
bam-10847	265	17	disorders	disorder	NOUN
bam-10847	265	18	.	.	PUNCT
bam-10847	266	1	braz	braz	PROPN
bam-10847	266	2	oral	oral	PROPN
bam-10847	266	3	res	re	NOUN
bam-10847	266	4	.	.	PUNCT
bam-10847	267	1	2011	2011	NUM
bam-10847	267	2	jan	jan	PROPN
bam-10847	267	3	-	-	PUNCT
bam-10847	267	4	feb;25(1):34	feb;25(1):34	PROPN
bam-10847	267	5	-	-	PUNCT
bam-10847	267	6	41	41	NUM
bam-10847	267	7	.	.	PUNCT
bam-10847	268	1	doi	doi	NOUN
bam-10847	268	2	:	:	PUNCT
bam-10847	268	3	10.1590	10.1590	NUM
bam-10847	268	4	/	/	SYM
bam-10847	268	5	s1806	s1806	NOUN
bam-10847	268	6	-	-	NOUN
bam-10847	268	7	83242011000100007	83242011000100007	NUM
bam-10847	268	8	.	.	PUNCT
bam-10847	269	1	pmid	pmid	NOUN
bam-10847	269	2	:	:	PUNCT
bam-10847	269	3	21359449	21359449	NUM
bam-10847	269	4	.	.	PUNCT
bam-10847	270	1	34	34	NUM
bam-10847	270	2	.	.	PUNCT
bam-10847	271	1	fan	fan	PROPN
bam-10847	271	2	cc	cc	PROPN
bam-10847	271	3	,	,	PUNCT
bam-10847	271	4	wang	wang	PROPN
bam-10847	271	5	ty	ty	PROPN
bam-10847	271	6	,	,	PUNCT
bam-10847	271	7	cheng	cheng	PROPN
bam-10847	271	8	ya	ya	PROPN
bam-10847	271	9	,	,	PUNCT
bam-10847	271	10	jiang	jiang	PROPN
bam-10847	271	11	ss	ss	PROPN
bam-10847	271	12	,	,	PUNCT
bam-10847	271	13	cheng	cheng	PROPN
bam-10847	271	14	cw	cw	PROPN
bam-10847	271	15	,	,	PUNCT
bam-10847	271	16	lee	lee	PROPN
bam-10847	271	17	ay	ay	PROPN
bam-10847	271	18	,	,	PUNCT
bam-10847	271	19	kao	kao	PROPN
bam-10847	271	20	ty	ty	INTJ
bam-10847	271	21	.	.	PUNCT
bam-10847	272	1	expression	expression	NOUN
bam-10847	272	2	of	of	ADP
bam-10847	272	3	e	e	NOUN
bam-10847	272	4	-	-	NOUN
bam-10847	272	5	cadherin	cadherin	NOUN
bam-10847	272	6	,	,	PUNCT
bam-10847	272	7	twist	twist	NOUN
bam-10847	272	8	,	,	PUNCT
bam-10847	272	9	and	and	CCONJ
bam-10847	272	10	p53	p53	NOUN
bam-10847	272	11	and	and	CCONJ
bam-10847	272	12	their	their	PRON
bam-10847	272	13	prognostic	prognostic	ADJ
bam-10847	272	14	value	value	NOUN
bam-10847	272	15	in	in	ADP
bam-10847	272	16	patients	patient	NOUN
bam-10847	272	17	with	with	ADP
bam-10847	272	18	oral	oral	ADJ
bam-10847	272	19	squamous	squamous	ADJ
bam-10847	272	20	cell	cell	NOUN
bam-10847	272	21	carcinoma	carcinoma	NOUN
bam-10847	272	22	.	.	PUNCT
bam-10847	273	1	j	j	PROPN
bam-10847	273	2	cancer	cancer	NOUN
bam-10847	273	3	res	re	VERB
bam-10847	273	4	clin	clin	PROPN
bam-10847	273	5	oncol	oncol	PROPN
bam-10847	273	6	.	.	PUNCT
bam-10847	274	1	2013	2013	NUM
bam-10847	274	2	oct;139(10):173544	oct;139(10):173544	PROPN
bam-10847	274	3	.	.	PUNCT
bam-10847	275	1	doi	doi	NOUN
bam-10847	275	2	:	:	PUNCT
bam-10847	276	1	10.1007	10.1007	NUM
bam-10847	276	2	/	/	SYM
bam-10847	276	3	s00432	s00432	NOUN
bam-10847	276	4	-	-	PUNCT
bam-10847	276	5	013	013	NUM
bam-10847	276	6	-	-	PUNCT
bam-10847	276	7	1499	1499	NUM
bam-10847	276	8	-	-	SYM
bam-10847	276	9	9	9	NUM
bam-10847	276	10	.	.	PUNCT
bam-10847	276	11	epub	epub	PROPN
bam-10847	276	12	2013	2013	NUM
bam-10847	276	13	aug	aug	PROPN
bam-10847	276	14	30	30	NUM
bam-10847	276	15	.	.	PUNCT
bam-10847	276	16	35	35	NUM
bam-10847	276	17	.	.	PUNCT
bam-10847	277	1	mneimneh	mneimneh	PROPN
bam-10847	277	2	ws	ws	PROPN
bam-10847	277	3	,	,	PUNCT
bam-10847	277	4	xu	xu	PROPN
bam-10847	278	1	b	b	PROPN
bam-10847	278	2	,	,	PUNCT
bam-10847	278	3	ghossein	ghossein	ADJ
bam-10847	278	4	c	c	NOUN
bam-10847	278	5	,	,	PUNCT
bam-10847	278	6	alzumaili	alzumaili	NOUN
bam-10847	278	7	b	b	PROPN
bam-10847	278	8	,	,	PUNCT
bam-10847	278	9	sethi	sethi	PROPN
bam-10847	278	10	s	s	PROPN
bam-10847	278	11	,	,	PUNCT
bam-10847	278	12	ganly	ganly	PROPN
bam-10847	278	13	i	i	PRON
bam-10847	278	14	,	,	PUNCT
bam-10847	278	15	khimraj	khimraj	VERB
bam-10847	278	16	a	a	PRON
bam-10847	278	17	,	,	PUNCT
bam-10847	278	18	dogan	dogan	PROPN
bam-10847	278	19	s	s	PROPN
bam-10847	278	20	,	,	PUNCT
bam-10847	278	21	katabi	katabi	NOUN
bam-10847	278	22	n.	n.	ADJ
bam-10847	278	23	clinicopathologic	clinicopathologic	ADJ
bam-10847	278	24	characteristics	characteristic	NOUN
bam-10847	278	25	of	of	ADP
bam-10847	278	26	young	young	ADJ
bam-10847	278	27	patients	patient	NOUN
bam-10847	278	28	with	with	ADP
bam-10847	278	29	oral	oral	ADJ
bam-10847	278	30	squamous	squamous	ADJ
bam-10847	278	31	cell	cell	NOUN
bam-10847	278	32	carcinoma	carcinoma	NOUN
bam-10847	278	33	.	.	PUNCT
bam-10847	279	1	head	head	NOUN
bam-10847	279	2	neck	neck	NOUN
bam-10847	279	3	pathol	pathol	NOUN
bam-10847	279	4	.	.	PUNCT
bam-10847	280	1	2021	2021	NUM
bam-10847	280	2	dec;15(4):1099	dec;15(4):1099	PROPN
bam-10847	280	3	-	-	PUNCT
bam-10847	280	4	1108	1108	NUM
bam-10847	280	5	.	.	PUNCT
bam-10847	281	1	doi	doi	NOUN
bam-10847	281	2	:	:	PUNCT
bam-10847	281	3	10.1007	10.1007	NUM
bam-10847	281	4	/	/	SYM
bam-10847	281	5	s12105	s12105	NOUN
bam-10847	281	6	-	-	PUNCT
bam-10847	281	7	021	021	NUM
bam-10847	281	8	-	-	PUNCT
bam-10847	281	9	01320	01320	NUM
bam-10847	281	10	-	-	PUNCT
bam-10847	281	11	w.	w.	NOUN
bam-10847	281	12	epub	epub	PROPN
bam-10847	281	13	2021	2021	NUM
bam-10847	281	14	apr	apr	NOUN
bam-10847	281	15	2	2	NUM
bam-10847	281	16	.	.	NUM
bam-10847	281	17	36	36	NUM
bam-10847	281	18	.	.	X
bam-10847	282	1	santos	santos	PROPN
bam-10847	282	2	hb	hb	PROPN
bam-10847	282	3	,	,	PUNCT
bam-10847	282	4	dos	dos	PROPN
bam-10847	282	5	santos	santos	PROPN
bam-10847	282	6	tk	tk	PROPN
bam-10847	282	7	,	,	PUNCT
bam-10847	282	8	paz	paz	PROPN
bam-10847	282	9	ar	ar	PROPN
bam-10847	282	10	,	,	PUNCT
bam-10847	282	11	cavalcanti	cavalcanti	PROPN
bam-10847	282	12	yw	yw	PROPN
bam-10847	282	13	,	,	PUNCT
bam-10847	282	14	nonaka	nonaka	PROPN
bam-10847	282	15	cf	cf	PROPN
bam-10847	282	16	,	,	PUNCT
bam-10847	282	17	godoy	godoy	PROPN
bam-10847	282	18	gp	gp	PROPN
bam-10847	282	19	,	,	PUNCT
bam-10847	282	20	alves	alves	PROPN
bam-10847	282	21	pm	pm	PROPN
bam-10847	282	22	.	.	PUNCT
bam-10847	283	1	clinical	clinical	ADJ
bam-10847	283	2	findings	finding	NOUN
bam-10847	283	3	and	and	CCONJ
bam-10847	283	4	risk	risk	NOUN
bam-10847	283	5	factors	factor	NOUN
bam-10847	283	6	to	to	PART
bam-10847	283	7	oral	oral	VERB
bam-10847	283	8	squamous	squamous	ADJ
bam-10847	283	9	cell	cell	NOUN
bam-10847	283	10	carcinoma	carcinoma	NOUN
bam-10847	283	11	in	in	ADP
bam-10847	283	12	young	young	ADJ
bam-10847	283	13	patients	patient	NOUN
bam-10847	283	14	:	:	PUNCT
bam-10847	283	15	a	a	DET
bam-10847	283	16	12	12	NUM
bam-10847	283	17	-	-	PUNCT
bam-10847	283	18	year	year	NOUN
bam-10847	283	19	retrospective	retrospective	ADJ
bam-10847	283	20	analysis	analysis	NOUN
bam-10847	283	21	.	.	PUNCT
bam-10847	284	1	med	med	ADJ
bam-10847	284	2	oral	oral	ADJ
bam-10847	284	3	patol	patol	NOUN
bam-10847	284	4	oral	oral	ADJ
bam-10847	284	5	cir	cir	NOUN
bam-10847	284	6	bucal	bucal	NOUN
bam-10847	284	7	.	.	PUNCT
bam-10847	285	1	2016	2016	NUM
bam-10847	285	2	mar	mar	PROPN
bam-10847	285	3	1;21(2):e151	1;21(2):e151	PROPN
bam-10847	285	4	-	-	PUNCT
bam-10847	285	5	6	6	NUM
bam-10847	285	6	.	.	PUNCT
bam-10847	285	7	doi	doi	NOUN
bam-10847	285	8	:	:	PUNCT
bam-10847	285	9	10.4317	10.4317	NUM
bam-10847	285	10	/	/	SYM
bam-10847	285	11	medoral.20770	medoral.20770	NOUN
bam-10847	285	12	.	.	NOUN
bam-10847	285	13	37	37	NUM
bam-10847	285	14	.	.	PUNCT
bam-10847	286	1	mineta	mineta	PROPN
bam-10847	286	2	h	h	PROPN
bam-10847	286	3	,	,	PUNCT
bam-10847	286	4	borg	borg	PROPN
bam-10847	286	5	a	a	PROPN
bam-10847	286	6	,	,	PUNCT
bam-10847	286	7	dictor	dictor	NOUN
bam-10847	286	8	m	m	PROPN
bam-10847	286	9	,	,	PUNCT
bam-10847	286	10	wahlberg	wahlberg	PROPN
bam-10847	286	11	p	p	PROPN
bam-10847	286	12	,	,	PUNCT
bam-10847	286	13	akervall	akervall	PROPN
bam-10847	286	14	j	j	PROPN
bam-10847	286	15	,	,	PUNCT
bam-10847	286	16	wennerberg	wennerberg	PROPN
bam-10847	286	17	j.	j.	PROPN
bam-10847	286	18	p53	p53	PROPN
bam-10847	286	19	mutation	mutation	NOUN
bam-10847	286	20	,	,	PUNCT
bam-10847	286	21	but	but	CCONJ
bam-10847	286	22	not	not	PART
bam-10847	286	23	p53	p53	NOUN
bam-10847	286	24	overexpression	overexpression	NOUN
bam-10847	286	25	,	,	PUNCT
bam-10847	286	26	correlates	correlate	VERB
bam-10847	286	27	with	with	ADP
bam-10847	286	28	survival	survival	NOUN
bam-10847	286	29	in	in	ADP
bam-10847	286	30	head	head	NOUN
bam-10847	286	31	and	and	CCONJ
bam-10847	286	32	neck	neck	VERB
bam-10847	286	33	squamous	squamous	ADJ
bam-10847	286	34	cell	cell	NOUN
bam-10847	286	35	carcinoma	carcinoma	NOUN
bam-10847	286	36	.	.	PUNCT
bam-10847	287	1	br	br	X
bam-10847	287	2	j	j	PROPN
bam-10847	287	3	cancer	cancer	NOUN
bam-10847	287	4	.	.	PUNCT
bam-10847	288	1	1998	1998	NUM
bam-10847	289	1	oct;78(8):1084	oct;78(8):1084	NUM
bam-10847	289	2	-	-	PUNCT
bam-10847	289	3	90	90	NUM
bam-10847	289	4	.	.	PUNCT
bam-10847	290	1	doi	doi	NOUN
bam-10847	290	2	:	:	PUNCT
bam-10847	290	3	10.1038	10.1038	NUM
bam-10847	290	4	/	/	SYM
bam-10847	290	5	bjc.1998.632	bjc.1998.632	PROPN
bam-10847	290	6	.	.	PUNCT
bam-10847	291	1	38	38	NUM
bam-10847	291	2	.	.	PUNCT
bam-10847	291	3	nylander	nylander	PROPN
bam-10847	291	4	k	k	PROPN
bam-10847	291	5	,	,	PUNCT
bam-10847	291	6	stenling	stenle	VERB
bam-10847	291	7	r	r	NOUN
bam-10847	291	8	,	,	PUNCT
bam-10847	291	9	gustafsson	gustafsson	PROPN
bam-10847	291	10	h	h	NOUN
bam-10847	291	11	,	,	PUNCT
bam-10847	291	12	zackrisson	zackrisson	NOUN
bam-10847	291	13	b	b	NOUN
bam-10847	291	14	,	,	PUNCT
bam-10847	291	15	roos	roos	PROPN
bam-10847	291	16	g.	g.	PROPN
bam-10847	291	17	p53	p53	NOUN
bam-10847	291	18	expression	expression	NOUN
bam-10847	291	19	and	and	CCONJ
bam-10847	291	20	cell	cell	NOUN
bam-10847	291	21	proliferation	proliferation	NOUN
bam-10847	291	22	in	in	ADP
bam-10847	291	23	squamous	squamous	ADJ
bam-10847	291	24	cell	cell	NOUN
bam-10847	291	25	carcinomas	carcinoma	NOUN
bam-10847	291	26	of	of	ADP
bam-10847	291	27	the	the	DET
bam-10847	291	28	head	head	NOUN
bam-10847	291	29	and	and	CCONJ
bam-10847	291	30	neck	neck	NOUN
bam-10847	291	31	.	.	PUNCT
bam-10847	292	1	cancer	cancer	NOUN
bam-10847	292	2	.	.	PUNCT
bam-10847	293	1	1995	1995	NUM
bam-10847	293	2	jan	jan	PROPN
bam-10847	293	3	1;75(1):87	1;75(1):87	PROPN
bam-10847	293	4	-	-	PUNCT
bam-10847	293	5	93	93	NUM
bam-10847	293	6	.	.	PUNCT
bam-10847	294	1	doi	doi	NOUN
bam-10847	294	2	:	:	PUNCT
bam-10847	294	3	10.1002/1097	10.1002/1097	NUM
bam-10847	294	4	-	-	SYM
bam-10847	294	5	0142(19950101)75:1<87::aidcncr2820750115>3.0.co;2	0142(19950101)75:1<87::aidcncr2820750115>3.0.co;2	NUM
bam-10847	294	6	-	-	PUNCT
bam-10847	294	7	v.	v.	ADP
bam-10847	294	8	39	39	NUM
bam-10847	294	9	.	.	PUNCT
bam-10847	295	1	perisanidis	perisanidi	NOUN
bam-10847	295	2	c	c	X
bam-10847	295	3	,	,	PUNCT
bam-10847	295	4	perisanidis	perisanidi	NOUN
bam-10847	295	5	b	b	NOUN
bam-10847	295	6	,	,	PUNCT
bam-10847	295	7	wrba	wrba	NOUN
bam-10847	295	8	f	f	NOUN
bam-10847	295	9	,	,	PUNCT
bam-10847	295	10	brandstetter	brandstetter	DET
bam-10847	295	11	a	a	PRON
bam-10847	295	12	,	,	PUNCT
bam-10847	295	13	el	el	PROPN
bam-10847	295	14	gazzar	gazzar	PROPN
bam-10847	295	15	s	s	PROPN
bam-10847	295	16	,	,	PUNCT
bam-10847	295	17	papadogeorgakis	papadogeorgaki	NOUN
bam-10847	295	18	n	n	CCONJ
bam-10847	295	19	,	,	PUNCT
bam-10847	295	20	seemann	seemann	ADJ
bam-10847	295	21	r	r	NOUN
bam-10847	295	22	,	,	PUNCT
bam-10847	295	23	ewers	ewer	NOUN
bam-10847	295	24	r	r	NOUN
bam-10847	295	25	,	,	PUNCT
bam-10847	295	26	kyzas	kyzas	PROPN
bam-10847	295	27	pa	pa	PROPN
bam-10847	295	28	,	,	PUNCT
bam-10847	295	29	filipits	filipit	VERB
bam-10847	295	30	m.	m.	NOUN
bam-10847	295	31	evaluation	evaluation	NOUN
bam-10847	295	32	of	of	ADP
bam-10847	295	33	immunohistochemical	immunohistochemical	ADJ
bam-10847	295	34	expression	expression	NOUN
bam-10847	295	35	of	of	ADP
bam-10847	295	36	p53	p53	NOUN
bam-10847	295	37	,	,	PUNCT
bam-10847	295	38	p21	p21	NOUN
bam-10847	295	39	,	,	PUNCT
bam-10847	295	40	p27	p27	PROPN
bam-10847	295	41	,	,	PUNCT
bam-10847	295	42	cyclin	cyclin	NOUN
bam-10847	295	43	d1	d1	NOUN
bam-10847	295	44	,	,	PUNCT
bam-10847	295	45	and	and	CCONJ
bam-10847	295	46	ki67	ki67	PROPN
bam-10847	295	47	in	in	ADP
bam-10847	295	48	oral	oral	ADJ
bam-10847	295	49	and	and	CCONJ
bam-10847	295	50	oropharyngeal	oropharyngeal	ADJ
bam-10847	295	51	squamous	squamous	ADJ
bam-10847	295	52	cell	cell	NOUN
bam-10847	295	53	carcinoma	carcinoma	NOUN
bam-10847	295	54	.	.	PUNCT
bam-10847	296	1	j	j	PROPN
bam-10847	296	2	oral	oral	ADJ
bam-10847	296	3	pathol	pathol	NOUN
bam-10847	296	4	med	me	VERB
bam-10847	296	5	.	.	PUNCT
bam-10847	297	1	2012	2012	NUM
bam-10847	297	2	jan;41(1):40	jan;41(1):40	PROPN
bam-10847	297	3	-	-	PUNCT
bam-10847	297	4	6	6	NUM
bam-10847	297	5	.	.	PUNCT
bam-10847	297	6	doi	doi	NOUN
bam-10847	297	7	:	:	PUNCT
bam-10847	297	8	10.1111	10.1111	NUM
bam-10847	297	9	/	/	SYM
bam-10847	297	10	j.1600	j.1600	NOUN
bam-10847	297	11	-	-	PUNCT
bam-10847	297	12	0714.2011	0714.2011	NOUN
bam-10847	297	13	.	.	PUNCT
bam-10847	298	1	01071.x	01071.x	NOUN
bam-10847	298	2	.	.	PUNCT
bam-10847	299	1	epub	epub	PROPN
bam-10847	299	2	2011	2011	NUM
bam-10847	299	3	aug	aug	PROPN
bam-10847	299	4	29	29	NUM
bam-10847	299	5	.	.	PUNCT
bam-10847	299	6	40	40	NUM
bam-10847	299	7	.	.	PUNCT
bam-10847	300	1	frank	frank	PROPN
bam-10847	300	2	jl	jl	PROPN
bam-10847	300	3	,	,	PUNCT
bam-10847	300	4	bur	bur	PROPN
bam-10847	300	5	me	me	PROPN
bam-10847	300	6	,	,	PUNCT
bam-10847	300	7	garb	garb	PROPN
bam-10847	300	8	jl	jl	NOUN
bam-10847	300	9	,	,	PUNCT
bam-10847	300	10	kay	kay	PROPN
bam-10847	300	11	s	s	PROPN
bam-10847	300	12	,	,	PUNCT
bam-10847	300	13	ware	ware	VERB
bam-10847	300	14	jl	jl	PROPN
bam-10847	300	15	,	,	PUNCT
bam-10847	300	16	sismanis	sismanis	PROPN
bam-10847	300	17	a	a	PRON
bam-10847	300	18	,	,	PUNCT
bam-10847	300	19	neifeld	neifeld	PROPN
bam-10847	300	20	jp	jp	PROPN
bam-10847	300	21	.	.	PUNCT
bam-10847	300	22	p53	p53	PROPN
bam-10847	300	23	tumor	tumor	NOUN
bam-10847	300	24	suppressor	suppressor	NOUN
bam-10847	300	25	oncogene	oncogene	NOUN
bam-10847	300	26	expression	expression	NOUN
bam-10847	300	27	in	in	ADP
bam-10847	300	28	squamous	squamous	ADJ
bam-10847	300	29	cell	cell	NOUN
bam-10847	300	30	carcinoma	carcinoma	NOUN
bam-10847	300	31	of	of	ADP
bam-10847	300	32	the	the	DET
bam-10847	300	33	hypopharynx	hypopharynx	NOUN
bam-10847	300	34	.	.	PUNCT
bam-10847	301	1	cancer	cancer	NOUN
bam-10847	301	2	.	.	PUNCT
bam-10847	302	1	1994	1994	NUM
bam-10847	302	2	jan	jan	PROPN
bam-10847	302	3	1;73(1):181	1;73(1):181	NUM
bam-10847	302	4	-	-	SYM
bam-10847	302	5	6	6	NUM
bam-10847	302	6	.	.	PUNCT
bam-10847	302	7	doi	doi	NOUN
bam-10847	302	8	:	:	PUNCT
bam-10847	302	9	10.1002/1097	10.1002/1097	NUM
bam-10847	302	10	-	-	SYM
bam-10847	302	11	0142(19940101	0142(19940101	NUM
bam-10847	302	12	)	)	PUNCT
bam-10847	303	1	73:1<181::aid	73:1<181::aid	PROPN
bam-10847	303	2	-	-	PUNCT
bam-10847	303	3	cncr2820730131>3.0.co;2	cncr2820730131>3.0.co;2	NOUN
bam-10847	303	4	-	-	PUNCT
bam-10847	303	5	3	3	NUM
bam-10847	303	6	.	.	NOUN
bam-10847	303	7	41	41	NUM
bam-10847	303	8	.	.	PUNCT
bam-10847	304	1	jalali	jalali	PROPN
bam-10847	304	2	mm	mm	PROPN
bam-10847	304	3	,	,	PUNCT
bam-10847	304	4	heidarzadeh	heidarzadeh	PROPN
bam-10847	304	5	a	a	DET
bam-10847	304	6	,	,	PUNCT
bam-10847	304	7	zavarei	zavarei	NOUN
bam-10847	304	8	mj	mj	PROPN
bam-10847	304	9	,	,	PUNCT
bam-10847	304	10	sarmast	sarmast	PROPN
bam-10847	304	11	h.	h.	PROPN
bam-10847	304	12	p53	p53	NOUN
bam-10847	304	13	overexpression	overexpression	NOUN
bam-10847	304	14	impacts	impact	NOUN
bam-10847	304	15	on	on	ADP
bam-10847	304	16	the	the	DET
bam-10847	304	17	prognosis	prognosis	NOUN
bam-10847	304	18	of	of	ADP
bam-10847	304	19	laryngeal	laryngeal	ADJ
bam-10847	304	20	squamous	squamous	ADJ
bam-10847	304	21	cell	cell	NOUN
bam-10847	304	22	carcinomas	carcinoma	NOUN
bam-10847	304	23	.	.	PUNCT
bam-10847	305	1	asian	asian	PROPN
bam-10847	305	2	pac	pac	PROPN
bam-10847	305	3	j	j	PROPN
bam-10847	305	4	cancer	cancer	NOUN
bam-10847	305	5	prev	prev	X
bam-10847	305	6	.	.	PUNCT
bam-10847	306	1	2011;12(7):1731	2011;12(7):1731	NUM
bam-10847	306	2	-	-	SYM
bam-10847	306	3	4	4	NUM
bam-10847	306	4	.	.	NUM
bam-10847	306	5	42	42	NUM
bam-10847	306	6	.	.	PUNCT
bam-10847	307	1	geisler	geisler	PROPN
bam-10847	307	2	sa	sa	PROPN
bam-10847	307	3	,	,	PUNCT
bam-10847	307	4	olshan	olshan	PROPN
bam-10847	307	5	af	af	PROPN
bam-10847	307	6	,	,	PUNCT
bam-10847	307	7	weissler	weissler	PROPN
bam-10847	307	8	mc	mc	PROPN
bam-10847	307	9	,	,	PUNCT
bam-10847	307	10	cai	cai	PROPN
bam-10847	307	11	j	j	PROPN
bam-10847	307	12	,	,	PUNCT
bam-10847	307	13	funkhouser	funkhouser	PROPN
bam-10847	307	14	wk	wk	PROPN
bam-10847	307	15	,	,	PUNCT
bam-10847	307	16	smith	smith	PROPN
bam-10847	307	17	j	j	PROPN
bam-10847	307	18	,	,	PUNCT
bam-10847	307	19	vick	vick	PROPN
bam-10847	307	20	k.	k.	PROPN
bam-10847	307	21	p16	p16	PROPN
bam-10847	307	22	and	and	CCONJ
bam-10847	307	23	p53	p53	NOUN
bam-10847	307	24	protein	protein	NOUN
bam-10847	307	25	expression	expression	NOUN
bam-10847	307	26	as	as	ADP
bam-10847	307	27	prognostic	prognostic	ADJ
bam-10847	307	28	indicators	indicator	NOUN
bam-10847	307	29	of	of	ADP
bam-10847	307	30	survival	survival	NOUN
bam-10847	307	31	and	and	CCONJ
bam-10847	307	32	disease	disease	NOUN
bam-10847	307	33	recurrence	recurrence	NOUN
bam-10847	307	34	from	from	ADP
bam-10847	307	35	head	head	NOUN
bam-10847	307	36	and	and	CCONJ
bam-10847	307	37	neck	neck	NOUN
bam-10847	307	38	cancer	cancer	NOUN
bam-10847	307	39	.	.	PUNCT
bam-10847	308	1	clin	clin	PROPN
bam-10847	308	2	cancer	cancer	NOUN
bam-10847	308	3	res	re	NOUN
bam-10847	308	4	.	.	PROPN
bam-10847	308	5	2002	2002	NUM
bam-10847	308	6	nov;8(11):3445	nov;8(11):3445	NOUN
bam-10847	308	7	-	-	SYM
bam-10847	308	8	53	53	NUM
bam-10847	308	9	.	.	PUNCT
bam-10847	308	10	43	43	NUM
bam-10847	308	11	.	.	PUNCT
bam-10847	309	1	zhang	zhang	PROPN
bam-10847	309	2	c	c	PROPN
bam-10847	309	3	,	,	PUNCT
bam-10847	309	4	liu	liu	PROPN
bam-10847	309	5	j	j	PROPN
bam-10847	309	6	,	,	PUNCT
bam-10847	309	7	xu	xu	PROPN
bam-10847	310	1	d	d	PROPN
bam-10847	310	2	,	,	PUNCT
bam-10847	310	3	zhang	zhang	PROPN
bam-10847	310	4	t	t	PROPN
bam-10847	310	5	,	,	PUNCT
bam-10847	310	6	hu	hu	PROPN
bam-10847	310	7	w	w	PROPN
bam-10847	310	8	,	,	PUNCT
bam-10847	310	9	feng	feng	PROPN
bam-10847	310	10	z.	z.	PROPN
bam-10847	310	11	gain	gain	PROPN
bam-10847	310	12	-	-	PUNCT
bam-10847	310	13	of	of	ADP
bam-10847	310	14	-	-	PUNCT
bam-10847	310	15	function	function	NOUN
bam-10847	310	16	mutant	mutant	NOUN
bam-10847	310	17	p53	p53	NOUN
bam-10847	310	18	in	in	ADP
bam-10847	310	19	cancer	cancer	NOUN
bam-10847	310	20	progression	progression	NOUN
bam-10847	310	21	and	and	CCONJ
bam-10847	310	22	therapy	therapy	NOUN
bam-10847	310	23	.	.	PUNCT
bam-10847	311	1	j	j	PROPN
bam-10847	311	2	mol	mol	PROPN
bam-10847	311	3	cell	cell	NOUN
bam-10847	311	4	biol	biol	NOUN
bam-10847	311	5	.	.	PUNCT
bam-10847	312	1	2020	2020	NUM
bam-10847	312	2	sep	sep	PROPN
bam-10847	312	3	1;12(9):674	1;12(9):674	NUM
bam-10847	312	4	-	-	SYM
bam-10847	312	5	687	687	NUM
bam-10847	312	6	.	.	PUNCT
bam-10847	313	1	doi	doi	NOUN
bam-10847	313	2	:	:	PUNCT
bam-10847	313	3	10.1093	10.1093	NUM
bam-10847	313	4	/	/	SYM
bam-10847	313	5	jmcb	jmcb	PROPN
bam-10847	313	6	/	/	SYM
bam-10847	313	7	mjaa040	mjaa040	PROPN
bam-10847	313	8	.	.	PROPN
bam-10847	313	9	44	44	NUM
bam-10847	313	10	.	.	PUNCT
bam-10847	314	1	roszkowska	roszkowska	PROPN
bam-10847	314	2	ka	ka	PROPN
bam-10847	314	3	,	,	PUNCT
bam-10847	314	4	gizinski	gizinski	NOUN
bam-10847	314	5	s	s	PROPN
bam-10847	314	6	,	,	PUNCT
bam-10847	314	7	sady	sady	PROPN
bam-10847	314	8	m	m	PROPN
bam-10847	314	9	,	,	PUNCT
bam-10847	314	10	gajewski	gajewski	VERB
bam-10847	314	11	z	z	PROPN
bam-10847	314	12	,	,	PUNCT
bam-10847	314	13	olszewski	olszewski	ADJ
bam-10847	314	14	mb	mb	NOUN
bam-10847	314	15	.	.	PUNCT
bam-10847	314	16	gain	gain	VERB
bam-10847	314	17	-	-	PUNCT
bam-10847	314	18	of	of	ADP
bam-10847	314	19	-	-	PUNCT
bam-10847	314	20	function	function	NOUN
bam-10847	314	21	mutations	mutation	NOUN
bam-10847	314	22	in	in	ADP
bam-10847	314	23	p53	p53	NOUN
bam-10847	314	24	in	in	ADP
bam-10847	314	25	cancer	cancer	NOUN
bam-10847	314	26	invasiveness	invasiveness	NOUN
bam-10847	314	27	and	and	CCONJ
bam-10847	314	28	metastasis	metastasis	NOUN
bam-10847	314	29	.	.	PUNCT
bam-10847	315	1	int	int	PROPN
bam-10847	315	2	j	j	PROPN
bam-10847	315	3	mol	mol	ADP
bam-10847	315	4	sci	sci	PROPN
bam-10847	315	5	.	.	PROPN
bam-10847	315	6	2020	2020	NUM
bam-10847	315	7	feb	feb	PROPN
bam-10847	315	8	17;21(4):1334	17;21(4):1334	NUM
bam-10847	315	9	.	.	PUNCT
bam-10847	316	1	doi	doi	NOUN
bam-10847	316	2	:	:	PUNCT
bam-10847	316	3	10.3390	10.3390	NUM
bam-10847	316	4	/	/	SYM
bam-10847	316	5	ijms21041334	ijms21041334	NOUN
bam-10847	316	6	.	.	PUNCT
bam-10847	317	1	45	45	NUM
bam-10847	317	2	.	.	PUNCT
bam-10847	318	1	chen	chen	PROPN
bam-10847	318	2	y	y	PROPN
bam-10847	318	3	,	,	PUNCT
bam-10847	318	4	xu	xu	PROPN
bam-10847	319	1	l	l	PROPN
bam-10847	319	2	,	,	PUNCT
bam-10847	319	3	massey	massey	PROPN
bam-10847	319	4	l	l	PROPN
bam-10847	319	5	,	,	PUNCT
bam-10847	319	6	zlotolow	zlotolow	PROPN
bam-10847	319	7	i	i	NOUN
bam-10847	319	8	,	,	PUNCT
bam-10847	319	9	huvos	huvos	X
bam-10847	319	10	a	a	NOUN
bam-10847	319	11	,	,	PUNCT
bam-10847	319	12	garinchesa	garinchesa	NOUN
bam-10847	319	13	p	p	NOUN
bam-10847	319	14	,	,	PUNCT
bam-10847	319	15	old	old	ADJ
bam-10847	319	16	l.	l.	PROPN
bam-10847	319	17	frameshift	frameshift	NOUN
bam-10847	319	18	and	and	CCONJ
bam-10847	319	19	nonsense	nonsense	NOUN
bam-10847	319	20	p53	p53	NOUN
bam-10847	319	21	mutations	mutation	NOUN
bam-10847	319	22	in	in	ADP
bam-10847	319	23	squamous	squamous	ADJ
bam-10847	319	24	-	-	PUNCT
bam-10847	319	25	cell	cell	NOUN
bam-10847	319	26	carcinoma	carcinoma	NOUN
bam-10847	319	27	of	of	ADP
bam-10847	319	28	head	head	NOUN
bam-10847	319	29	and	and	CCONJ
bam-10847	319	30	neck	neck	NOUN
bam-10847	319	31	non	non	ADJ
bam-10847	319	32	-	-	NOUN
bam-10847	319	33	reactivity	reactivity	NOUN
bam-10847	319	34	with	with	ADP
bam-10847	319	35	3	3	NUM
bam-10847	319	36	anti	anti	ADJ
bam-10847	319	37	-	-	ADJ
bam-10847	319	38	p53	p53	ADJ
bam-10847	319	39	monoclonalantibodies	monoclonalantibodie	NOUN
bam-10847	319	40	.	.	PUNCT
bam-10847	320	1	int	int	NOUN
bam-10847	320	2	j	j	PROPN
bam-10847	320	3	oncol	oncol	ADJ
bam-10847	320	4	.	.	PUNCT
bam-10847	321	1	1994	1994	NUM
bam-10847	321	2	mar;4(3):609	mar;4(3):609	NOUN
bam-10847	321	3	-	-	SYM
bam-10847	321	4	14	14	NUM
bam-10847	321	5	.	.	PUNCT
bam-10847	322	1	doi	doi	NOUN
bam-10847	322	2	:	:	PUNCT
bam-10847	322	3	10.3892	10.3892	NUM
bam-10847	322	4	/	/	SYM
bam-10847	322	5	ijo.4.3.609	ijo.4.3.609	NOUN
bam-10847	322	6	.	.	PUNCT
bam-10847	323	1	disclaimer	disclaimer	NOUN
bam-10847	323	2	all	all	DET
bam-10847	323	3	claims	claim	NOUN
bam-10847	323	4	expressed	express	VERB
bam-10847	323	5	in	in	ADP
bam-10847	323	6	this	this	DET
bam-10847	323	7	article	article	NOUN
bam-10847	323	8	are	be	AUX
bam-10847	323	9	solely	solely	ADV
bam-10847	323	10	those	those	PRON
bam-10847	323	11	of	of	ADP
bam-10847	323	12	the	the	DET
bam-10847	323	13	authors	author	NOUN
bam-10847	323	14	and	and	CCONJ
bam-10847	323	15	do	do	AUX
bam-10847	323	16	not	not	PART
bam-10847	323	17	necessarily	necessarily	ADV
bam-10847	323	18	represent	represent	VERB
bam-10847	323	19	those	those	PRON
bam-10847	323	20	of	of	ADP
bam-10847	323	21	their	their	PRON
bam-10847	323	22	affiliated	affiliated	ADJ
bam-10847	323	23	organizations	organization	NOUN
bam-10847	323	24	,	,	PUNCT
bam-10847	323	25	or	or	CCONJ
bam-10847	323	26	those	those	PRON
bam-10847	323	27	of	of	ADP
bam-10847	323	28	the	the	DET
bam-10847	323	29	publisher	publisher	NOUN
bam-10847	323	30	,	,	PUNCT
bam-10847	323	31	the	the	DET
bam-10847	323	32	editors	editor	NOUN
bam-10847	323	33	and	and	CCONJ
bam-10847	323	34	the	the	DET
bam-10847	323	35	reviewers	reviewer	NOUN
bam-10847	323	36	.	.	PUNCT
bam-10847	324	1	any	any	DET
bam-10847	324	2	product	product	NOUN
bam-10847	324	3	that	that	PRON
bam-10847	324	4	may	may	AUX
bam-10847	324	5	be	be	AUX
bam-10847	324	6	evaluated	evaluate	VERB
bam-10847	324	7	in	in	ADP
bam-10847	324	8	this	this	DET
bam-10847	324	9	article	article	NOUN
bam-10847	324	10	or	or	CCONJ
bam-10847	324	11	claim	claim	NOUN
bam-10847	324	12	that	that	PRON
bam-10847	324	13	may	may	AUX
bam-10847	324	14	be	be	AUX
bam-10847	324	15	made	make	VERB
bam-10847	324	16	by	by	ADP
bam-10847	324	17	its	its	PRON
bam-10847	324	18	manufacturer	manufacturer	NOUN
bam-10847	324	19	is	be	AUX
bam-10847	324	20	not	not	PART
bam-10847	324	21	guaranteed	guarantee	VERB
bam-10847	324	22	or	or	CCONJ
bam-10847	324	23	endorsed	endorse	VERB
bam-10847	324	24	by	by	ADP
bam-10847	324	25	the	the	DET
bam-10847	324	26	publisher	publisher	NOUN
bam-10847	324	27	.	.	PUNCT
bam-10847	325	1	submission	submission	NOUN
bam-10847	325	2	:	:	PUNCT
bam-10847	325	3	july	july	PROPN
bam-10847	325	4	7	7	NUM
bam-10847	325	5	,	,	PUNCT
bam-10847	325	6	2022	2022	NUM
bam-10847	325	7	revision	revision	NOUN
bam-10847	325	8	received	receive	VERB
bam-10847	325	9	:	:	PUNCT
bam-10847	325	10	october	october	PROPN
bam-10847	325	11	10	10	NUM
bam-10847	325	12	,	,	PUNCT
bam-10847	325	13	2022	2022	NUM
bam-10847	325	14	accepted	accept	VERB
bam-10847	325	15	for	for	ADP
bam-10847	325	16	publication	publication	NOUN
bam-10847	325	17	:	:	PUNCT
bam-10847	325	18	october	october	PROPN
bam-10847	325	19	10	10	NUM
bam-10847	325	20	,	,	PUNCT
bam-10847	325	21	2022	2022	NUM
bam-10847	325	22	non	non	ADJ
bam-10847	325	23	-co	-co	PROPN
bam-10847	325	24	mmerc	mmerc	PROPN
bam-10847	325	25	ial	ial	PROPN
bam-10847	325	26	us	us	PROPN
bam-10847	325	27	e	e	NOUN
bam-10847	325	28	o	o	NOUN
bam-10847	325	29	nly	nly	ADV
bam-10847	325	30	results	result	VERB